Number	NNP	O	O
of	IN	O	O
in	IN	O	O
and	CC	O	O
their	PRP$	O	O
sensitivity	NN	O	O
to	TO	O	O
hormone	NN	O	O
human	JJ	B-DNA	B-DNA
interleukin-2	CD	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
action	NN	O	O
.	.	O	O
messenger	NN	B-RNA	B-RNA
RNA	NNP	I-RNA	I-RNA
The	DT	O	O
study	NN	O	O
B	NNP	B-cell_line	B-cell_line
or	CC	I-cell_line	O
HeLa	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
demonstrated	VBN	O	O
a	DT	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
decreased	VBN	O	O
level	NN	O	O
glucocorticoid	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
of	IN	O	O
(	(	O	O
human	JJ	B-DNA	B-DNA
interleukin-2	CD	I-DNA	I-DNA
(	(	I-DNA	I-DNA
IL-2	CD	I-DNA	I-DNA
)	)	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
)	)	O	O
in	IN	O	O
estrogen	NN	B-RNA	B-RNA
receptor	NN	I-RNA	I-RNA
(	(	I-RNA	I-RNA
ER	NNP	I-RNA	I-RNA
)	)	I-RNA	I-RNA
transcripts	NNS	I-RNA	I-RNA
from	IN	O	O
hypercholesterolemic	JJ	O	O
B-cell	NN	B-cell_line	B-cell_line
line	NN	I-cell_line	I-cell_line
subjects	NNS	O	O
","		O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
and	CC	O	O
an	DT	O	O
glucocorticoid	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
elevated	VBN	O	O
level	NN	O	O
IL-2	CD	B-DNA	B-DNA
receptor	NN	I-DNA	I-DNA
alpha	NN	I-DNA	I-DNA
(	(	I-DNA	I-DNA
IL-2R	CD	I-DNA	I-DNA
alpha	NN	I-DNA	I-DNA
)	)	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
in	IN	O	O
patients	NNS	O	O
ER	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
with	IN	O	O
acute	NN	O	O
BJA-B	NN	B-cell_line	B-cell_line
myocardial	JJ	O	O
infarction	NN	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
.	.	O	O
In	IN	O	O
GR	NNP	B-protein	B-protein
the	DT	O	O
with	IN	O	O
kappa	NN	B-DNA	B-DNA
B	NNP	I-DNA	I-DNA
core	NN	I-DNA	I-DNA
sequence	NN	I-DNA	I-DNA
a	DT	O	O
high	RB	O	O
ER	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
number	NN	O	O
","		O	O
HeLa	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
dexamethasone	NN	O	O
inhibited	VBN	O	O
control	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
[	LS	O	O
3H	CD	O	O
GR	NNP	B-protein	B-protein
]	LS	O	O
#NAME?	# NAME	O	O
IL-2	CD	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
and	CC	O	O
[	LS	O	O
human	JJ	B-RNA	B-RNA
ER	NNP	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
3H	CD	O	O
]	LS	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
#NAME?	# NAME	O	O
incorporation	NN	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
into	IN	O	O
DNA	NN	O	O
GR	NNP	B-protein	B-protein
and	CC	O	O
cholesterol	NN	O	O
IL-2R	CD	B-DNA	B-DNA
alpha	NN	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
","		O	O
respectively	RB	O	O
ER	NNP	B-RNA	B-RNA
transcripts	NNS	I-RNA	I-RNA
","		O	O
in	IN	O	O
human	JJ	B-cell_line	B-cell_line
IM-9	CD	I-cell_line	I-cell_line
lymphocytes	NNS	I-cell_line	I-cell_line
the	DT	O	O
same	JJ	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
manner	NN	O	O
as	IN	O	O
GR	NNP	B-protein	B-protein
in	IN	O	O
the	DT	O	O
V	NNP	B-DNA	B-DNA
kappa	NN	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
.	.	O	O
On	IN	O	O
ER	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
the	DT	O	O
other	JJ	O	O
human	JJ	B-cell_line	B-cell_line
lymphoblastoid	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
hand	NN	O	O
","		O	O
T-	:	B-cell_type	B-cell_type
and	CC	I-cell_type	O
B-lymphocyte	NN	I-cell_type	I-cell_type
a	DT	O	O
decreased	VBN	O	O
1	CD	B-protein	B-protein
","		I-protein	I-protein
25-Dihydroxyvitamin	JJ	I-protein	I-protein
D3	CD	I-protein	I-protein
receptors	NNS	I-protein	I-protein
number	NN	O	O
resulted	VBD	O	O
immunoglobulin	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
in	IN	O	O
a	DT	O	O
AML1/ETO	ETO	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
less	JJR	O	O
efficient	JJ	O	O
IM-9	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
dexamethasone	NN	O	O
inhibition	NN	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
of	IN	O	O
the	DT	O	O
receptors	NNS	B-protein	B-protein
incorporation	NN	O	O
of	IN	O	O
immunoglobulin	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
labeled	VBN	O	O
compounds	NNS	O	O
PML/RAR	RAR	B-RNA	O
alpha	NN	I-RNA	I-RNA
transcript	VB	I-RNA	O
.	.	O	O
These	DT	O	O
human	JJ	B-cell_line	B-cell_line
IM-9	CD	I-cell_line	I-cell_line
lymphocyte	NN	I-cell_line	I-cell_line
data	NNS	O	O
showed	VBD	O	O
T	NNP	B-cell_type	B-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
that	IN	O	O
the	DT	O	O
receptors	NNS	B-protein	B-protein
sensitivity	NN	O	O
of	IN	O	O
unrearranged	JJ	B-DNA	B-DNA
human	JJ	I-DNA	I-DNA
variable	JJ	I-DNA	I-DNA
region	NN	I-DNA	I-DNA
to	TO	O	O
glucocorticoids	NNS	O	O
AML1/ETO	ETO	B-RNA	B-RNA
transcript	VB	I-RNA	O
changed	VBN	O	O
only	RB	O	O
mutant	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
with	IN	O	O
a	DT	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
decrease	NN	O	O
of	IN	O	O
beta-2-microglobulin	CD	B-protein	B-protein
level	NN	O	O
.	.	O	O
immunoglobulin	NN	B-DNA	B-DNA
kappa	NN	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
[	LS	O	O
in	IN	O	O
transcripts	NNS	B-RNA	B-RNA
and	CC	O	O
count	NN	O	O
mutant	JJ	B-cell_line	B-cell_line
line	NN	I-cell_line	I-cell_line
in	IN	O	O
patients	NNS	O	O
T	NNP	B-cell_type	B-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
with	IN	O	O
glomerulonephritis	NN	O	O
beta	NNS	B-protein	B-protein
2-M	CD	I-protein	I-protein
]	LS	O	O
Content	NNP	O	O
V	NNP	B-DNA	B-DNA
kappa	NN	I-DNA	I-DNA
of	IN	O	O
receptors	NNS	O	O
mRNA	NN	B-RNA	B-RNA
to	TO	O	O
hormonal	JJ	O	O
RJ2.2.5	CD	B-cell_line	B-cell_line
form	NN	O	O
of	IN	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
vitamin	NN	O	O
D3	CD	O	O
beta	NNS	B-protein	B-protein
2-M	CD	I-protein	I-protein
","		O	O
1.25	CD	O	O
V	NNP	B-DNA	B-DNA
kappa	NN	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
(	(	O	O
OH	NNP	O	O
PCD/DCoH	DCoH	B-RNA	O
mRNA	NN	I-RNA	I-RNA
)	)	O	O
2D3	CD	O	O
mutant	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
","		O	O
constituted	VBN	O	O
tumor	NN	B-cell_type	B-cell_type
27.3	CD	O	O
fmole/mg	mg	O	O
tumor	NN	B-protein	B-protein
beta	NNS	I-protein	I-protein
2-M	CD	I-protein	I-protein
of	IN	O	O
protein	NN	O	O
immunoglobulin	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
in	IN	O	O
of	IN	O	O
5.4-kilobase	JJ	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
peripheric	JJ	O	O
blood	NN	O	O
Epstein-Barr	NN	B-cell_line	B-cell_line
virus-transformed	JJ	I-cell_line	I-cell_line
lymphocytes	NNS	I-cell_line	I-cell_line
of	IN	O	O
children	NNS	O	O
breast	NN	B-cell_type	B-cell_type
carcinomas	NNS	I-cell_type	I-cell_type
with	IN	O	O
glomerulonephritis	NN	O	O
beta	NNS	B-protein	B-protein
2-M	CD	I-protein	I-protein
.	.	O	O
In	IN	O	O
immunoglobulin	NN	B-DNA	B-DNA
heavy-chain	NN	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
the	DT	O	O
patients	NNS	O	O
5	CD	B-RNA	B-RNA
'	''	I-RNA	I-RNA
end	VB	I-RNA	O
concentration	NN	O	O
of	IN	O	O
cultured	VBN	B-cell_line	O
fibroblasts	NNS	I-cell_line	I-cell_line
total	NN	O	O
and	CC	O	O
malignant	JJ	B-cell_type	B-cell_type
tumors	NNS	I-cell_type	I-cell_type
ionized	VBN	O	O
form	NN	O	O
tumor	NN	B-protein	B-protein
beta	NNS	I-protein	I-protein
2-M	CD	I-protein	I-protein
of	IN	O	O
Ca2+	CD	O	O
octanucleotide	NN	B-DNA	B-DNA
(	(	I-DNA	I-DNA
OCTA	NNP	I-DNA	I-DNA
)	)	I-DNA	I-DNA
element	NN	I-DNA	I-DNA
was	VBD	O	O
decreased	VBN	O	O
RNA	NNP	B-RNA	B-RNA
down	RB	O	O
to	TO	O	O
Epstein-Barr	NN	B-cell_line	B-cell_line
virus-transformed	JJ	I-cell_line	I-cell_line
lymphocytes	NNS	I-cell_line	I-cell_line
2.04	CD	O	O
mmole/L	L	O	O
T	NNP	B-cell_type	B-cell_type
cell	NN	I-cell_type	I-cell_type
and	CC	O	O
1.09	CD	O	O
Beta	NN	B-protein	B-protein
2-M	CD	I-protein	I-protein
mmole/L	L	O	O
","		O	O
RNA	NNP	B-DNA	B-DNA
polymerase	NN	I-DNA	I-DNA
II	NNP	I-DNA	I-DNA
promoters	NNS	I-DNA	I-DNA
respectively	RB	O	O
","		O	O
human	JJ	B-RNA	B-RNA
retinoid	NN	I-RNA	I-RNA
receptor	NN	I-RNA	I-RNA
RXRalpha	NNP	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
while	IN	O	O
an	DT	O	O
transformed	VBN	B-cell_line	O
cells	NNS	I-cell_line	I-cell_line
increase	NN	O	O
in	IN	O	O
T	NNP	B-cell_type	B-cell_type
cell	NN	I-cell_type	I-cell_type
parathormone	NN	O	O
(	(	O	O
beta	NNS	B-protein	B-protein
2-M	CD	I-protein	I-protein
PTH	NNP	O	O
)	)	O	O
OCTA	NNP	B-DNA	B-DNA
element	NN	I-DNA	I-DNA
by	IN	O	O
36	CD	O	O
3	CD	B-RNA	B-RNA
'	''	I-RNA	I-RNA
end	VB	I-RNA	O
%	NN	O	O
and	CC	O	O
lymphocyte	NN	B-cell_line	B-cell_line
line	NN	I-cell_line	I-cell_line
a	DT	O	O
distinct	JJ	O	O
human	JJ	B-cell_type	B-cell_type
lymphoid	NN	I-cell_type	I-cell_type
neoplasms	NNS	I-cell_type	I-cell_type
decrease	NN	O	O
in	IN	O	O
serum	NN	B-protein	B-protein
beta	NNS	I-protein	I-protein
2-M	CD	I-protein	I-protein
25	CD	O	O
(	(	O	O
Ig	NNP	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
OH	NNP	O	O
)	)	O	O
RXRalpha	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
D	NNP	O	O
concentration	NN	O	O
cloned	VBN	B-cell_line	O
murine	NN	I-cell_line	I-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
(	(	O	O
lower	JJR	O	O
B-cell	NN	B-cell_type	B-cell_type
than	IN	O	O
1.25	CD	O	O
free-form	JJ	B-protein	B-protein
E	VB	I-protein	I-protein
receptor	NN	I-protein	I-protein
ng/ml	ml	O	O
)	)	O	O
OCTA	NNP	B-DNA	B-DNA
element	NN	I-DNA	I-DNA
was	VBD	O	O
found	VBN	O	O
RXRalpha	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
in	IN	O	O
blood	NN	O	O
cytotoxic	NN	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
(	(	I-cell_line	I-cell_line
CTL	NNP	I-cell_line	I-cell_line
)	)	I-cell_line	I-cell_line
clones	NNS	I-cell_line	I-cell_line
;	:	O	O
content	NN	O	O
B-cell	NN	B-cell_type	B-cell_type
neoplasms	NNS	I-cell_type	I-cell_type
of	IN	O	O
cAMP	NN	O	O
free	JJ	B-protein	B-protein
form	NN	I-protein	I-protein
E	VB	I-protein	I-protein
receptor	NN	I-protein	I-protein
was	VBD	O	O
also	RB	O	O
Ig	NNP	B-DNA	B-DNA
promoters	NNS	I-DNA	I-DNA
decreased	VBN	O	O
in	IN	O	O
RXRalpha	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
lymphocytes	NNS	O	O
by	IN	O	O
IL	NNP	B-cell_line	B-cell_line
2-depleted	JJ	I-cell_line	I-cell_line
cultures	NNS	I-cell_line	I-cell_line
33	CD	O	O
%	NN	O	O
B-cell	NN	B-cell_type	B-cell_type
.	.	O	O
At	IN	O	O
sE	NN	B-protein	B-protein
the	DT	O	O
same	JJ	O	O
Ig	NNP	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
time	NN	O	O
","		O	O
tissue	NN	B-RNA	B-RNA
factor	NN	I-RNA	I-RNA
transcripts	NNS	I-RNA	I-RNA
total	NN	O	O
content	NN	O	O
CTL	NNP	B-cell_line	B-cell_line
of	IN	O	O
was	VBD	O	O
human	JJ	B-cell_type	B-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
decreased	VBN	O	O
1.5-fold	RB	O	O
sE	NN	B-protein	B-protein
in	IN	O	O
peripheric	JJ	O	O
Ig	NNP	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
blood	NN	O	O
.	.	O	O
IL-4	CD	B-RNA	B-RNA
and	CC	I-RNA	O
IL-10	CD	I-RNA	I-RNA
transcripts	NNS	I-RNA	I-RNA
Treatment	NN	O	O
with	IN	O	O
CTL	NNP	B-cell_line	B-cell_line
I-hydroxyvitamin	JJ	O	O
D3	CD	O	O
lymphocyte	NN	B-cell_type	B-cell_type
(	(	O	O
1-1.5	CD	O	O
Kappa	NNP	B-protein	B-protein
B-specific	JJ	I-protein	I-protein
DNA	NN	I-protein	I-protein
binding	VBG	I-protein	I-protein
proteins	NNS	I-protein	I-protein
mg	NN	O	O
daily	RB	O	O
Ig	NNP	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
","		O	O
within	IN	O	O
TNF-alpha	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
4	CD	O	O
weeks	NNS	O	O
CTL	NNP	B-cell_line	B-cell_line
clones	NNS	I-cell_line	I-cell_line
)	)	O	O
led	VBN	O	O
B-cell	NN	B-cell_type	B-cell_type
to	TO	O	O
normalization	NN	O	O
kappa	NN	B-protein	B-protein
B-like	JJ	I-protein	I-protein
enhancer	NN	I-protein	I-protein
element	NN	I-protein	I-protein
of	IN	O	O
total	NN	O	O
Ig	NNP	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
and	CC	O	O
ionized	VBN	O	O
CRABP	NNP	B-RNA	B-RNA
II	NNP	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
form	NN	O	O
of	IN	O	O
Namalwa	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
Ca2+	CD	O	O
and	CC	O	O
B	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
of	IN	O	O
25	CD	O	O
transcription	NN	B-protein	B-protein
unit	NN	I-protein	I-protein
(	(	O	O
OH	NNP	O	O
snRNA	NN	B-DNA	B-DNA
promoters	NNS	I-DNA	I-DNA
)	)	O	O
D	NNP	O	O
cytokine	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
","		O	O
but	CC	O	O
human	JJ	B-cell_line	B-cell_line
Burkitt	NNP	I-cell_line	I-cell_line
lymphoma	NN	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
did	VBD	O	O
not	RB	O	O
B-cell	NN	B-cell_type	B-cell_type
affect	VB	O	O
the	DT	O	O
inducible	JJ	B-protein	B-protein
cellular	JJ	I-protein	I-protein
factors	NNS	I-protein	I-protein
PTH	NNP	O	O
content	NN	O	O
OCTA	NNP	B-DNA	B-DNA
element	NN	I-DNA	I-DNA
in	IN	O	O
blood	NN	O	O
cytokine	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
.	.	O	O
Concentration	NN	O	O
skin	NN	B-cell_line	B-cell_line
fibroblasts	NNS	I-cell_line	I-cell_line
of	IN	O	O
the	DT	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
to	TO	O	O
1.25	CD	O	O
kappa	NN	B-protein	B-protein
B-specific	JJ	I-protein	I-protein
proteins	NNS	I-protein	I-protein
(	(	O	O
OH	NNP	O	O
promoters	NNS	B-DNA	B-DNA
)	)	O	O
2D3	CD	O	O
differentiation	NN	B-RNA	B-RNA
inhibitory	NN	I-RNA	I-RNA
factor	NN	I-RNA	I-RNA
nm23	CD	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
was	VBD	O	O
elevated	VBN	O	O
cultured	VBN	B-cell_line	O
skin	NN	I-cell_line	I-cell_line
fibroblasts	NNS	I-cell_line	I-cell_line
up	RB	O	O
to	TO	O	O
T	NNP	B-cell_type	B-cell_type
cell	NN	I-cell_type	I-cell_type
39.7	CD	O	O
fmole/mg	mg	O	O
kappa	NN	B-protein	B-protein
B	NNP	I-protein	I-protein
enhancer	NN	I-protein	I-protein
after	IN	O	O
I	PRP	O	O
early	RB	B-DNA	O
T	NNP	I-DNA	I-DNA
cell	NN	I-DNA	I-DNA
activation	NN	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
week	NN	O	O
of	IN	O	O
nm23	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
the	DT	O	O
treatment	NN	O	O
cultured	VBN	B-cell_line	O
skin	NN	I-cell_line	I-cell_line
fibroblasts	NNS	I-cell_line	I-cell_line
","		O	O
whereas	NNS	O	O
antigen	NN	B-cell_type	B-cell_type
receptor-activated	JJ	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
it	PRP	O	O
was	VBD	O	O
kappa	NN	B-protein	B-protein
B-specific	JJ	I-protein	I-protein
proteins	NNS	I-protein	I-protein
decreased	VBN	O	O
to	TO	O	O
early	RB	B-DNA	O
T	NNP	I-DNA	I-DNA
cell	NN	I-DNA	I-DNA
activation	NN	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
the	DT	O	O
initial	JJ	O	O
nm23-H1	NN	B-RNA	B-RNA
and	CC	I-RNA	O
0	CD	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
level	NN	O	O
24.8	CD	O	O
cultured	VBN	B-cell_line	O
skin	NN	I-cell_line	I-cell_line
fibroblasts	NNS	I-cell_line	I-cell_line
fmole/mg	mg	O	O
within	IN	O	O
CD4+	CD	B-cell_type	B-cell_type
T-cell	NNP	I-cell_type	I-cell_type
lines	NNS	I-cell_type	I-cell_type
4	CD	O	O
weeks	NNS	O	O
Immunoglobulin	NNP	B-protein	B-protein
gene-specific	JJ	I-protein	I-protein
transacting	VBG	I-protein	I-protein
factors	NNS	I-protein	I-protein
;	:	O	O
simultaneous	JJ	O	O
IL-2	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
alteration	NN	O	O
in	IN	O	O
nm23-H1	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
the	DT	O	O
cAMP	NN	O	O
GR	NNP	B-cell_line	B-cell_line
complex	NN	I-cell_line	I-cell_line
activation	NN	I-cell_line	I-cell_line
content	NN	O	O
was	VBD	O	O
B-cell	NN	B-cell_type	B-cell_type
observed	VBN	O	O
in	IN	O	O
glucocorticoids	NNS	B-protein	B-protein
.	.	O	O
Treatment	NN	O	O
IL-2	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
with	IN	O	O
1-	CD	O	O
nm23-H1	NN	B-RNA	B-RNA
and	CC	I-RNA	O
0	CD	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
(	(	O	O
OH	NNP	O	O
DEAE-cellulose	JJ	B-cell_line	B-cell_line
chromatography	NN	I-cell_line	I-cell_line
)	)	O	O
D3	CD	O	O
non-lymphoid	JJ	B-cell_type	B-cell_type
cell	NN	I-cell_type	I-cell_type
lines	NNS	I-cell_type	I-cell_type
normalized	VBN	O	O
also	RB	O	O
glucocorticoid	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
the	DT	O	O
content	NN	O	O
long	RB	B-DNA	O
terminal	NN	I-DNA	I-DNA
repeat	VB	I-DNA	O
in	IN	O	O
peripheric	JJ	O	O
Tk	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
blood	NN	O	O
.	.	O	O
T	NNP	B-cell_line	B-cell_line
lymphocytes	NNS	I-cell_line	I-cell_line
from	IN	I-cell_line	O
a	DT	I-cell_line	O
line	NN	I-cell_line	I-cell_line
(	(	I-cell_line	I-cell_line
S-LB1	CD	I-cell_line	I-cell_line
)	)	I-cell_line	I-cell_line
transformed	VBN	I-cell_line	O
with	IN	I-cell_line	O
human	JJ	I-cell_line	I-cell_line
T	NNP	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lymphotropic	NN	I-cell_line	I-cell_line
virus	NN	I-cell_line	I-cell_line
1	CD	I-cell_line	I-cell_line
The	DT	O	O
data	NNS	O	O
T-cell	NNP	B-cell_type	B-cell_type
obtained	VBN	O	O
suggest	JJS	O	O
hormone	NN	B-protein	B-protein
that	IN	O	O
under	IN	O	O
LTR	NNP	B-DNA	B-DNA
conditions	NNS	O	O
of	IN	O	O
c-myb	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
glomerulonephritis	NN	O	O
only	RB	O	O
HTLV-1	CD	B-cell_line	B-cell_line
transformed	VBN	I-cell_line	O
T	NNP	I-cell_line	I-cell_line
lymphocyte	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
high	RB	O	O
content	NN	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
of	IN	O	O
to	TO	O	O
hormone	NN	B-protein	B-protein
1.25	CD	O	O
(	(	O	O
LTR	NNP	B-DNA	B-DNA
OH	NNP	O	O
)	)	O	O
TNF-alpha-induced	VBN	B-RNA	O
MCP-1	CD	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
2D3	CD	O	O
in	IN	O	O
Ab-VDR	NNP	B-cell_line	B-cell_line
enabled	VBN	O	O
to	TO	O	O
B-lymphoblastoid	JJ	B-cell_type	B-cell_type
cell	NN	I-cell_type	I-cell_type
lines	NNS	I-cell_type	I-cell_type
perform	VB	O	O
the	DT	O	O
hormone	NN	B-protein	B-protein
cell	NN	O	O
response	NN	O	O
binding	VBG	B-DNA	B-DNA
site	NN	I-DNA	I-DNA
to	TO	O	O
the	DT	O	O
adhesion	NN	B-RNA	B-RNA
molecule	NN	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
hormone	NN	O	O
effect	NN	O	O
K	NNP	B-cell_line	B-cell_line
562	CD	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
.	.	O	O
Tumor	NN	O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
and	CC	O	O
serum	NN	O	O
corticosteroid	NN	B-protein	B-protein
beta-2-microglobulin	CD	O	O
expression	NN	O	O
3'-silencer	CD	B-DNA	B-DNA
in	IN	O	O
women	NNS	O	O
E-selectin-specific	JJ	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
with	IN	O	O
breast	NN	O	O
human	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
cancer	NN	O	O
.	.	O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
polymorphonuclear	JJ	I-cell_type	I-cell_type
leukocyte	NN	I-cell_type	I-cell_type
To	TO	O	O
investigate	NN	O	O
Octamer-binding	JJ	B-protein	B-protein
proteins	NNS	I-protein	I-protein
whether	IN	O	O
the	DT	O	O
CD4+	CD	B-DNA	B-DNA
T-cell	NNP	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
Rpt-1	CD	I-DNA	I-DNA
expression	NN	O	O
of	IN	O	O
E-selectin	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
(	(	O	O
)	)	O	O
B	NNP	B-cell_line	B-cell_line
lymphoid	NN	I-cell_line	I-cell_line
and	CC	I-cell_line	O
non-lymphoid	JJ	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
could	MD	O	O
serve	VB	O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
lymphocyte	NN	I-cell_type	I-cell_type
as	IN	O	O
a	DT	O	O
immunoglobulin	NN	B-protein	B-protein
marker	NN	O	O
of	IN	O	O
CD4+	CD	B-DNA	B-DNA
T-cell	NNP	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
Rpt-1	CD	I-DNA	I-DNA
tumor	NN	O	O
biologic	NN	O	O
SRA	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
behavior	NN	O	O
","		O	O
HeLa	NNP	B-cell_line	B-cell_line
the	DT	O	O
authors	NNS	O	O
polymorphonuclear	JJ	B-cell_type	B-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
studied	VBN	O	O
specimens	NNS	O	O
Ig	NNP	B-protein	B-protein
of	IN	O	O
from	IN	O	O
silencer	NN	B-DNA	B-DNA
element	NN	I-DNA	I-DNA
60	CD	O	O
consecutive	JJ	O	O
MCP-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
female	NN	O	O
patients	NNS	O	O
CESS	NNS	B-cell_line	B-cell_line
.	.	O	O
Presence	NN	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
of	IN	O	O
was	VBD	O	O
nuclear	JJ	B-protein	B-protein
proteins	NNS	I-protein	I-protein
analyzed	VBN	O	O
by	IN	O	O
heterologous	JJ	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
immunohistochemistry	NN	O	O
.	.	O	O
MCP-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
No	DT	O	O
significant	JJ	O	O
Epstein-Barr	NN	B-cell_line	B-cell_line
virus-transformed	JJ	I-cell_line	I-cell_line
human	JJ	I-cell_line	I-cell_line
B	NNP	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
correlations	NNS	O	O
were	VBD	O	O
polymorphonuclear	JJ	B-cell_type	B-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
found	VBN	O	O
between	IN	O	O
NF-A1	CD	B-protein	B-protein
expression	NN	O	O
and	CC	O	O
silencer	NN	B-DNA	B-DNA
several	JJ	O	O
histologic	NN	O	O
MCP-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
attributes	NNS	O	O
such	JJ	O	O
MT-1	CD	B-cell_line	B-cell_line
as	IN	O	O
type	NN	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
","		O	O
histologic	NN	O	O
NF-A2	CD	B-protein	B-protein
and	CC	O	O
nuclear	JJ	O	O
HIV-1	CD	B-DNA	B-DNA
grades	NNS	O	O
","		O	O
TNF-alpha	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
mitotic	JJ	O	O
index	NN	O	O
HTLV-I-infected	JJ	B-cell_line	B-cell_line
human	JJ	I-cell_line	I-cell_line
T	NNP	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
","		O	O
necrosis	NN	O	O
polymorphonuclear	JJ	B-cell_type	B-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
","		O	O
vascular	JJ	O	O
NF-A2	CD	B-protein	B-protein
invasion	NN	O	O
","		O	O
silencer	NN	B-DNA	B-DNA
element	NN	I-DNA	I-DNA
and	CC	O	O
lymphocytic	JJ	O	O
TNF-alpha	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
infiltration	NN	O	O
.	.	O	O
MT-2	CD	B-cell_line	B-cell_line
Likewise	RB	O	O
","		O	O
polymorphonuclear	JJ	B-cell_type	B-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
was	VBD	O	O
not	RB	O	O
NF-A1	CD	B-protein	B-protein
associated	VBN	O	O
with	IN	O	O
transcriptional	JJ	B-DNA	B-DNA
silencer	NN	I-DNA	I-DNA
element	NN	I-DNA	I-DNA
markers	NNS	O	O
of	IN	O	O
PPAR-alpha	NN	B-RNA	B-RNA
and	CC	I-RNA	O
#NAME?	# NAME	I-RNA	O
disease	NN	O	O
extension	NN	O	O
HTLV-I-infected	JJ	B-cell_line	B-cell_line
human	JJ	I-cell_line	I-cell_line
T	NNP	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
such	JJ	O	O
as	IN	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
TNM	NNP	O	O
","		O	O
NF-A2	CD	B-protein	B-protein
(	(	O	O
UICC	NNP	O	O
HLA	NNP	B-DNA	B-DNA
class	NN	I-DNA	I-DNA
II	NNP	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
","		O	O
classification	NN	O	O
OBF-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
of	IN	O	O
)	)	O	O
MT-2	CD	B-cell_line	B-cell_line
staging	VBG	O	O
and	CC	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
axillary	NN	O	O
lymph	NN	O	O
OCTA-binding	JJ	B-protein	B-protein
factor	NN	I-protein	I-protein
NF-A1	CD	I-protein	I-protein
node	RB	O	O
involvement	NN	O	O
class	NN	B-DNA	B-DNA
II	NNP	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
or	CC	O	O
with	IN	O	O
cytokine	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
estrogen	NN	O	O
","		O	O
human	JJ	B-cell_line	B-cell_line
HeLa	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
progesterone	NN	O	O
","		O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
and	CC	O	O
glucocorticoid	NN	O	O
OCTA-binding	JJ	B-protein	B-protein
protein	NN	I-protein	I-protein
receptor	NN	O	O
levels	NNS	O	O
class	NN	B-DNA	B-DNA
II	NNP	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
.	.	O	O
However	RB	O	O
adipophilin	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
","		O	O
there	RB	O	O
cultured	VBN	B-cell_line	O
skin	NN	I-cell_line	I-cell_line
fibroblasts	NNS	I-cell_line	I-cell_line
was	VBD	O	O
a	DT	O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
significantly	RB	O	O
positive	JJ	O	O
NF-A1	CD	B-protein	B-protein
association	NN	O	O
between	IN	O	O
class	NN	B-DNA	B-DNA
II	NNP	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
expression	NN	O	O
and	CC	O	O
CIITA	NNP	B-RNA	B-RNA
(	(	I-RNA	I-RNA
class	NN	I-RNA	I-RNA
II	NNP	I-RNA	I-RNA
transactivator	NN	I-RNA	I-RNA
)	)	I-RNA	I-RNA
transcripts	NNS	I-RNA	I-RNA
the	DT	O	O
degree	VB	O	O
T-cell	NNP	B-cell_line	B-cell_line
clones	NNS	I-cell_line	I-cell_line
of	IN	O	O
lymphocytic	JJ	O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
infiltration	NN	O	O
in	IN	O	O
Ig	NNP	B-protein	B-protein
the	DT	O	O
tumor	NN	O	O
DRA	NNP	B-DNA	B-DNA
X	NNP	I-DNA	I-DNA
consensus	NN	I-DNA	I-DNA
element	NN	I-DNA	I-DNA
tissue	NN	O	O
.	.	O	O
Fas	NNS	B-RNA	B-RNA
ligand	NN	I-RNA	I-RNA
(	(	I-RNA	I-RNA
FasL	NNP	I-RNA	I-RNA
)	)	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
serum	NN	O	O
levels	NNS	O	O
tegument-specific	JJ	B-cell_line	B-cell_line
CD4	CD	I-cell_line	I-cell_line
T-cell	NNP	I-cell_line	I-cell_line
clones	NNS	I-cell_line	I-cell_line
were	VBD	O	O
determined	VBN	O	O
mononuclear	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
by	IN	O	O
an	DT	O	O
T	NNP	B-protein	B-protein
cell	NN	I-protein	I-protein
activation-specific	JJ	I-protein	I-protein
enhancer	NN	I-protein	I-protein
enzyme-linked	JJ	O	O
immunosorbent	JJ	O	O
X	NNP	B-DNA	B-DNA
box	NN	I-DNA	I-DNA
assay	NN	O	O
in	IN	O	O
endogenous	JJ	B-RNA	B-RNA
germ-line	NN	I-RNA	I-RNA
(	(	I-RNA	I-RNA
GL	NNP	I-RNA	I-RNA
)	)	I-RNA	I-RNA
alpha	NN	I-RNA	I-RNA
transcripts	NNS	I-RNA	I-RNA
samples	NNS	O	O
from	IN	O	O
U937	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
22	CD	O	O
of	IN	O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
the	DT	O	O
above	IN	O	O
interleukin-2	CD	B-protein	B-protein
women	NNS	O	O
.	.	O	O
functional	JJ	B-DNA	B-DNA
elements	NNS	I-DNA	I-DNA
Although	IN	O	O
some	DT	O	O
endogenous	JJ	B-RNA	B-RNA
GLalpha	NNP	I-RNA	I-RNA
transcripts	NNS	I-RNA	I-RNA
of	IN	O	O
the	DT	O	O
nonadherent	JJ	B-cell_line	B-cell_line
culture	NN	I-cell_line	I-cell_line
highest	JJS	O	O
values	NNS	O	O
mononuclear	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
had	VBD	O	O
been	VBN	O	O
IL-2	CD	B-protein	B-protein
obtained	VBN	O	O
in	IN	O	O
immunoglobulin	NN	B-DNA	B-DNA
heavy-chain	NN	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
women	NNS	O	O
with	IN	O	O
endogenous	JJ	B-RNA	B-RNA
GLalpha	NNP	I-RNA	I-RNA
transcripts	NNS	I-RNA	I-RNA
larger	JJR	O	O
(	(	O	O
U937	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
T4	CD	O	O
)	)	O	O
mononuclear	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
primary	NN	O	O
tumors	NNS	O	O
NFAT-1	CD	B-protein	B-protein
","		O	O
the	DT	O	O
Immunoglobulin	NNP	B-DNA	B-DNA
heavy-chain	NN	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
authors	NNS	O	O
failed	VBN	O	O
MIP-1alpha	NN	B-RNA	B-RNA
and	CC	I-RNA	O
MIP-1beta	JJ	I-RNA	I-RNA
messenger	NN	I-RNA	I-RNA
RNA	NNP	I-RNA	I-RNA
to	TO	O	O
detect	VB	O	O
B	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
any	DT	O	O
statistical	JJ	O	O
natural	JJ	B-cell_type	B-cell_type
killer	NN	I-cell_type	I-cell_type
(	(	I-cell_type	I-cell_type
NK	NNP	I-cell_type	I-cell_type
)	)	I-cell_type	I-cell_type
cell	NN	I-cell_type	I-cell_type
relationship	NN	O	O
between	IN	O	O
NFAT-1	CD	B-protein	B-protein
expression	NN	O	O
in	IN	O	O
conserved	VBN	B-DNA	O
sequence	NN	I-DNA	I-DNA
elements	NNS	I-DNA	I-DNA
the	DT	O	O
tumor	NN	O	O
ACAT-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
with	IN	O	O
serum	NN	O	O
B	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
levels	NNS	O	O
or	CC	O	O
cytotoxic	NN	B-cell_type	B-cell_type
T-cells	NNS	I-cell_type	I-cell_type
between	IN	O	O
and	CC	O	O
NFAT-1	CD	B-protein	B-protein
the	DT	O	O
above	IN	O	O
normal	JJ	B-DNA	B-DNA
cell-specific	JJ	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
histologic	NN	O	O
","		O	O
interleukin-6	CD	B-RNA	B-RNA
laboratory	NN	O	O
","		O	O
B	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
hybridomas	NNS	I-cell_line	I-cell_line
and	CC	O	O
clinical	JJ	O	O
NK	NNP	B-cell_type	B-cell_type
factors	NNS	O	O
.	.	O	O
NFAT-1	CD	B-protein	B-protein
[	LS	O	O
Preliminary	NNP	O	O
conserved	VBN	B-DNA	O
sequence	NN	I-DNA	I-DNA
elements	NNS	I-DNA	I-DNA
observation	NN	O	O
of	IN	O	O
NF-kappaB	NNP	B-RNA	B-RNA
and	CC	I-RNA	O
cytokine	NN	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
level	NN	O	O
levels	NNS	O	O
1G5	CD	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
in	IN	O	O
serum	NN	O	O
NK	NNP	B-cell_type	B-cell_type
cell	NN	I-cell_type	I-cell_type
of	IN	O	O
normal	JJ	O	O
T	NNP	B-protein	B-protein
cell	NN	I-protein	I-protein
antigen	NN	I-protein	I-protein
receptor	NN	I-protein	I-protein
childbearing-aged	JJ	O	O
and	CC	O	O
octamer	NN	B-DNA	B-DNA
element	NN	I-DNA	I-DNA
pregnant	JJ	O	O
women	NNS	O	O
IFN-gamma	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
]	LS	O	O
In	IN	O	O
U-373	CD	B-cell_line	B-cell_line
MG	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
137	CD	O	O
cases	NNS	O	O
cytotoxic	NN	B-cell_type	B-cell_type
effector	NN	I-cell_type	I-cell_type
cell	NN	I-cell_type	I-cell_type
of	IN	O	O
childbearing-aged	JJ	O	O
thyroid	NN	B-protein	B-protein
hormone	NN	I-protein	I-protein
receptors	NNS	I-protein	I-protein
and	CC	O	O
pregnant	JJ	O	O
heptamer	NN	B-DNA	B-DNA
sequence	NN	I-DNA	I-DNA
women	NNS	O	O
","		O	O
IL-6	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
levels	NNS	O	O
(	(	O	O
astrocytoma	NN	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
)	)	O	O
in	IN	O	O
cytotoxic	NN	B-cell_type	B-cell_type
effector	NN	I-cell_type	I-cell_type
cell	NN	I-cell_type	I-cell_type
serum	NN	O	O
were	VBD	O	O
thyroid	NN	B-protein	B-protein
hormone	NN	I-protein	I-protein
receptors	NNS	I-protein	I-protein
measured	VBN	O	O
by	IN	O	O
2	CD	B-DNA	B-DNA
or	CC	I-DNA	O
14	CD	I-DNA	I-DNA
base	NN	I-DNA	I-DNA
pairs	NNS	I-DNA	I-DNA
ELISA	NNP	O	O
.	.	O	O
IL-6	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
The	DT	O	O
level	NN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
of	IN	O	O
was	VBD	O	O
peripheral	JJ	B-cell_type	B-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
significantly	RB	O	O
decreased	VBN	O	O
T3	CD	B-protein	B-protein
binding	VBG	I-protein	I-protein
sites	NNS	I-protein	I-protein
during	IN	O	O
the	DT	O	O
immunoglobulin	NN	B-DNA	B-DNA
(	(	I-DNA	I-DNA
Ig	NNP	I-DNA	I-DNA
)	)	I-DNA	I-DNA
heavy	NN	I-DNA	I-DNA
and	CC	I-DNA	O
light	NN	I-DNA	I-DNA
chain	NN	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
first	RB	O	O
trimester	NN	O	O
GATA-3	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
","		O	O
slightly	RB	O	O
CD4-positive	JJ	B-cell_line	B-cell_line
lymphocyte	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
higher	JJR	O	O
in	IN	O	O
peripheral	JJ	B-cell_type	B-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
the	DT	O	O
second	JJ	O	O
[	LS	B-protein	O
125I	NNP	I-protein	I-protein
]	LS	I-protein	O
T3	CD	I-protein	I-protein
trimester	NN	O	O
","		O	O
heavy	NN	B-DNA	B-DNA
chain	NN	I-DNA	I-DNA
enhancer	NN	I-DNA	I-DNA
and	CC	O	O
recovered	VBD	O	O
EBV-encoded	JJ	B-RNA	B-RNA
nuclear	JJ	I-RNA	I-RNA
RNA	NNP	I-RNA	I-RNA
to	TO	O	O
normal	JJ	O	O
U-373	CD	B-cell_line	B-cell_line
MG	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
in	IN	O	O
the	DT	O	O
B	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
third	JJ	O	O
trimester	NN	O	O
binding	VBG	B-protein	B-protein
sites	NNS	I-protein	I-protein
.	.	O	O
The	DT	O	O
Ig	NNP	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
level	NN	O	O
remained	VBN	O	O
EBER	NNP	B-RNA	B-RNA
lower	JJR	O	O
in	IN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
29	CD	O	O
PIH	NNP	O	O
B	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
women	NNS	O	O
but	CC	O	O
[	LS	B-protein	O
125I	NNP	I-protein	I-protein
]	LS	I-protein	O
T3	CD	I-protein	I-protein
appeared	VBD	O	O
higher	JJR	O	O
upstream	NN	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
or	CC	I-DNA	O
enhancer	NN	I-DNA	I-DNA
element	NN	I-DNA	I-DNA
in	IN	O	O
overdue	JJ	O	O
EBV	NN	B-RNA	B-RNA
nuclear	JJ	I-RNA	I-RNA
antigen	NN	I-RNA	I-RNA
(	(	I-RNA	I-RNA
EBNA	NNP	I-RNA	I-RNA
)	)	I-RNA	I-RNA
-1	NNS	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
pregnancies	NNS	O	O
as	IN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
compared	VBN	O	O
with	IN	O	O
T	NNP	B-cell_type	B-cell_type
cell	NN	I-cell_type	I-cell_type
the	DT	O	O
normal	JJ	O	O
T3	CD	B-protein	B-protein
binding	VBG	I-protein	I-protein
sites	NNS	I-protein	I-protein
3rd	CD	O	O
trimester	NN	O	O
housekeeping	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
range	NN	O	O
.	.	O	O
Latent	NN	B-RNA	B-RNA
membrane	NN	I-RNA	I-RNA
protein-1	NN	I-RNA	I-RNA
(	(	I-RNA	I-RNA
LMP-1	CD	I-RNA	I-RNA
)	)	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
The	DT	O	O
results	NNS	O	O
human	JJ	B-cell_line	B-cell_line
monocytic	JJ	I-cell_line	I-cell_line
leukemia	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
indicate	VB	O	O
that	IN	O	O
T	NNP	B-cell_type	B-cell_type
cell	NN	I-cell_type	I-cell_type
there	RB	O	O
is	VBZ	O	O
T3	CD	B-protein	B-protein
binding	VBG	I-protein	I-protein
sites	NNS	I-protein	I-protein
a	DT	O	O
relationship	NN	O	O
histone	NN	B-DNA	B-DNA
H2B	NN	I-DNA	I-DNA
and	CC	I-DNA	O
U	NNP	I-DNA	I-DNA
snRNA	NN	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
between	IN	O	O
a	DT	O	O
EBNA-2	CD	B-RNA	B-RNA
transcripts	NNS	I-RNA	I-RNA
change	NN	O	O
in	IN	O	O
monoblastic	NN	B-cell_line	B-cell_line
ML-1	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
function	NN	O	O
and	CC	O	O
Lymphocyte	NNP	B-cell_type	B-cell_type
pregnancy	NN	O	O
.	.	O	O
thyroid	NN	B-protein	B-protein
hormone	NN	I-protein	I-protein
receptors	NNS	I-protein	I-protein
:	:	O	O
role	NN	O	O
Ig	NNP	B-DNA	B-DNA
promoters	NNS	I-DNA	I-DNA
in	IN	O	O
the	DT	O	O
Latent	NN	B-RNA	B-RNA
BHRF1	CD	I-RNA	I-RNA
transcripts	NNS	I-RNA	I-RNA
regulation	NN	O	O
of	IN	O	O
promonocytic	JJ	B-cell_line	B-cell_line
U-937	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
expression	NN	O	O
.	.	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
Transcriptional	JJ	O	O
activation	NN	O	O
human	JJ	B-protein	B-protein
T3	CD	I-protein	I-protein
receptors	NNS	I-protein	I-protein
of	IN	O	O
the	DT	O	O
TATA-box	NNP	B-DNA	B-DNA
","		O	O
like	IN	O	O
bcl-2	CD	B-RNA	B-RNA
homologue	NN	I-RNA	I-RNA
induction	NN	O	O
of	IN	O	O
promyelocytic	JJ	B-cell_line	B-cell_line
HL-60	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
the	DT	O	O
and	CC	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
the	DT	O	O
type	NN	O	O
T-cell	NNP	B-protein	B-protein
specific	JJ	I-protein	I-protein
DNA-binding	JJ	I-protein	I-protein
factors	NNS	I-protein	I-protein
1	CD	O	O
human	JJ	O	O
octamer	NN	B-DNA	B-DNA
sequence	NN	I-DNA	I-DNA
immunodeficiency	NN	O	O
virus	NN	O	O
BCRF1	CD	B-RNA	B-RNA
transcripts	NNS	I-RNA	I-RNA
(	(	O	O
HIV-1	CD	O	O
monocytic	JJ	B-cell_line	B-cell_line
THP-1	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
)	)	O	O
","		O	O
B	NNP	B-cell_type	B-cell_type
cell	NN	I-cell_type	I-cell_type
is	VBZ	O	O
shown	VBN	O	O
T-lymphocyte	JJ	B-protein	B-protein
1	CD	I-protein	I-protein
to	TO	O	O
be	VB	O	O
IgH	NNP	B-DNA	B-DNA
enhancer	NN	I-DNA	I-DNA
modulated	VBN	O	O
by	IN	O	O
vIL-10	NN	B-RNA	B-RNA
and	CC	I-RNA	O
bcl-2	CD	I-RNA	I-RNA
homologue	NN	I-RNA	I-RNA
a	DT	O	O
.	.	O	O
HL-60	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
Mutation	NN	O	O
of	IN	O	O
peripheral	JJ	B-cell_type	B-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
a	DT	O	O
identified	VBN	O	O
silencer-DNA-protein	NN	B-protein	B-protein
complex	NN	I-protein	I-protein
in	IN	O	O
the	DT	O	O
IgH	NNP	B-DNA	B-DNA
enhancer	NN	I-DNA	I-DNA
(	(	O	O
-206	NNS	O	O
PPAR-gamma	NNP	B-RNA	B-RNA
to	TO	O	O
-195	NNS	O	O
HL-60	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
)	)	O	O
partially	RB	O	O
human	JJ	B-cell_type	B-cell_type
peripheral	JJ	I-cell_type	I-cell_type
blood	NN	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
inhibits	NNS	O	O
both	DT	O	O
DNA-binding	JJ	B-protein	B-protein
factors	NNS	I-protein	I-protein
mitogen-	:	O	O
and	CC	O	O
human	JJ	B-DNA	B-DNA
immunodeficiency	NN	I-DNA	I-DNA
virus	NN	I-DNA	I-DNA
type	NN	I-DNA	I-DNA
1	CD	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
HTLV-I	NNP	O	O
Tax-mediated	JJ	O	O
TCF-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
activation	NN	O	O
of	IN	O	O
THP-1	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
this	DT	O	O
and	CC	O	O
normal	JJ	B-cell_type	B-cell_type
human	JJ	I-cell_type	I-cell_type
mitogen-activated	JJ	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
blocks	NNS	O	O
the	DT	O	O
HLA	NNP	B-protein	B-protein
class	NN	I-protein	I-protein
II	NNP	I-protein	I-protein
antigens	NNS	I-protein	I-protein
specific	JJ	O	O
binding	VBG	O	O
immunoglobulin	NN	B-DNA	B-DNA
light	NN	I-DNA	I-DNA
chain	NN	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
of	IN	O	O
two	CD	O	O
Id3	CD	B-RNA	B-RNA
transcripts	NNS	I-RNA	I-RNA
.	.	O	O
These	DT	O	O
VD3-treated	JJ	B-cell_line	B-cell_line
HL-60	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
and	CC	I-cell_line	O
THP-1	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
(	(	O	O
80	CD	O	O
human	JJ	B-cell_type	B-cell_type
natural	JJ	I-cell_type	I-cell_type
killer	NN	I-cell_type	I-cell_type
(	(	I-cell_type	I-cell_type
NK	NNP	I-cell_type	I-cell_type
)	)	I-cell_type	I-cell_type
cell	NN	I-cell_type	I-cell_type
to	TO	O	O
90	CD	O	O
trans-acting	NN	B-protein	B-protein
factors	NNS	I-protein	I-protein
and	CC	O	O
50	CD	O	O
kappa	NN	B-DNA	B-DNA
light	NN	I-DNA	I-DNA
chain	NN	I-DNA	I-DNA
enhancer	NN	I-DNA	I-DNA
sequence	NN	I-DNA	I-DNA
to	TO	O	O
55	CD	O	O
RAR	NN	B-RNA	B-RNA
alpha	NN	I-RNA	I-RNA
","		I-RNA	I-RNA
RAR	NN	I-RNA	I-RNA
gamma	NN	I-RNA	I-RNA
","		I-RNA	I-RNA
RXR	NNP	I-RNA	I-RNA
beta	NNS	I-RNA	I-RNA
","		I-RNA	I-RNA
and	CC	I-RNA	O
RXR	NNP	I-RNA	I-RNA
gamma	NN	I-RNA	I-RNA
transcripts	NNS	I-RNA	I-RNA
kilodaltons	NNS	O	O
)	)	O	O
THP-1	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
similarly	RB	O	O
interact	VB	O	O
natural	JJ	B-cell_type	B-cell_type
killer	NN	I-cell_type	I-cell_type
with	IN	O	O
the	DT	O	O
soluble	RB	B-protein	O
factors	NNS	I-protein	I-protein
functional	JJ	O	O
present	VB	O	O
human	JJ	B-DNA	B-DNA
immunodeficiency	NN	I-DNA	I-DNA
virus	NN	I-DNA	I-DNA
type	NN	I-DNA	I-DNA
I	PRP	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
in	IN	O	O
the	DT	O	O
RARbeta	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
.	.	O	O
These	DT	O	O
VD3-treated	JJ	B-cell_line	B-cell_line
HL-60	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
data	NNS	O	O
suggest	JJS	O	O
human	JJ	B-cell_type	B-cell_type
peripheral	JJ	I-cell_type	I-cell_type
blood	NN	I-cell_type	I-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
(	(	I-cell_type	I-cell_type
PBM	NNP	I-cell_type	I-cell_type
)	)	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
that	IN	O	O
these	DT	O	O
trans-acting	NN	B-protein	B-protein
factor	NN	I-protein	I-protein
have	VB	O	O
a	DT	O	O
upstream	NN	B-DNA	B-DNA
NF-kappa	NN	I-DNA	I-DNA
B-binding	JJ	I-DNA	I-DNA
site	NN	I-DNA	I-DNA
role	NN	O	O
in	IN	O	O
TNFalpha	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
the	DT	O	O
coordinate	VB	O	O
HL-60	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
regulation	NN	O	O
of	IN	O	O
PBM	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
this	DT	O	O
growth	NN	O	O
class	NN	B-protein	B-protein
II	NNP	I-protein	I-protein
antigens	NNS	I-protein	I-protein
factor-growth	NN	O	O
factor	NN	O	O
immunoglobulin	NN	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
receptor	NN	O	O
gene	NN	O	O
MCP-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
system	NN	O	O
that	IN	O	O
THP-1	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
controls	NNS	O	O
proliferation	NN	O	O
NK	NNP	B-cell_type	B-cell_type
cell	NN	I-cell_type	I-cell_type
.	.	O	O
Novel	NNP	O	O
NFX1.1	CD	B-protein	B-protein
region	NN	O	O
within	IN	O	O
upstream	NN	B-DNA	B-DNA
element	NN	I-DNA	I-DNA
the	DT	O	O
is	VBZ	O	O
messenger	NN	B-RNA	B-RNA
RNA	NNP	I-RNA	I-RNA
responsible	JJ	O	O
for	IN	O	O
THP-1	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
tissue	NN	O	O
and	CC	O	O
effector	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
stage-specific	JJ	O	O
expression	NN	O	O
NFX1.2	CD	B-protein	B-protein
of	IN	O	O
in	IN	O	O
promoters	NNS	B-DNA	B-DNA
.	.	O	O
have	VB	O	O
mRNA	NN	B-RNA	B-RNA
been	VBN	O	O
shown	VBN	O	O
VD3-treated	JJ	B-cell_line	B-cell_line
HL-60	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
to	TO	O	O
play	NN	O	O
PBM	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
a	DT	O	O
role	NN	O	O
NFX1.1	CD	B-protein	B-protein
in	IN	O	O
lymphoid	NN	O	O
modular	JJ	B-DNA	B-DNA
enhancer	NN	I-DNA	I-DNA
element	NN	I-DNA	I-DNA
tissue-specific	JJ	O	O
expression	NN	O	O
intercellular	JJ	B-RNA	B-RNA
adhesion	NN	I-RNA	I-RNA
molecule-1	NN	I-RNA	I-RNA
of	IN	O	O
.	.	O	O
HL-60	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
The	DT	O	O
role	NN	O	O
PBM	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
of	IN	O	O
these	DT	O	O
NFX1.2	CD	B-protein	B-protein
factors	NNS	O	O
in	IN	O	O
immunoglobulin	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
differentiation	NN	O	O
and	CC	O	O
intercellular	JJ	B-RNA	B-RNA
adhesion	NN	I-RNA	I-RNA
molecule-1	NN	I-RNA	I-RNA
stage-specific	JJ	O	O
expression	NN	O	O
THP-1	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
of	IN	O	O
these	DT	O	O
NK	NNP	B-cell_type	B-cell_type
effectors	NNS	I-cell_type	I-cell_type
genes	NNS	O	O
is	VBZ	O	O
glucocorticoid	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
","		O	O
however	RB	O	O
upstream	NN	B-DNA	B-DNA
regions	NNS	I-DNA	I-DNA
","		O	O
not	RB	O	O
RAR-alpha	NN	B-RNA	B-RNA
fully	RB	O	O
understood	NN	O	O
HL-60	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
.	.	O	O
We	PRP	O	O
NK	NNP	B-cell_type	B-cell_type
have	VB	O	O
used	VBN	O	O
glucocorticoid	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
a	DT	O	O
model	NN	O	O
heavy	NN	B-DNA	B-DNA
and	CC	I-DNA	O
light	NN	I-DNA	I-DNA
chain	NN	I-DNA	I-DNA
promoters	NNS	I-DNA	I-DNA
of	IN	O	O
human	JJ	O	O
RAR-beta	JJ	B-RNA	B-RNA
lymphoid	NN	O	O
neoplasia	NN	O	O
VD3-treated	JJ	B-cell_line	B-cell_line
HL-60	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
and	CC	I-cell_line	O
THP-1	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
to	TO	O	O
address	NN	O	O
human	JJ	B-cell_type	B-cell_type
NK	NNP	I-cell_type	I-cell_type
cell	NN	I-cell_type	I-cell_type
this	DT	O	O
question	NN	O	O
glucocorticoid	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
.	.	O	O
Different	JJ	O	O
heavy	NN	B-DNA	B-DNA
chain	NN	I-DNA	I-DNA
enhancer	NN	I-DNA	I-DNA
fragments	NNS	O	O
of	IN	O	O
RXR-alpha	NN	B-RNA	B-RNA
of	IN	O	O
(	(	O	O
VD3-untreated	JJ	B-cell_line	B-cell_line
HL-60	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
)	)	O	O
were	VBD	O	O
human	JJ	B-cell_type	B-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
used	VBN	O	O
for	IN	O	O
glucocorticoid	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
cell-free	JJ	O	O
in	IN	O	O
kappa	NN	B-DNA	B-DNA
light	NN	I-DNA	I-DNA
chain	NN	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
vitro	NN	O	O
transcription	NN	O	O
RXR-gamma	NNP	B-RNA	B-RNA
and	CC	O	O
DNA	NN	O	O
cultured	VBN	B-cell_line	O
human	JJ	I-cell_line	I-cell_line
B-lymphoblastoid	JJ	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
mobility	NN	O	O
shift	VB	O	O
lymphoid	NN	B-cell_type	B-cell_type
and	CC	I-cell_type	O
non-lymphoid	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
assays	NNS	O	O
.	.	O	O
glucocorticoid	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
Previously	RB	O	O
described	VBN	O	O
kappa	NN	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
enhancement	NN	O	O
of	IN	O	O
IL-2	CD	B-RNA	B-RNA
in	IN	O	O
vitro	NN	O	O
B-LCL	NN	B-cell_line	B-cell_line
transcription	NN	O	O
that	IN	O	O
circulating	VBG	B-cell_type	B-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
was	VBD	O	O
only	RB	O	O
glucocorticoid	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
seen	VBN	O	O
with	IN	O	O
DNA	NN	B-DNA	B-DNA
nuclear	JJ	O	O
extracts	NNS	O	O
AP-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
derived	VBN	O	O
from	IN	O	O
B-LCL	NN	B-cell_line	B-cell_line
corresponding	VBG	O	O
to	TO	O	O
B-lymphocytes	NNS	B-cell_type	B-cell_type
the	DT	O	O
late	RB	O	O
interferon-alpha	NN	B-protein	B-protein
stages	NNS	O	O
of	IN	O	O
DNA	NN	B-DNA	B-DNA
differentiation	NN	O	O
was	VBD	O	O
PPAR-gamma	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
shown	VBN	O	O
to	TO	O	O
class	NN	B-cell_line	B-cell_line
II-	NNP	I-cell_line	I-cell_line
mutant	JJ	I-cell_line	I-cell_line
B-cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
be	VB	O	O
dependent	JJ	O	O
erythroid	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
on	IN	O	O
the	DT	O	O
Estradiol	NNP	B-protein	B-protein
receptors	NNS	I-protein	I-protein
actions	NNS	O	O
of	IN	O	O
immunoglobulin	NN	B-DNA	B-DNA
VH	NNP	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
region	NN	I-DNA	I-DNA
sequences	NNS	I-DNA	I-DNA
these	DT	O	O
factor	NN	O	O
eosinophil	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
(	(	O	O
s	NNS	O	O
bare	NN	B-cell_line	B-cell_line
lymphocyte	NN	I-cell_line	I-cell_line
syndrome	NN	I-cell_line	I-cell_line
group	NN	I-cell_line	I-cell_line
II	NNP	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
)	)	O	O
on	IN	O	O
CD4	CD	B-cell_type	B-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
the	DT	O	O
DNA	NN	O	O
interferon-alpha	NN	B-protein	B-protein
region	NN	O	O
within	IN	O	O
human	JJ	B-DNA	B-DNA
and	CC	I-DNA	O
murine	NN	I-DNA	I-DNA
immunoglobulin	NN	I-DNA	I-DNA
heavy	NN	I-DNA	I-DNA
chain	NN	I-DNA	I-DNA
variable	JJ	I-DNA	I-DNA
region	NN	I-DNA	I-DNA
(	(	I-DNA	I-DNA
VH	NNP	I-DNA	I-DNA
)	)	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
the	DT	O	O
.	.	O	O
NFATc	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
This	DT	O	O
region	NN	O	O
RJ2.2.5	CD	B-cell_line	B-cell_line
is	VBZ	O	O
located	VBN	O	O
infiltrating	VBG	B-cell_type	B-cell_type
CD4-bearing	NN	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
within	IN	O	O
the	DT	O	O
IFN-alpha	NN	B-protein	B-protein
920	CD	O	O
bp	NN	O	O
light	NN	B-DNA	B-DNA
chain	NN	I-DNA	I-DNA
variable	JJ	I-DNA	I-DNA
region	NN	I-DNA	I-DNA
(	(	I-DNA	I-DNA
VL	NNP	I-DNA	I-DNA
)	)	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
fragment	NN	O	O
located	VBN	O	O
chemokine	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
210	CD	O	O
bp	NN	O	O
RM3	CD	B-cell_line	B-cell_line
upstream	NN	O	O
from	IN	O	O
HSV-specific	JJ	B-cell_type	B-cell_type
CD4	CD	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
the	DT	O	O
coding	VBG	O	O
estradiol	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
region	NN	O	O
and	CC	O	O
immunoglobulin	NN	B-DNA	B-DNA
heavy	NN	I-DNA	I-DNA
chain	NN	I-DNA	I-DNA
transcriptional	JJ	I-DNA	I-DNA
enhancer	NN	I-DNA	I-DNA
this	DT	O	O
fragment	NN	O	O
macrophage	NN	B-RNA	B-RNA
inflammatory	NN	I-RNA	I-RNA
protein	NN	I-RNA	I-RNA
(	(	I-RNA	I-RNA
MIP	NNP	I-RNA	I-RNA
)	)	I-RNA	I-RNA
-2	NNS	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
represents	NNS	O	O
a	DT	O	O
70Z/3	3	B-cell_line	B-cell_line
pre-B	NN	I-cell_line	I-cell_line
lymphocytes	NNS	I-cell_line	I-cell_line
possible	JJ	O	O
novel	NN	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
DNA	NN	O	O
region	NN	O	O
estradiol	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
","		O	O
which	WDT	O	O
immunoglobulin	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
plays	NNS	O	O
a	DT	O	O
MIP-1alpha	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
role	NN	O	O
in	IN	O	O
macrophage	NN	B-cell_line	B-cell_line
line	NN	I-cell_line	I-cell_line
the	DT	O	O
stage-	NN	O	O
HSV-infected	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
and	CC	O	O
tissue-specific	JJ	O	O
estradiol	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
expression	NN	O	O
of	IN	O	O
Octamer-containing	JJ	B-DNA	B-DNA
fragments	NNS	I-DNA	I-DNA
.	.	O	O
[	LS	O	O
MIP-1alpha	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
Determination	NN	O	O
of	IN	O	O
macrophage	NN	B-cell_line	B-cell_line
line	NN	I-cell_line	I-cell_line
the	DT	O	O
sensitivity	NN	O	O
mononuclear	JJ	B-cell_type	B-cell_type
phagocytes	NNS	I-cell_type	I-cell_type
to	TO	O	O
in	IN	O	O
IFN-alpha	NN	B-protein	B-protein
vitro	NN	O	O
]	LS	O	O
octamer-containing	JJ	B-DNA	B-DNA
fragments	NNS	I-DNA	I-DNA
A	DT	O	O
modified	VBN	O	O
MIP-2	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
method	NN	O	O
for	IN	O	O
transfected	VBN	B-cell_line	O
liver	RB	I-cell_line	O
cells	NNS	I-cell_line	I-cell_line
the	DT	O	O
determination	NN	O	O
Mononuclear	JJ	B-cell_type	B-cell_type
phagocytes	NNS	I-cell_type	I-cell_type
of	IN	O	O
in	IN	O	O
IFN-alpha	NN	B-protein	B-protein
is	VBZ	O	O
suggested	VBN	O	O
HTLV-I	NNP	B-DNA	B-DNA
LTR	NNP	I-DNA	I-DNA
.	.	O	O
The	DT	O	O
MIP-2	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
principal	NN	O	O
distinction	NN	O	O
HepG2	CD	B-cell_line	B-cell_line
human	JJ	I-cell_line	I-cell_line
hepatoma	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
of	IN	O	O
the	DT	O	O
unstimulated	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
method	NN	O	O
is	VBZ	O	O
estradiol	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
standardization	NN	O	O
by	IN	O	O
promoters	NNS	B-DNA	B-DNA
the	DT	O	O
count	NN	O	O
IRF-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
in	IN	O	O
a	DT	O	O
MVh2E1-9	CD	B-cell_line	B-cell_line
sample	NN	O	O
(	(	O	O
Peripheral	NNP	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
and	CC	I-cell_type	O
monocytes	NNS	I-cell_type	I-cell_type
1	CD	O	O
mln	NN	O	O
IFN-alpha	NN	B-protein	B-protein
)	)	O	O
and	CC	O	O
adenovirus	NN	B-DNA	B-DNA
2	CD	I-DNA	I-DNA
major	JJ	I-DNA	I-DNA
late	RB	I-DNA	O
gene	NN	I-DNA	I-DNA
the	DT	O	O
labeled	VBN	O	O
IRF-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
concentration	NN	O	O
.	.	O	O
HepG2	CD	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
The	DT	O	O
modification	NN	O	O
normal	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
saves	NNS	O	O
time	NN	O	O
estradiol	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
and	CC	O	O
money	NN	O	O
mouse	NN	B-DNA	B-DNA
beta-globin	RB	I-DNA	O
gene	NN	I-DNA	I-DNA
","		O	O
limits	NNS	O	O
IL-1beta-converting	JJ	B-RNA	B-RNA
enzyme	VB	I-RNA	O
mRNA	NN	I-RNA	I-RNA
the	DT	O	O
range	NN	O	O
HepG2	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
of	IN	O	O
the	DT	O	O
immune	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
data	NNS	O	O
variations	NNS	O	O
estrogen	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
","		O	O
and	CC	O	O
mouse	NN	B-DNA	B-DNA
immunoglobulin	NN	I-DNA	I-DNA
VH	NNP	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
makes	NNS	O	O
use	NN	O	O
AP-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
of	IN	O	O
a	DT	O	O
HepG2	CD	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lesser	JJR	O	O
volume	NN	O	O
Peripheral	NNP	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
monocytes	NNS	I-cell_type	I-cell_type
and	CC	I-cell_type	O
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
of	IN	O	O
blood	NN	O	O
estrogen	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
.	.	O	O
Examinations	NNS	O	O
LTR	NNP	B-DNA	B-DNA
of	IN	O	O
70	CD	O	O
Human	NNP	B-RNA	B-RNA
p45	CD	I-RNA	I-RNA
mRNAs	NNS	I-RNA	I-RNA
children	NNS	O	O
aged	VBN	O	O
HepG2	CD	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
4	CD	O	O
to	TO	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
15	CD	O	O
suffering	VBG	O	O
ER	NNP	B-protein	B-protein
from	IN	O	O
the	DT	O	O
LTR	NNP	B-DNA	B-DNA
nephrotic	JJ	O	O
form	NN	O	O
aNF-E2	NN	B-RNA	B-RNA
of	IN	O	O
glomerulonephritis	NN	O	O
TNF	IN	B-cell_line	B-cell_line
cytotoxicity	NN	I-cell_line	I-cell_line
have	VB	O	O
made	VBN	O	O
CD4	CD	B-cell_type	B-cell_type
it	PRP	O	O
possible	JJ	O	O
ER	NNP	B-protein	B-protein
to	TO	O	O
distinguish	VB	O	O
HTLV-I	NNP	B-DNA	B-DNA
LTR	NNP	I-DNA	I-DNA
two	CD	O	O
groups	NNS	O	O
fNF-E2	NN	B-RNA	B-RNA
of	IN	O	O
patients	NNS	O	O
liver	RB	B-cell_line	O
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
:	:	O	O
with	IN	O	O
CD8	CD	B-cell_type	B-cell_type
relatively	RB	O	O
high	RB	O	O
glucocorticoid	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
values	NNS	O	O
of	IN	O	O
transcriptional	JJ	B-DNA	B-DNA
control	NN	I-DNA	I-DNA
elements	NNS	I-DNA	I-DNA
specific	JJ	O	O
binding	VBG	O	O
fNF-E2	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
X	NNP	O	O
=	SYM	O	O
HeLa	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
6820.1	CD	O	O
+/-	-	O	O
monocytes	NNS	B-cell_type	B-cell_type
530	CD	O	O
(	(	O	O
glucocorticoid	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
n	NN	O	O
=	SYM	O	O
immunoglobulin	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
30	CD	O	O
","		O	O
fNF-E2	NN	B-RNA	B-RNA
p	NN	O	O
=	SYM	O	O
HeLa	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
0.95	CD	O	O
","		O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
t	NN	O	O
=	SYM	O	O
GR	NNP	B-protein	B-protein
2.04	CD	O	O
)	)	O	O
immunoglobulin	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
","		O	O
this	DT	O	O
GM-CSF	NNP	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
corresponding	VBG	O	O
to	TO	O	O
HeLa	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
a	DT	O	O
clinical	JJ	O	O
Monocytes	NNS	B-cell_type	B-cell_type
form	NN	O	O
of	IN	O	O
GR	NNP	B-protein	B-protein
#NAME?	# NAME	O	O
glomerulonephritis	NN	O	O
immunoglobulin	NN	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
recombinants	NNS	I-DNA	I-DNA
","		O	O
and	CC	O	O
Egr-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
with	IN	O	O
relatively	RB	O	O
HeLa	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
low	JJ	O	O
values	NNS	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
of	IN	O	O
specific	JJ	O	O
GR	NNP	B-protein	B-protein
binding	VBG	O	O
X	NNP	O	O
cis-acting	NN	B-DNA	B-DNA
transcriptional	JJ	I-DNA	I-DNA
regulatory	JJ	I-DNA	I-DNA
elements	NNS	I-DNA	I-DNA
=	SYM	O	O
1815.2	CD	O	O
Egr-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
+/-	-	O	O
302.8	CD	O	O
human	JJ	B-cell_line	B-cell_line
interleukin-2-dependent	JJ	I-cell_line	I-cell_line
T	NNP	I-cell_line	I-cell_line
lymphoblasts	NNS	I-cell_line	I-cell_line
(	(	O	O
n	NN	O	O
B	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
=	SYM	O	O
40	CD	O	O
GR	NNP	B-protein	B-protein
","		O	O
p	NN	O	O
heavy	NN	B-DNA	B-DNA
and	CC	I-DNA	O
kappa	NN	I-DNA	I-DNA
light-chain	NN	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
=	SYM	O	O
0.95	CD	O	O
Egr-1	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
","		O	O
t	NN	O	O
human	JJ	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
Jurkat	NNP	I-cell_line	I-cell_line
=	SYM	O	O
1.96	CD	O	O
T	NNP	B-cell_type	B-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
)	)	O	O
","		O	O
GR	NNP	B-protein	B-protein
that	IN	O	O
corresponds	NNS	O	O
element	NN	B-DNA	B-DNA
to	TO	O	O
#NAME?	# NAME	O	O
c-myc	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
glomerulonephritis	NN	O	O
.	.	O	O
Jurkat	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
Dynamic	NNP	O	O
studies	NNS	O	O
cultured	VBN	B-cell_type	O
cells	NNS	I-cell_type	I-cell_type
have	VB	O	O
not	RB	O	O
GR	NNP	B-protein	B-protein
shown	VBN	O	O
any	DT	O	O
heavy	NN	B-DNA	B-DNA
and	CC	I-DNA	O
kappa	NN	I-DNA	I-DNA
light-chain	NN	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
promoters	NNS	I-DNA	I-DNA
statistically	RB	O	O
significant	JJ	O	O
TNF-alpha	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
changes	NNS	O	O
in	IN	O	O
THP1	CD	B-cell_line	B-cell_line
monocytes	NNS	I-cell_line	I-cell_line
the	DT	O	O
specific	JJ	O	O
primary	NN	B-cell_type	B-cell_type
murine	NN	I-cell_type	I-cell_type
bone	NN	I-cell_type	I-cell_type
marrow	VB	I-cell_type	O
cells	NNS	I-cell_type	I-cell_type
binding	VBG	O	O
values	NNS	O	O
cytosolic	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
.	.	O	O
These	DT	O	O
viral	JJ	B-DNA	B-DNA
enhancers	NNS	I-DNA	I-DNA
results	NNS	O	O
permit	NN	O	O
TNF-alpha	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
regarding	VBG	O	O
the	DT	O	O
human	JJ	B-cell_line	B-cell_line
THP1	CD	I-cell_line	I-cell_line
monocytes	NNS	I-cell_line	I-cell_line
specific	JJ	O	O
binding	VBG	O	O
granulocytic	JJ	B-cell_type	B-cell_type
colonies	NNS	I-cell_type	I-cell_type
value	NN	O	O
as	IN	O	O
GR	NNP	B-protein	B-protein
a	DT	O	O
prognostic	JJ	O	O
regulatory	JJ	B-DNA	B-DNA
elements	NNS	I-DNA	I-DNA
criterion	NN	O	O
in	IN	O	O
jun	NN	B-RNA	B-RNA
D	NNP	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
the	DT	O	O
assessment	NN	O	O
THP1	CD	B-cell_line	B-cell_line
monocytes	NNS	I-cell_line	I-cell_line
of	IN	O	O
therapy	NN	O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
neutrophil	NN	I-cell_type	I-cell_type
;	:	O	O
this	DT	O	O
GR	NNP	B-protein	B-protein
allows	NNS	O	O
a	DT	O	O
DNA	NN	B-DNA	B-DNA
sequences	NNS	I-DNA	I-DNA
wide	RB	O	O
employment	NN	O	O
mRNAs	NNS	B-RNA	B-RNA
of	IN	O	O
the	DT	O	O
THP1	CD	B-cell_line	B-cell_line
monocytes	NNS	I-cell_line	I-cell_line
described	VBN	O	O
method	NN	O	O
T	NNP	B-cell_type	B-cell_type
and	CC	I-cell_type	O
natural	JJ	I-cell_type	I-cell_type
killer	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
in	IN	O	O
practical	JJ	O	O
GR	NNP	B-protein	B-protein
nephrology	NN	O	O
.	.	O	O
upstream	NN	B-DNA	B-DNA
regions	NNS	I-DNA	I-DNA
from	IN	O	O
stimulate	VB	O	O
IL-6	CD	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
transcription	NN	O	O
of	IN	O	O
cell	NN	B-cell_line	B-cell_line
lines	NNS	I-cell_line	I-cell_line
the	DT	O	O
in	IN	O	O
lymphocyte	NN	B-cell_type	B-cell_type
subsets	NNS	I-cell_type	I-cell_type
vitro	NN	O	O
.	.	O	O
GR	NNP	B-protein	B-protein
The	DT	O	O
#NAME?	# NAME	O	O
mouse	NN	B-DNA	B-DNA
heavy	NN	I-DNA	I-DNA
and	CC	I-DNA	O
kappa	NN	I-DNA	I-DNA
light-chain	NN	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
promoters	NNS	I-DNA	I-DNA
specificity	NN	O	O
of	IN	O	O
leukemia	NN	B-RNA	B-RNA
inhibitory	NN	I-RNA	I-RNA
factor	NN	I-RNA	I-RNA
mRNA	NN	I-RNA	I-RNA
the	DT	O	O
(	(	O	O
B-cell	NN	B-cell_line	B-cell_line
lines	NNS	I-cell_line	I-cell_line
)	)	O	O
heavy-chain	NN	O	O
T	NNP	B-cell_type	B-cell_type
lymphocyte	NN	I-cell_type	I-cell_type
subsets	NNS	I-cell_type	I-cell_type
and	CC	O	O
light-chain	NN	O	O
ubiquitous	JJ	B-protein	B-protein
and	CC	I-protein	O
lymphoid-cell-specific	JJ	I-protein	I-protein
octamer	NN	I-protein	I-protein
transcription	NN	I-protein	I-protein
factors	NNS	I-protein	I-protein
promoters	NNS	O	O
is	VBZ	O	O
mouse	NN	B-DNA	B-DNA
heavy-chain	NN	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
enhancer	NN	I-DNA	I-DNA
mediated	VBN	O	O
by	IN	O	O
cytokine	NN	B-RNA	B-RNA
mRNA	NN	I-RNA	I-RNA
an	DT	O	O
","		O	O
non-B-cell	NN	B-cell_line	B-cell_line
or	CC	I-cell_line	O
plasma	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
ATGCAAAT	NNP	O	O
","		O	O
NK	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
that	IN	O	O
is	VBZ	O	O
OTF-1	CD	B-protein	B-protein
also	RB	O	O
a	DT	O	O
transcriptional	JJ	B-DNA	B-DNA
elements	NNS	I-DNA	I-DNA
functional	JJ	O	O
component	NN	O	O
cytokine	NN	B-RNA	B-RNA
genes	NNS	I-RNA	I-RNA
T	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
clone	NN	I-cell_line	I-cell_line
variant	NN	I-cell_line	I-cell_line
of	IN	O	O
other	JJ	O	O
T-cell	NNP	B-cell_type	B-cell_type
and	CC	I-cell_type	O
natural	JJ	I-cell_type	I-cell_type
killer	NN	I-cell_type	I-cell_type
(	(	I-cell_type	I-cell_type
T/NK	NK	I-cell_type	O
)	)	I-cell_type	I-cell_type
populations	NNS	I-cell_type	I-cell_type
","		O	O
such	JJ	O	O
OTF-2	CD	B-protein	B-protein
as	IN	O	O
snRNA	NN	O	O
IgNF-A	NNP	B-DNA	B-DNA
and	CC	O	O
histone	NN	O	O
resting	VBG	B-cell_line	B-cell_line
cloned	VBN	I-cell_line	O
T	NNP	I-cell_line	I-cell_line
lymphocyte	NN	I-cell_line	I-cell_line
H2B	NN	O	O
promoters	NNS	O	O
CD8+	CD	B-cell_type	B-cell_type
CD28+	CD	I-cell_type	I-cell_type
population	NN	I-cell_type	I-cell_type
.	.	O	O
Two	CD	O	O
homo-	NN	B-protein	B-protein
or	CC	I-protein	O
heterodimeric	JJ	I-protein	I-protein
complexes	NNS	I-protein	I-protein
that	IN	O	O
bind	NN	O	O
beta-like	IN	B-DNA	O
globin	NN	I-DNA	I-DNA
locus	NN	I-DNA	I-DNA
specifically	RB	O	O
and	CC	O	O
L2	CD	B-cell_line	B-cell_line
with	IN	O	O
high	RB	O	O
T/NK	NK	B-cell_type	O
subsets	NNS	I-cell_type	I-cell_type
affinity	NN	O	O
to	TO	O	O
OTF	IN	B-protein	B-protein
the	DT	O	O
have	VB	O	O
beta-globin	RB	B-DNA	O
promoter	NN	I-DNA	I-DNA
been	VBN	O	O
identified	VBN	O	O
L2	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
.	.	O	O
is	VBZ	O	O
CD4+	CD	B-cell_type	B-cell_type
","		I-cell_type	I-cell_type
CD8+	CD	I-cell_type	I-cell_type
and	CC	I-cell_type	O
CD56+	CD	I-cell_type	I-cell_type
cell	NN	I-cell_type	I-cell_type
populations	NNS	I-cell_type	I-cell_type
present	VB	O	O
in	IN	O	O
OTFs	NNS	B-protein	B-protein
a	DT	O	O
variety	NN	O	O
beta-like	IN	B-DNA	O
globin	NN	I-DNA	I-DNA
cluster	NN	I-DNA	I-DNA
of	IN	O	O
cell	NN	O	O
L2	CD	B-cell_line	B-cell_line
and	CC	I-cell_line	O
L2	CD	I-cell_line	I-cell_line
variant	NN	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
types	NNS	O	O
","		O	O
T/NK-cell	NK-cell	B-cell_type	O
subsets	NNS	I-cell_type	I-cell_type
whereas	NNS	O	O
the	DT	O	O
lymphoid	NN	B-protein	B-protein
specific	JJ	I-protein	I-protein
octamer	NN	I-protein	I-protein
binding	VBG	I-protein	I-protein
protein	NN	I-protein	I-protein
presence	NN	O	O
of	IN	O	O
HSV	NNP	B-DNA	B-DNA
DNA	NN	I-DNA	I-DNA
is	VBZ	O	O
essentially	RB	O	O
L2	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
confined	VBN	O	O
to	TO	O	O
T/NK-cell	NK-cell	B-cell_type	O
","		O	O
leading	VBG	O	O
OTF-2B	NN	B-protein	B-protein
to	TO	O	O
the	DT	O	O
genes	NNS	B-DNA	B-DNA
UL49	CD	I-DNA	I-DNA
and	CC	I-DNA	O
UL50	CD	I-DNA	I-DNA
hypothesis	NN	O	O
that	IN	O	O
L2	CD	B-cell_line	B-cell_line
variant	NN	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
activates	NNS	O	O
cell-type-specific	JJ	O	O
T/NK	NK	B-cell_type	O
cells	NNS	I-cell_type	I-cell_type
transcription	NN	O	O
of	IN	O	O
octamer	NN	B-protein	B-protein
binding	VBG	I-protein	I-protein
proteins	NNS	I-protein	I-protein
the	DT	O	O
and	CC	O	O
UL21	CD	B-DNA	B-DNA
mediates	NNS	O	O
the	DT	O	O
L2	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
other	JJ	O	O
responses	NNS	O	O
AML	NNP	B-cell_type	B-cell_type
of	IN	O	O
the	DT	O	O
OTF-1	CD	B-protein	B-protein
.	.	O	O
Extracts	NNS	O	O
HIV-1	CD	B-DNA	B-DNA
enhancer	NN	I-DNA	I-DNA
of	IN	O	O
the	DT	O	O
LPS-stimulated	JJ	B-cell_line	B-cell_line
human	JJ	I-cell_line	I-cell_line
blood	NN	I-cell_line	I-cell_line
monocytes	NNS	I-cell_line	I-cell_line
","		O	O
","		O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
contain	VB	O	O
high	RB	O	O
transcription	NN	B-protein	B-protein
factors	NNS	I-protein	I-protein
levels	NNS	O	O
of	IN	O	O
NF-kappa	NN	B-DNA	B-DNA
B	NNP	I-DNA	I-DNA
sites	NNS	I-DNA	I-DNA
and	CC	O	O
specifically	RB	O	O
CML	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
transcribe	NN	O	O
.	.	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
In	IN	O	O
contrast	NN	O	O
lymphoid	NN	B-protein	B-protein
cell	NN	I-protein	I-protein
specific	JJ	I-protein	I-protein
octamer	NN	I-protein	I-protein
binding	VBG	I-protein	I-protein
protein	NN	I-protein	I-protein
","		O	O
extracts	NNS	O	O
chloramphenicol	NN	B-DNA	B-DNA
acetyltransferase	NN	I-DNA	I-DNA
(	(	I-DNA	I-DNA
CAT	NN	I-DNA	I-DNA
)	)	I-DNA	I-DNA
reporter	NN	I-DNA	I-DNA
from	IN	O	O
transcribed	VBN	O	O
thymidine	CD	B-cell_line	B-cell_line
kinase	NN	I-cell_line	I-cell_line
(	(	I-cell_line	I-cell_line
tk	NN	I-cell_line	I-cell_line
)	)	I-cell_line	I-cell_line
inducible	JJ	I-cell_line	I-cell_line
human	JJ	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
the	DT	O	O
poorly	RB	O	O
T	NNP	B-cell_type	B-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
.	.	O	O
Surprisingly	RB	O	O
OTF-2A	CD	B-protein	B-protein
","		O	O
addition	NN	O	O
cDNA	NN	B-DNA	B-DNA
of	IN	O	O
either	DT	O	O
TK6i-G3	CD	B-cell_line	B-cell_line
and	CC	I-cell_line	O
G9	CD	I-cell_line	I-cell_line
tk	NN	I-cell_line	I-cell_line
heterozygous	JJ	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
affinity-enriched	JJ	O	O
NF-A2	CD	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
or	CC	O	O
NF-A1	CD	O	O
B	NNP	B-protein	B-protein
cell	NN	I-protein	I-protein
specific	JJ	I-protein	I-protein
octamer	NN	I-protein	I-protein
binding	VBG	I-protein	I-protein
protein	NN	I-protein	I-protein
to	TO	O	O
either	DT	O	O
exons	NNS	B-DNA	B-DNA
1��8��	CD	I-DNA	I-DNA
a	DT	O	O
HeLa	NNP	O	O
human	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
extract	VB	O	O
or	CC	O	O
human	JJ	B-cell_type	B-cell_type
glial	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
and	CC	I-cell_type	O
lymphocytes	NNS	I-cell_type	I-cell_type
a	DT	O	O
partially	RB	O	O
OTF-2B	NN	B-protein	B-protein
purified	VBN	O	O
reaction	NN	O	O
exon	NN	B-DNA	B-DNA
5	CD	I-DNA	I-DNA
system	NN	O	O
specifically	RB	O	O
PMA	NNP	B-cell_line	B-cell_line
induced	VBN	I-cell_line	O
HL60	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
stimulates	NNS	O	O
the	DT	O	O
lymphocyte	NN	B-cell_type	B-cell_type
.	.	O	O
This	DT	O	O
OTF-2B	NN	B-protein	B-protein
suggests	NNS	O	O
that	IN	O	O
exon	NN	B-DNA	B-DNA
7	CD	I-DNA	I-DNA
the	DT	O	O
constitutive	JJ	O	O
TF-1	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
can	MD	O	O
activate	NN	O	O
lymphocyte	NN	B-cell_type	B-cell_type
transcription	NN	O	O
of	IN	O	O
OTF-2A	CD	B-protein	B-protein
the	DT	O	O
and	CC	O	O
FasL	NNP	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
that	IN	O	O
#NAME?	# NAME	O	O
erythroleukemia	NN	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
transcription	NN	O	O
of	IN	O	O
human	JJ	B-cell_type	B-cell_type
tumors	NNS	I-cell_type	I-cell_type
this	DT	O	O
promoter	NN	O	O
novel	NN	B-protein	B-protein
octamer	NN	I-protein	I-protein
factor	NN	I-protein	I-protein
","		O	O
at	IN	O	O
NF-kappa	NN	B-DNA	B-DNA
B	NNP	I-DNA	I-DNA
and	CC	I-DNA	O
AP-1	CD	I-DNA	I-DNA
binding	VBG	I-DNA	I-DNA
sites	NNS	I-DNA	I-DNA
least	JJS	O	O
in	IN	O	O
TF-1	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
vitro	NN	O	O
","		O	O
mature	VB	B-cell_type	O
peripheral	JJ	I-cell_type	I-cell_type
blood-derived	JJ	I-cell_type	I-cell_type
myeloid	NN	I-cell_type	I-cell_type
and	CC	I-cell_type	O
lymphoid	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
is	VBZ	O	O
partially	RB	O	O
OTF-2B	NN	B-protein	B-protein
due	JJ	O	O
to	TO	O	O
human	JJ	B-DNA	B-DNA
immunodeficiency	NN	I-DNA	I-DNA
virus	NN	I-DNA	I-DNA
type	NN	I-DNA	I-DNA
1	CD	I-DNA	I-DNA
long	RB	I-DNA	O
terminal	NN	I-DNA	I-DNA
repeat	VB	I-DNA	O
a	DT	O	O
quantitative	JJ	O	O
TF-1	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
difference	NN	O	O
in	IN	O	O
bone	NN	B-cell_type	B-cell_type
marrow	VB	I-cell_type	O
haemopoietic	JJ	I-cell_type	I-cell_type
progenitors	NNS	I-cell_type	I-cell_type
the	DT	O	O
amount	NN	O	O
60	CD	B-protein	B-protein
kd	NN	I-protein	I-protein
species	NNS	I-protein	I-protein
OTF-2A	CD	I-protein	I-protein
of	IN	O	O
.	.	O	O
HIV-1	CD	B-DNA	B-DNA
LTR	NNP	I-DNA	I-DNA
Because	IN	O	O
can	MD	O	O
TF-1	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
stimulate	VB	O	O
transcription	NN	O	O
ringed	VBN	B-cell_type	O
sideroblasts	NNS	I-cell_type	I-cell_type
","		O	O
the	DT	O	O
interleukin	VB	B-protein	O
2	CD	I-protein	I-protein
inability	NN	O	O
of	IN	O	O
HIV-1	CD	B-DNA	B-DNA
LTR-dependent	JJ	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
this	DT	O	O
factor	NN	O	O
TF-1	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
to	TO	O	O
activate	NN	O	O
highly	RB	B-cell_type	O
purified	VBN	I-cell_type	O
immature	NN	I-cell_type	I-cell_type
CD34+	CD	I-cell_type	I-cell_type
38-	CD	I-cell_type	I-cell_type
and	CC	I-cell_type	O
committed	VBN	I-cell_type	O
CD34+	CD	I-cell_type	I-cell_type
38+	CD	I-cell_type	I-cell_type
marrow-derived	JJ	I-cell_type	I-cell_type
progenitors	NNS	I-cell_type	I-cell_type
in	IN	O	O
vivo	NN	O	O
inhibitory	NN	B-protein	B-protein
protein	NN	I-protein	I-protein
the	DT	O	O
to	TO	O	O
luciferase	NN	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
the	DT	O	O
same	JJ	O	O
HL-60	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
degree	VB	O	O
as	IN	O	O
CD16+	CD	B-cell_type	B-cell_type
14-	CD	I-cell_type	I-cell_type
granulocytes	NNS	I-cell_type	I-cell_type
the	DT	O	O
probably	RB	O	O
interleukin	VB	B-protein	O
2	CD	I-protein	I-protein
reflects	NNS	O	O
a	DT	O	O
wild-type	JJ	B-DNA	B-DNA
","		I-DNA	I-DNA
but	CC	I-DNA	O
not	RB	I-DNA	O
the	DT	I-DNA	O
kappaB-mutated	JJ	I-DNA	I-DNA
","		I-DNA	I-DNA
HIV-1	CD	I-DNA	I-DNA
LTR	NNP	I-DNA	I-DNA
region	NN	I-DNA	I-DNA
difference	NN	O	O
in	IN	O	O
HL-60	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
the	DT	O	O
context	NN	O	O
CD14+	CD	B-cell_type	B-cell_type
monocytes	NNS	I-cell_type	I-cell_type
of	IN	O	O
the	DT	O	O
IL	NNP	B-protein	B-protein
2	CD	I-protein	I-protein
in	IN	O	O
these	DT	O	O
Human	NNP	B-DNA	B-DNA
immunodeficiency	NN	I-DNA	I-DNA
virus	NN	I-DNA	I-DNA
type	NN	I-DNA	I-DNA
1	CD	I-DNA	I-DNA
long	RB	I-DNA	O
terminal	NN	I-DNA	I-DNA
repeat	VB	I-DNA	O
two	CD	O	O
types	NNS	O	O
HL-60	CD	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
of	IN	O	O
.	.	O	O
CD3+	CD	B-cell_type	B-cell_type
T	NNP	I-cell_type	I-cell_type
and	CC	I-cell_type	O
CD19+	CD	I-cell_type	I-cell_type
B	NNP	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
Identification	NN	O	O
of	IN	O	O
hormone	NN	B-protein	B-protein
a	DT	O	O
putative	JJ	O	O
long	RB	B-DNA	O
terminal	NN	I-DNA	I-DNA
repeat	VB	I-DNA	O
regulator	NN	O	O
of	IN	O	O
Tax-expressing	JJ	B-cell_line	B-cell_line
JPX-9	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
.	.	O	O
Molecules	NNS	O	O
granulocytes	NNS	B-cell_type	B-cell_type
involved	VBN	O	O
in	IN	O	O
IL	NNP	B-protein	B-protein
2	CD	I-protein	I-protein
the	DT	O	O
antigen	NN	O	O
LTR	NNP	B-DNA	B-DNA
receptor-dependent	JJ	O	O
regulation	NN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
of	IN	O	O
were	VBD	O	O
monocytes	NNS	B-cell_type	B-cell_type
investigated	VBN	O	O
with	IN	O	O
IL	NNP	B-protein	B-protein
2	CD	I-protein	I-protein
the	DT	O	O
use	NN	O	O
LTR-directed	JJ	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
of	IN	O	O
functional	JJ	O	O
ovarian	JJ	B-cell_line	B-cell_line
cancer	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
sequences	NNS	O	O
of	IN	O	O
CD34+	CD	B-cell_type	B-cell_type
progenitor	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
the	DT	O	O
of	IN	O	O
IL	NNP	B-protein	B-protein
2	CD	I-protein	I-protein
receptors	NNS	I-protein	I-protein
(	(	O	O
)	)	O	O
LTRs	NNS	B-DNA	B-DNA
.	.	O	O
One	CD	O	O
purified	VBN	B-cell_line	O
human	JJ	I-cell_line	I-cell_line
erythroid	NN	I-cell_line	I-cell_line
colony-forming	VBG	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
of	IN	O	O
these	DT	O	O
CD3+	CD	B-cell_type	B-cell_type
T	NNP	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
sequences	NNS	O	O
forms	NNS	O	O
glucocorticoid	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
a	DT	O	O
protein	NN	O	O
LTRs	NNS	B-DNA	B-DNA
complex	NN	O	O
","		O	O
ECFC	NNP	B-cell_line	B-cell_line
","		O	O
specifically	RB	O	O
CD19+	CD	B-cell_type	B-cell_type
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
with	IN	O	O
nuclear	JJ	O	O
hormones	NNS	B-protein	B-protein
extracts	NNS	O	O
of	IN	O	O
LAI	NNP	B-DNA	B-DNA
LTR	NNP	I-DNA	I-DNA
activated	VBN	O	O
.	.	O	O
human	JJ	B-cell_line	B-cell_line
Jurkat	NNP	I-cell_line	I-cell_line
T-cells	NNS	I-cell_line	I-cell_line
This	DT	O	O
complex	NN	O	O
CD3+	CD	B-cell_type	B-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
appeared	VBD	O	O
10	CD	O	O
inhibitory	NN	B-protein	B-protein
protein	NN	I-protein	I-protein
to	TO	O	O
25	CD	O	O
455-bp	CD	B-DNA	B-DNA
U3	CD	I-DNA	I-DNA
region	NN	I-DNA	I-DNA
minutes	NNS	O	O
before	IN	O	O
human	JJ	B-cell_line	B-cell_line
Jurkat	NNP	I-cell_line	I-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
the	DT	O	O
activation	NN	O	O
monoclonal	JJ	B-cell_type	B-cell_type
B	NNP	I-cell_type	I-cell_type
and	CC	I-cell_type	O
polyclonal	JJ	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
of	IN	O	O
the	DT	O	O
IL	NNP	B-protein	B-protein
2	CD	I-protein	I-protein
.	.	O	O
Studies	NNS	O	O
LTRs	NNS	B-DNA	B-DNA
with	IN	O	O
inhibitors	NNS	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T-cells	NNS	I-cell_line	I-cell_line
of	IN	O	O
protein	NN	O	O
progenitor	NN	B-cell_type	B-cell_type
synthesis	NN	O	O
indicated	VBN	O	O
IL	NNP	B-protein	B-protein
2	CD	I-protein	I-protein
that	IN	O	O
the	DT	O	O
LAI	NNP	B-DNA	B-DNA
LTR	NNP	I-DNA	I-DNA
time	NN	O	O
of	IN	O	O
Raji	NNP	B-cell_line	B-cell_line
B	NNP	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lymphoma	NN	I-cell_line	I-cell_line
synthesis	NN	O	O
of	IN	O	O
myeloid	NN	B-cell_type	B-cell_type
and	CC	I-cell_type	O
B-lymphoid	JJ	I-cell_type	I-cell_type
lineages	NNS	I-cell_type	I-cell_type
the	DT	O	O
activator	NN	O	O
IL	NNP	B-protein	B-protein
2	CD	I-protein	I-protein
receptor	NN	I-protein	I-protein
of	IN	O	O
the	DT	O	O
LTRs	NNS	B-DNA	B-DNA
in	IN	O	O
corresponds	NNS	O	O
CHO	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
to	TO	O	O
the	DT	O	O
mature	VB	B-cell_type	O
myeloid	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
time	NN	O	O
of	IN	O	O
hormones	NNS	B-protein	B-protein
appearance	NN	O	O
of	IN	O	O
LTRs	NNS	B-DNA	B-DNA
.	.	O	O
","		O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
or	CC	O	O
a	DT	O	O
committed	VBN	B-cell_type	O
marrow	VB	I-cell_type	O
progenitors	NNS	I-cell_type	I-cell_type
very	RB	O	O
similar	JJ	O	O
IL	NNP	B-protein	B-protein
2	CD	I-protein	I-protein
protein	NN	O	O
","		O	O
LAI	NNP	B-DNA	B-DNA
LTR	NNP	I-DNA	I-DNA
bound	VBN	O	O
functional	JJ	O	O
neuroblastoma	NN	B-cell_line	B-cell_line
(	(	I-cell_line	I-cell_line
NB	NNP	I-cell_line	I-cell_line
)	)	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
sequences	NNS	O	O
of	IN	O	O
human	JJ	B-cell_type	B-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
the	DT	O	O
(	(	O	O
human	JJ	B-protein	B-protein
immunoglobulin-enhancer-binding	JJ	I-protein	I-protein
protein	NN	I-protein	I-protein
)	)	O	O
of	IN	O	O
LTR	NNP	B-DNA	B-DNA
sequence	NN	I-DNA	I-DNA
the	DT	O	O
human	JJ	O	O
NB	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
immunodeficiency	NN	O	O
virus	NN	O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
and	CC	I-cell_type	O
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
type	NN	O	O
1	CD	O	O
NF-kappa	NN	B-protein	B-protein
B	NNP	I-protein	I-protein
;	:	O	O
the	DT	O	O
cis-acting	NN	B-DNA	B-DNA
sites	NNS	I-DNA	I-DNA
of	IN	O	O
this	DT	O	O
NB	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
virus	NN	O	O
is	VBZ	O	O
peripheral	JJ	B-cell_type	B-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
known	VBN	O	O
to	TO	O	O
enhancer-binding	JJ	B-protein	B-protein
factor	NN	I-protein	I-protein
NF-kappa	NN	I-protein	I-protein
B	NNP	I-protein	I-protein
be	VB	O	O
stimulated	VBN	O	O
U3	CD	B-DNA	B-DNA
region	NN	I-DNA	I-DNA
during	IN	O	O
early	RB	O	O
NB	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
activation	NN	O	O
.	.	O	O
T	NNP	B-cell_type	B-cell_type
and	CC	I-cell_type	O
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
The	DT	O	O
for	IN	O	O
NF-kappa	NN	B-protein	B-protein
B	NNP	I-protein	I-protein
this	DT	O	O
complex	NN	O	O
LTR	NNP	B-DNA	B-DNA
activated	VBN	O	O
a	DT	O	O
clonogenic	NN	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
linked	VBN	O	O
promoter	NN	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
after	IN	O	O
transfection	NN	O	O
51-kDa	NN	B-protein	B-protein
polypeptide	NN	I-protein	I-protein
into	IN	O	O
but	CC	O	O
LEF-1	CD	B-DNA	B-DNA
and	CC	I-DNA	O
distal	JJ	I-DNA	I-DNA
NF-kappaB	NNP	I-DNA	I-DNA
transcription	NN	I-DNA	I-DNA
factor	NN	I-DNA	I-DNA
binding	VBG	I-DNA	I-DNA
sites	NNS	I-DNA	I-DNA
not	RB	O	O
other	JJ	O	O
human	JJ	B-cell_line	B-cell_line
acute	NN	I-cell_line	I-cell_line
nonlymphocytic	JJ	I-cell_line	I-cell_line
leukemia	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
HL-60	CD	I-cell_line	I-cell_line
and	CC	I-cell_line	O
KG-1	CD	I-cell_line	I-cell_line
cell	NN	O	O
types	NNS	O	O
Human	NNP	B-cell_type	B-cell_type
white	JJ	I-cell_type	I-cell_type
blood	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
.	.	O	O
These	DT	O	O
NF-kappa	NN	B-protein	B-protein
B	NNP	I-protein	I-protein
characteristics	NNS	O	O
suggest	JJS	O	O
HIV-1	CD	B-DNA	B-DNA
LTR	NNP	I-DNA	I-DNA
that	IN	O	O
transmits	NNS	O	O
Mononuclear	JJ	B-cell_line	B-cell_line
or	CC	I-cell_line	O
clonogenic	NN	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
signals	NNS	O	O
initiated	VBN	O	O
human	JJ	B-cell_type	B-cell_type
white	JJ	I-cell_type	I-cell_type
blood	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
at	IN	O	O
the	DT	O	O
glucocorticoid	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
.	.	O	O
Characterization	NN	O	O
LTR	NNP	B-DNA	B-DNA
sequence	NN	I-DNA	I-DNA
of	IN	O	O
in	IN	O	O
clonogenic	NN	B-cell_line	B-cell_line
HL-60	CD	I-cell_line	I-cell_line
and	CC	I-cell_line	O
KG-1	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
.	.	O	O
Although	IN	O	O
class	NN	B-cell_type	B-cell_type
II+	NNP	I-cell_type	I-cell_type
mature	VB	I-cell_type	O
B-cells	NNS	I-cell_type	I-cell_type
putatively	RB	O	O
identified	VBN	O	O
glucocorticoid	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
more	JJR	O	O
than	IN	O	O
mammalian	JJ	B-DNA	B-DNA
sex-determining	NN	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
Sry	NNP	I-DNA	I-DNA
10	CD	O	O
years	NNS	O	O
mononuclear	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
preparations	NNS	I-cell_line	I-cell_line
ago	RB	O	O
","		O	O
class	NN	B-cell_type	B-cell_type
II-	NNP	I-cell_type	I-cell_type
plasma	NN	I-cell_type	I-cell_type
B-cells	NNS	I-cell_type	I-cell_type
in	IN	O	O
human	JJ	O	O
glucocorticoid	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
tissues	NNS	O	O
remain	VB	O	O
MRP14	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
poorly	RB	O	O
characterized	VBN	O	O
labeled	VBN	B-cell_line	O
cells	NNS	I-cell_line	I-cell_line
.	.	O	O
As	IN	O	O
class	NN	B-cell_type	B-cell_type
II+	NNP	I-cell_type	I-cell_type
mature	VB	I-cell_type	O
B-cells	NNS	I-cell_type	I-cell_type
a	DT	O	O
first	RB	O	O
glucocorticoid	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
step	NN	O	O
towards	NNS	O	O
transcription	NN	B-DNA	B-DNA
factor	NN	I-DNA	I-DNA
binding	VBG	I-DNA	I-DNA
motifs	NNS	I-DNA	I-DNA
understanding	VBG	O	O
the	DT	O	O
CML	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
mechanism	NN	O	O
of	IN	O	O
antibody-secreting	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
thyroid	NN	O	O
hormone	NN	O	O
human	JJ	B-protein	B-protein
lymphoid-specific	JJ	I-protein	I-protein
octamer-binding	JJ	I-protein	I-protein
protein	NN	I-protein	I-protein
action	NN	O	O
in	IN	O	O
CCAAT/enhancer	enhancer	B-DNA	O
binding	VBG	I-DNA	I-DNA
protein	NN	I-DNA	I-DNA
(	(	I-DNA	I-DNA
C/EBP	EBP	I-DNA	O
)	)	I-DNA	I-DNA
#NAME?	# NAME	I-DNA	O
motif	NN	I-DNA	I-DNA
man	NN	O	O
we	PRP	O	O
1	CD	B-cell_line	B-cell_line
","		I-cell_line	I-cell_line
25-	CD	I-cell_line	I-cell_line
(	(	I-cell_line	I-cell_line
OH	NNP	I-cell_line	I-cell_line
)	)	I-cell_line	I-cell_line
2D3	CD	I-cell_line	I-cell_line
receptor-positive	JJ	I-cell_line	I-cell_line
T47D	CD	I-cell_line	I-cell_line
have	VB	O	O
characterized	VBN	O	O
B	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
in	IN	O	O
nuclei	NNS	O	O
OTF-2	CD	B-protein	B-protein
of	IN	O	O
the	DT	O	O
upstream	NN	B-DNA	B-DNA
region	NN	I-DNA	I-DNA
","		O	O
.	.	O	O
T47D	CD	B-cell_line	B-cell_line
In	IN	O	O
whole	WP	O	O
gp39-expressing	JJ	B-cell_type	B-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
cell	NN	O	O
experiments	NNS	O	O
ubiquitous	JJ	B-protein	B-protein
and	CC	I-protein	O
B	NNP	I-protein	I-protein
cell-specific	JJ	I-protein	I-protein
octamer-binding	JJ	I-protein	I-protein
proteins	NNS	I-protein	I-protein
at	IN	O	O
37	CD	O	O
MRP14	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
degrees	NNS	O	O
C	NNP	O	O
T47D	CD	B-cell_line	B-cell_line
","		O	O
nuclear	JJ	O	O
human	JJ	B-cell_type	B-cell_type
Wurzburg	NNP	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
binding	VBG	O	O
of	IN	O	O
B	NNP	B-protein	B-protein
cell	NN	I-protein	I-protein
factor	NN	I-protein	I-protein
was	VBD	O	O
saturable	JJ	O	O
luciferase	NN	B-DNA	B-DNA
reporter	NN	I-DNA	I-DNA
DNAs	NNS	I-DNA	I-DNA
(	(	O	O
Kd	NNP	O	O
CML	NNP	B-cell_line	B-cell_line
34	CD	O	O
+/-	-	O	O
rat	NN	B-cell_type	B-cell_type
thymocytes	NNS	I-cell_type	I-cell_type
6	CD	O	O
pmol/l	l	O	O
B	NNP	B-protein	B-protein
cell-specific	JJ	I-protein	I-protein
factor	NN	I-protein	I-protein
)	)	O	O
and	CC	O	O
MRP14	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
of	IN	O	O
finite	VB	O	O
CML	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
capacity	NN	O	O
(	(	O	O
affected	VBN	B-cell_type	O
blood	NN	I-cell_type	I-cell_type
cell	NN	I-cell_type	I-cell_type
lineages	NNS	I-cell_type	I-cell_type
approximately	RB	O	O
equal	JJ	O	O
affinity-purified	JJ	B-protein	B-protein
ubiquitous	JJ	I-protein	I-protein
factor	NN	I-protein	I-protein
to	TO	O	O
350	CD	O	O
X-chromosome	JJ	B-DNA	B-DNA
sites/cell	cell	O	O
)	)	O	O
mouse	NN	B-cell_line	B-cell_line
and	CC	I-cell_line	O
human	JJ	I-cell_line	I-cell_line
lymphoid	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
.	.	O	O
The	DT	O	O
lymphoid	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
were	VBD	O	O
extracted	VBN	O	O
B	NNP	B-protein	B-protein
cell-specific	JJ	I-protein	I-protein
octamer-binding	JJ	I-protein	I-protein
factor	NN	I-protein	I-protein
from	IN	O	O
a	DT	O	O
X-chromosome	JJ	B-DNA	B-DNA
nuclear	JJ	O	O
pellet	NN	O	O
mouse	NN	B-cell_line	B-cell_line
and	CC	I-cell_line	O
human	JJ	I-cell_line	I-cell_line
lymphoid	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
by	IN	O	O
treatment	NN	O	O
human	JJ	B-cell_type	B-cell_type
umbilical	JJ	I-cell_type	I-cell_type
vein	NN	I-cell_type	I-cell_type
endothelial	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
with	IN	O	O
0.4	CD	O	O
B	NNP	B-protein	B-protein
cell-specific	JJ	I-protein	I-protein
transcription	NN	I-protein	I-protein
factor	NN	I-protein	I-protein
mol/l	l	O	O
KCl	NNP	O	O
major	JJ	B-DNA	B-DNA
histocompatibility	NN	I-DNA	I-DNA
complex	NN	I-DNA	I-DNA
class	NN	I-DNA	I-DNA
II	NNP	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
and	CC	O	O
sonication	NN	O	O
Cell	NNP	B-cell_line	B-cell_line
lines	NNS	I-cell_line	I-cell_line
.	.	O	O
Separation	NNP	O	O
endothelial	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
of	IN	O	O
bound	VBN	O	O
ubiquitous	JJ	B-protein	B-protein
and	CC	I-protein	O
B	NNP	I-protein	I-protein
cell-specific	JJ	I-protein	I-protein
octamer-binding	JJ	I-protein	I-protein
factors	NNS	I-protein	I-protein
from	IN	O	O
free	JJ	O	O
CCAAT-box	NNP	B-DNA	B-DNA
DNA	NN	I-DNA	I-DNA
motifs	NNS	I-DNA	I-DNA
in	IN	O	O
the	DT	O	O
dexamethasone-sensitive	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
extracts	NNS	O	O
was	VBD	O	O
adherent	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
achieved	VBN	O	O
using	VBG	O	O
glucocorticoid-receptor	NN	B-protein	B-protein
complex	NN	I-protein	I-protein
the	DT	O	O
calcium	NN	O	O
class	NN	B-DNA	B-DNA
II	NNP	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
phosphate	NN	O	O
matrix	NN	O	O
dexamethasone-resistant	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
","		O	O
hydroxyapatite	NN	O	O
adherent	JJ	B-cell_type	B-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
at	IN	O	O
a	DT	O	O
glucocorticoid	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
concentration	NN	O	O
of	IN	O	O
abnormal	JJ	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
0.3	CD	O	O
ml	NN	O	O
pokeweed	NN	B-cell_line	B-cell_line
mitogen-stimulated	JJ	I-cell_line	I-cell_line
cultures	NNS	I-cell_line	I-cell_line
of	IN	O	O
a	DT	O	O
endothelial	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
150	CD	O	O
g/l	l	O	O
GR	NNP	B-protein	B-protein
slurry	NN	O	O
.	.	O	O
CAG	NNP	B-DNA	B-DNA
repeat	VB	I-DNA	O
Rectilinear	VB	O	O
Scatchard	NNP	O	O
CLL	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
plots	NNS	O	O
were	VBD	O	O
rolling	VBG	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
obtained	VBN	O	O
only	RB	O	O
GR	NNP	B-protein	B-protein
when	WRB	O	O
the	DT	O	O
first	RB	B-DNA	O
exon	NN	I-DNA	I-DNA
hydroxyapatite	NN	O	O
was	VBD	O	O
human	JJ	B-cell_line	B-cell_line
CLL	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
washed	VBD	O	O
with	IN	O	O
leukocytes	NNS	B-cell_type	B-cell_type
a	DT	O	O
buffer	NN	O	O
GR	NNP	B-protein	B-protein
complex	NN	I-protein	I-protein
containing	VBG	O	O
0.5	CD	O	O
androgen	NN	B-DNA	B-DNA
receptor	NN	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
%	NN	O	O
Triton	NNP	O	O
high	RB	B-cell_line	O
receptor	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
X-100	CD	O	O
.	.	O	O
IL-1beta-stimulated	JJ	B-cell_type	B-cell_type
endothelial	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
Under	IN	O	O
these	DT	O	O
GR	NNP	B-protein	B-protein
complexes	NNS	I-protein	I-protein
conditions	NNS	O	O
in	IN	O	O
active	JJ	B-DNA	B-DNA
X	NNP	I-DNA	I-DNA
chromosome	NN	I-DNA	I-DNA
the	DT	O	O
nuclear	JJ	O	O
low-receptor	NN	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
extracts	NNS	O	O
were	VBD	O	O
leukocytes	NNS	B-cell_type	B-cell_type
present	VB	O	O
at	IN	O	O
GR	NNP	B-protein	B-protein
complex	NN	I-protein	I-protein
a	DT	O	O
concentration	NN	O	O
paternal	NN	B-DNA	B-DNA
and	CC	I-DNA	O
maternal	NN	I-DNA	I-DNA
alleles	NNS	I-DNA	I-DNA
of	IN	O	O
22.4	CD	O	O
low-receptor	NN	B-cell_line	B-cell_line
lines	NNS	I-cell_line	I-cell_line
+/-	-	O	O
8.6	CD	O	O
leukocytes	NNS	B-cell_type	B-cell_type
fmol/mg	mg	O	O
protein	NN	O	O
Granulocyte-macrophage	NN	B-protein	B-protein
colony-stimulating	VBG	I-protein	I-protein
factor	NN	I-protein	I-protein
and	CC	O	O
showed	VBD	O	O
dominant	NN	B-DNA	B-DNA
negative	JJ	I-DNA	I-DNA
(	(	I-DNA	I-DNA
DN	NNP	I-DNA	I-DNA
)	)	I-DNA	I-DNA
Ikaros	NNS	I-DNA	I-DNA
mutation	NN	I-DNA	I-DNA
an	DT	O	O
affinity	NN	O	O
cultured	VBN	B-cell_line	O
human	JJ	I-cell_line	I-cell_line
lymphoblasts	NNS	I-cell_line	I-cell_line
of	IN	O	O
(	(	O	O
IL-1beta-treated	JJ	B-cell_type	B-cell_type
endothelial	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
Kd	NNP	O	O
","		O	O
multilineage	NN	B-protein	B-protein
growth	NN	I-protein	I-protein
factor	NN	I-protein	I-protein
room	NN	O	O
temperature	NN	O	O
Ikaros	NNS	B-DNA	B-DNA
mutations	NNS	I-DNA	I-DNA
)	)	O	O
140	CD	O	O
human	JJ	B-cell_line	B-cell_line
lymphoblast	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
+/-	-	O	O
10	CD	O	O
leukocytes	NNS	B-cell_type	B-cell_type
pmol/l	l	O	O
.	.	O	O
granulocyte-macrophage	NN	B-protein	B-protein
colony-stimulating	VBG	I-protein	I-protein
factor	NN	I-protein	I-protein
The	DT	O	O
same	JJ	O	O
multiple	JJ	B-DNA	B-DNA
B	NNP	I-DNA	I-DNA
lineage	NN	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
assay	NN	O	O
system	NN	O	O
LICR-LON-HMy2	CD	B-cell_line	B-cell_line
was	VBD	O	O
used	VBN	O	O
endothelial	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
to	TO	O	O
determine	NN	O	O
GM-CSF	NNP	B-protein	B-protein
the	DT	O	O
hierarchy	WRB	O	O
many	JJ	B-DNA	B-DNA
B	NNP	I-DNA	I-DNA
lineage	NN	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
of	IN	O	O
affinities	NNS	O	O
HMy2	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
for	IN	O	O
a	DT	O	O
human	JJ	B-cell_type	B-cell_type
umbilical	JJ	I-cell_type	I-cell_type
vein	NN	I-cell_type	I-cell_type
endothelial	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
range	NN	O	O
of	IN	O	O
GM-CSF	NNP	B-protein	B-protein
natural	JJ	O	O
and	CC	O	O
B	NNP	B-DNA	B-DNA
lineage-associated	JJ	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
synthetic	NN	O	O
analogues	NNS	O	O
GM4672A	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
.	.	O	O
Calling	VBG	O	O
adhering	VBG	B-cell_type	B-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
T3	CD	O	O
100	CD	O	O
1	CD	B-protein	B-protein
","		I-protein	I-protein
25	CD	I-protein	I-protein
(	(	I-protein	I-protein
OH	NNP	I-protein	I-protein
)	)	I-protein	I-protein
2D3	CD	I-protein	I-protein
cellular	JJ	I-protein	I-protein
receptors	NNS	I-protein	I-protein
","		O	O
the	DT	O	O
3.6	CD	B-DNA	B-DNA
kilobases	NNS	I-DNA	I-DNA
order	NN	O	O
of	IN	O	O
HMy2	CD	B-cell_line	B-cell_line
and	CC	I-cell_line	O
GM4672A	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
potencies	NNS	O	O
observed	VBN	O	O
hemopoietic	JJ	B-cell_type	B-cell_type
stem	NN	I-cell_type	I-cell_type
cell	NN	I-cell_type	I-cell_type
was	VBD	O	O
:	:	O	O
GM-CSF	NNP	B-protein	B-protein
Triac	NNP	O	O
","		O	O
c-myc	NN	B-DNA	B-DNA
500	CD	O	O
;	:	O	O
HMy2	CD	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
3	CD	O	O
","		O	O
B	NNP	B-cell_type	B-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
5-diiodo-3'-isopropylthyronine	CD	O	O
","		O	O
interleukin	VB	B-protein	O
2	CD	I-protein	I-protein
89	CD	O	O
;	:	O	O
bcl-6	CD	B-DNA	B-DNA
T4	CD	O	O
","		O	O
GM4672A	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
32	CD	O	O
;	:	O	O
B	NNP	B-cell_type	B-cell_type
lineage	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
3	CD	O	O
","		O	O
cellular	JJ	B-protein	B-protein
1	CD	I-protein	I-protein
","		I-protein	I-protein
25	CD	I-protein	I-protein
(	(	I-protein	I-protein
OH	NNP	I-protein	I-protein
)	)	I-protein	I-protein
2D3	CD	I-protein	I-protein
receptors	NNS	I-protein	I-protein
5-dimethyl-3'isopropylthyronine	CD	O	O
2	CD	O	O
tumor-suppressor	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
;	:	O	O
3	CD	O	O
Dex-treated	JJ	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
","		O	O
5-T2	CD	O	O
human	JJ	B-cell_type	B-cell_type
T	NNP	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
","		O	O
0.7	CD	O	O
nuclear	JJ	B-protein	B-protein
receptors	NNS	I-protein	I-protein
","		O	O
rT3	NN	O	O
IL-8	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
reporter	NN	I-DNA	I-DNA
constructs	NNS	I-DNA	I-DNA
","		O	O
0.4	CD	O	O
Dex-treated	JJ	B-cell_line	B-cell_line
GM4672A	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
;	:	O	O
3'5'-T2	CD	O	O
human	JJ	B-cell_type	B-cell_type
peripheral	JJ	I-cell_type	I-cell_type
blood	NN	I-cell_type	I-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
","		O	O
less	JJR	O	O
nuclear	JJ	B-protein	B-protein
receptors	NNS	I-protein	I-protein
than	IN	O	O
0.01	CD	O	O
NF-kappaB	NNP	B-DNA	B-DNA
and	CC	I-DNA	O
3'NF-IL-6	CD	I-DNA	I-DNA
DNA	NN	I-DNA	I-DNA
binding	VBG	I-DNA	I-DNA
sites	NNS	I-DNA	I-DNA
.	.	O	O
These	DT	O	O
GM4672A	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
results	NNS	O	O
suggest	JJS	O	O
PBMCs	NNS	B-cell_type	B-cell_type
that	IN	O	O
the	DT	O	O
thyroid	NN	B-protein	B-protein
hormone	NN	I-protein	I-protein
receptors	NNS	I-protein	I-protein
present	VB	O	O
in	IN	O	O
IL-8	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
nuclei	NNS	O	O
and	CC	O	O
HMy2	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
extracts	NNS	O	O
thereof	RB	O	O
PBMCs	NNS	B-cell_type	B-cell_type
are	VBP	O	O
.	.	O	O
monoclonal	JJ	B-protein	B-protein
anti-human	JJ	I-protein	I-protein
corticosteroid-binding	JJ	I-protein	I-protein
globulin	NN	I-protein	I-protein
(	(	I-protein	I-protein
CBG	NNP	I-protein	I-protein
)	)	I-protein	I-protein
antibody	NN	I-protein	I-protein
These	DT	O	O
cells	NNS	O	O
5'NF-IL-6	CD	B-DNA	B-DNA
binding	VBG	I-DNA	I-DNA
site	NN	I-DNA	I-DNA
may	MD	O	O
be	VB	O	O
HMy2	CD	B-cell_line	B-cell_line
and	CC	I-cell_line	O
GM4672A	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
a	DT	O	O
useful	JJ	O	O
epithelial	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
tool	NN	O	O
to	TO	O	O
phosphodiesterase	NN	B-protein	B-protein
increase	NN	O	O
our	PRP$	O	O
IL-8	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
understanding	VBG	O	O
of	IN	O	O
GM4672A	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
Definition	NN	O	O
of	IN	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
that	IN	O	O
interact	VB	O	O
adenylate	VB	B-protein	O
cyclase	NN	I-protein	I-protein
with	IN	O	O
a	DT	O	O
serum	NN	B-DNA	B-DNA
response	NN	I-DNA	I-DNA
region	NN	I-DNA	I-DNA
in	IN	O	O
the	DT	O	O
human	JJ	B-cell_line	B-cell_line
mononuclear	JJ	I-cell_line	I-cell_line
leukocytes	NNS	I-cell_line	I-cell_line
.	.	O	O
Analysis	NN	O	O
human	JJ	B-cell_type	B-cell_type
peripheral	JJ	I-cell_type	I-cell_type
blood-derived	JJ	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
lymphoblasts	NNS	I-cell_type	I-cell_type
of	IN	O	O
the	DT	O	O
phosphodiesterase	NN	B-protein	B-protein
region	NN	O	O
3	CD	O	O
tissue	NN	B-DNA	B-DNA
factor	NN	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
'	''	O	O
to	TO	O	O
lymphocyte	NN	B-cell_line	B-cell_line
subpopulations	NNS	I-cell_line	I-cell_line
the	DT	O	O
(	(	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
encoding	VBG	O	O
regulatory	JJ	O	O
anti-CBG	NN	B-protein	B-protein
antibody	NN	I-protein	I-protein
protein	NN	O	O
)	)	O	O
Egr-1	CD	B-DNA	B-DNA
motifs	NNS	I-DNA	I-DNA
led	VBN	O	O
to	TO	O	O
lymphocyte	NN	B-cell_line	B-cell_line
populations	NNS	I-cell_line	I-cell_line
the	DT	O	O
definition	NN	O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
of	IN	O	O
a	DT	O	O
glucocorticoid	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
that	IN	O	O
inhibits	NNS	O	O
chimeric	NN	B-DNA	B-DNA
plasmids	NNS	I-DNA	I-DNA
expression	NN	O	O
in	IN	O	O
CML	NNP	B-cell_line	B-cell_line
certain	JJ	O	O
but	CC	O	O
PBMC	NNP	B-cell_type	B-cell_type
not	RB	O	O
in	IN	O	O
CBG	NNP	B-protein	B-protein
or	CC	O	O
.	.	O	O
tissue	NN	B-DNA	B-DNA
factor	NN	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
Functional	JJ	O	O
activity	NN	O	O
CLL	NNP	B-cell_line	B-cell_line
in	IN	O	O
vivo	NN	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
was	VBD	O	O
associated	VBN	O	O
cell-type-specific	JJ	B-protein	B-protein
nuclear	JJ	I-protein	I-protein
proteins	NNS	I-protein	I-protein
with	IN	O	O
the	DT	O	O
intact	JJ	B-DNA	B-DNA
Sp1	CD	I-DNA	I-DNA
sites	NNS	I-DNA	I-DNA
presence	NN	O	O
of	IN	O	O
AML	NNP	B-cell_line	B-cell_line
a	DT	O	O
specific	JJ	O	O
LCL-stimulated	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
in	IN	O	O
electrophoretic	JJ	O	O
immunoglobulin	NN	B-protein	B-protein
mobility	NN	O	O
shift	VB	O	O
Egr-1	CD	B-DNA	B-DNA
sites	NNS	I-DNA	I-DNA
assays	NNS	O	O
with	IN	O	O
ALL	NNP	B-cell_line	B-cell_line
extracts	NNS	O	O
.	.	O	O
IL-2-dependent	JJ	B-cell_type	B-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
Formation	NN	O	O
of	IN	O	O
nuclear	JJ	B-protein	B-protein
protein	NN	I-protein	I-protein
this	DT	O	O
complex	NN	O	O
IL-6	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
was	VBD	O	O
selectively	RB	O	O
CML	NNP	B-cell_line	B-cell_line
inhibited	VBN	O	O
by	IN	O	O
HTLV-I-producing	VBG	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
the	DT	O	O
region	NN	O	O
HTLV-I	NNP	B-protein	B-protein
viral	JJ	I-protein	I-protein
proteins	NNS	I-protein	I-protein
in	IN	O	O
containing	VBG	O	O
IL-2	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
a	DT	O	O
.	.	O	O
AML	NNP	B-cell_line	B-cell_line
","		I-cell_line	I-cell_line
CLL	NNP	I-cell_line	I-cell_line
and	CC	I-cell_line	O
ALL	NNP	I-cell_line	I-cell_line
peripheral	JJ	I-cell_line	I-cell_line
leucocytes	NNS	I-cell_line	I-cell_line
We	PRP	O	O
discuss	VB	O	O
normal	JJ	B-cell_type	B-cell_type
resting	VBG	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
the	DT	O	O
possibility	NN	O	O
viral	JJ	B-protein	B-protein
proteins	NNS	I-protein	I-protein
that	IN	O	O
may	MD	O	O
IL-10	CD	B-DNA	B-DNA
","		I-DNA	I-DNA
IFN-gamma	NNP	I-DNA	I-DNA
and	CC	I-DNA	O
TNF-alpha	NN	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
coregulate	NN	O	O
HIV-1	CD	O	O
K562	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
and	CC	O	O
Rpt-1	CD	O	O
microglia	NN	B-cell_type	B-cell_type
gene	NN	O	O
expression	NN	O	O
nuclear	JJ	B-protein	B-protein
factor	NN	I-protein	I-protein
through	IN	O	O
a	DT	O	O
c-jun	NN	B-DNA	B-DNA
","		I-DNA	I-DNA
c-fos	NNS	I-DNA	I-DNA
and	CC	I-DNA	O
NFATc1	CD	I-DNA	I-DNA
(	(	I-DNA	I-DNA
NFATc	NNP	I-DNA	I-DNA
)	)	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
common	JJ	O	O
.	.	O	O
dexamethasone-treated	JJ	B-cell_line	B-cell_line
macrophages	NNS	I-cell_line	I-cell_line
Congenital	NNP	O	O
immunodeficiencies	NNS	O	O
microglia	NN	B-cell_type	B-cell_type
associated	VBN	O	O
with	IN	O	O
Trans-acting	JJ	B-protein	B-protein
factors	NNS	I-protein	I-protein
absence	NN	O	O
of	IN	O	O
gp34	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
on	IN	O	O
result	VB	O	O
macrophages	NNS	B-cell_line	B-cell_line
from	IN	O	O
distinct	JJ	O	O
primary	NN	B-cell_type	B-cell_type
rat	NN	I-cell_type	I-cell_type
microglia	NN	I-cell_type	I-cell_type
mutations	NNS	O	O
in	IN	O	O
human	JJ	B-protein	B-protein
B-cell	NN	I-protein	I-protein
nuclear	JJ	I-protein	I-protein
factor	NN	I-protein	I-protein
.	.	O	O
Coordinate	NNP	O	O
gp34	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
regulation	NN	O	O
of	IN	O	O
leukemic	JJ	B-cell_line	B-cell_line
T-cell	NNP	I-cell_line	I-cell_line
populations	NNS	I-cell_line	I-cell_line
expression	NN	O	O
during	IN	O	O
microglia	NN	B-cell_type	B-cell_type
development	NN	O	O
and	CC	O	O
IgNF-A	NNP	B-protein	B-protein
coinduction	NN	O	O
of	IN	O	O
gp34	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
by	IN	O	O
suggests	NNS	O	O
hydroxyurea-treated	JJ	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
that	IN	O	O
common	JJ	O	O
microglia	NN	B-cell_type	B-cell_type
(	(	O	O
s	NNS	O	O
glucocorticoid	NN	B-protein	B-protein
receptors	NNS	I-protein	I-protein
)	)	O	O
control	NN	O	O
NF-kappaB-like	JJ	B-DNA	B-DNA
elements	NNS	I-DNA	I-DNA
expression	NN	O	O
of	IN	O	O
human	JJ	B-cell_line	B-cell_line
clonal	JJ	I-cell_line	I-cell_line
monocytic	JJ	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
these	DT	O	O
genes	NNS	O	O
human	JJ	B-cell_type	B-cell_type
monocyte	NN	I-cell_type	I-cell_type
.	.	O	O
In	IN	O	O
glucocorticoid	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
derived	VBN	O	O
from	IN	O	O
regulatory	JJ	B-DNA	B-DNA
region	NN	I-DNA	I-DNA
two	CD	O	O
independent	JJ	O	O
CM-SM	NNP	B-cell_line	B-cell_line
class	NN	O	O
II-deficient	JJ	O	O
human	JJ	B-cell_type	B-cell_type
monocyte-derived	JJ	I-cell_type	I-cell_type
macrophages	NNS	I-cell_type	I-cell_type
bare	NN	O	O
lymphocyte	NN	O	O
cytosolic	NN	B-protein	B-protein
hormone-receptor-complexes	NNS	I-protein	I-protein
syndrome	NN	O	O
patients	NNS	O	O
NF-kappaB-like	JJ	B-DNA	B-DNA
elements	NNS	I-DNA	I-DNA
","		O	O
we	PRP	O	O
CM-SM	NNP	B-cell_line	B-cell_line
observed	VBN	O	O
a	DT	O	O
MAC	NNP	B-cell_type	B-cell_type
drastic	NN	O	O
decrease	NN	O	O
unactivated	JJ	B-protein	B-protein
receptor	NN	I-protein	I-protein
complexes	NNS	I-protein	I-protein
in	IN	O	O
transcription	NN	O	O
NF-kappaB-like	JJ	B-DNA	B-DNA
element	NN	I-DNA	I-DNA
1	CD	I-DNA	I-DNA
rates	NNS	O	O
of	IN	O	O
clonal	JJ	B-cell_line	B-cell_line
line	NN	I-cell_line	I-cell_line
the	DT	O	O
.	.	O	O
freshly	RB	B-cell_type	O
isolated	VBN	I-cell_type	O
monocytes	NNS	I-cell_type	I-cell_type
When	WRB	O	O
these	DT	O	O
aldosterone	NN	B-protein	B-protein
receptor	NN	I-protein	I-protein
cell	NN	O	O
lines	NNS	O	O
native	NN	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
are	VBP	O	O
fused	VBN	O	O
CM-SM	NNP	B-cell_line	B-cell_line
","		O	O
are	VBP	O	O
MO	NNP	B-cell_type	B-cell_type
reexpressed	VBN	O	O
","		O	O
erythroid	NN	B-protein	B-protein
Kruppel-like	JJ	I-protein	I-protein
factor	NN	I-protein	I-protein
indicating	VBG	O	O
that	IN	O	O
NF-kappaB-like	JJ	B-DNA	B-DNA
element	NN	I-DNA	I-DNA
1	CD	I-DNA	I-DNA
immunodeficiencies	NNS	O	O
in	IN	O	O
CM-SM	NNP	B-cell_line	B-cell_line
bare	NN	O	O
lymphocyte	NN	O	O
MO	NNP	B-cell_type	B-cell_type
syndrome	NN	O	O
patients	NNS	O	O
EKLF	IN	B-protein	B-protein
are	VBP	O	O
the	DT	O	O
NF-kappaB	NNP	B-DNA	B-DNA
elements	NNS	I-DNA	I-DNA
result	VB	O	O
of	IN	O	O
cell	NN	B-cell_line	B-cell_line
population	NN	I-cell_line	I-cell_line
two	CD	O	O
distinct	JJ	O	O
MAC	NNP	B-cell_type	B-cell_type
mutations	NNS	O	O
.	.	O	O
histone	NN	B-protein	B-protein
acetyltransferases	NNS	I-protein	I-protein
Further	RB	O	O
studies	NNS	O	O
NF-kappaB-like	JJ	B-DNA	B-DNA
elements	NNS	I-DNA	I-DNA
show	NN	O	O
that	IN	O	O
untreated	JJ	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
genes	NNS	O	O
governing	VBG	O	O
MO	NNP	B-cell_type	B-cell_type
the	DT	O	O
expression	NN	O	O
Erythroid	NN	B-protein	B-protein
Kruppel-like	JJ	I-protein	I-protein
factor	NN	I-protein	I-protein
of	IN	O	O
fall	NN	O	O
NF-kappaB-like	JJ	B-DNA	B-DNA
elements	NNS	I-DNA	I-DNA
into	IN	O	O
at	IN	O	O
DEX-treated	JJ	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
least	JJS	O	O
three	CD	O	O
MO	NNP	B-cell_type	B-cell_type
complementation	NN	O	O
groups	NNS	O	O
EKLF	IN	B-protein	B-protein
;	:	O	O
two	CD	O	O
cognate	NN	B-DNA	B-DNA
and	CC	I-DNA	O
noncognate	JJ	I-DNA	I-DNA
core	NN	I-DNA	I-DNA
promoters	NNS	I-DNA	I-DNA
of	IN	O	O
these	DT	O	O
malignant	JJ	B-cell_line	B-cell_line
clones	NNS	I-cell_line	I-cell_line
were	VBD	O	O
previously	RB	O	O
MAC	NNP	B-cell_type	B-cell_type
unidentified	JJ	O	O
in	IN	O	O
red	VBN	B-protein	O
cell-specific	JJ	I-protein	I-protein
transcriptional	JJ	I-protein	I-protein
activator	NN	I-protein	I-protein
generated	VBN	O	O
in	IN	O	O
gp34	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
vitro	NN	O	O
.	.	O	O
ALL	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
In	IN	O	O
addition	NN	O	O
MO-derived	JJ	B-cell_type	B-cell_type
dendritic	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
","		O	O
we	PRP	O	O
EKLF	IN	B-protein	B-protein
report	NN	O	O
the	DT	O	O
paired	VBN	B-DNA	O
box	NN	I-DNA	I-DNA
containing	VBG	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
identification	NN	O	O
of	IN	O	O
CLL	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
two	CD	O	O
discrete	VB	O	O
MAC	NNP	B-cell_type	B-cell_type
complexes	NNS	O	O
","		O	O
positive-acting	VBG	B-protein	B-protein
factor	NN	I-protein	I-protein
and	CC	O	O
","		O	O
PAX-5	CD	B-DNA	B-DNA
that	IN	O	O
bind	NN	O	O
PHA-stimulated	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
cultures	NNS	I-cell_line	I-cell_line
to	TO	O	O
the	DT	O	O
MO-derived	JJ	B-cell_type	B-cell_type
dendritic	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
.	.	O	O
Though	IN	O	O
EKLF	IN	B-protein	B-protein
the	DT	O	O
mutation	NN	O	O
PAX-5	CD	B-DNA	B-DNA
in	IN	O	O
at	IN	O	O
CML	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
least	JJS	O	O
one	CD	O	O
MAC	NNP	B-cell_type	B-cell_type
generated	VBN	O	O
in	IN	O	O
acetylated	VBN	B-protein	O
transcription	NN	I-protein	I-protein
factor	NN	I-protein	I-protein
vitro	NN	O	O
(	(	O	O
mammalian	JJ	B-DNA	B-DNA
interferon-gamma	NN	I-DNA	I-DNA
activation	NN	I-DNA	I-DNA
site	NN	I-DNA	I-DNA
)	)	O	O
affects	NNS	O	O
ANLL	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
products	NNS	O	O
functioning	VBG	O	O
MO	NNP	B-cell_type	B-cell_type
via	IN	O	O
interaction	NN	O	O
CBP	NNP	B-protein	B-protein
with	IN	O	O
the	DT	O	O
interferon-gamma	NN	B-DNA	B-DNA
activation	NN	I-DNA	I-DNA
site	NN	I-DNA	I-DNA
sequence	NN	I-DNA	I-DNA
","		O	O
clear	JJ	O	O
peanut-positive	JJ	B-cell_line	B-cell_line
and	CC	I-cell_line	O
peanut-negative	JJ	I-cell_line	I-cell_line
human	JJ	I-cell_line	I-cell_line
thymocyte	NN	I-cell_line	I-cell_line
subpopulations	NNS	I-cell_line	I-cell_line
alterations	NNS	O	O
in	IN	O	O
dendritic	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
either	DT	O	O
or	CC	O	O
p300	CD	B-protein	B-protein
are	VBP	O	O
not	RB	O	O
CRE	NN	B-DNA	B-DNA
sequences	NNS	I-DNA	I-DNA
found	VBN	O	O
in	IN	O	O
peanut-negative	JJ	B-cell_line	B-cell_line
thymocyte	NN	I-cell_line	I-cell_line
subpopulation	NN	I-cell_line	I-cell_line
any	DT	O	O
of	IN	O	O
B	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
the	DT	O	O
.	.	O	O
P/CAF	CAF	B-protein	O
In	IN	O	O
vivo	NN	O	O
nm23	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
responsiveness	NN	O	O
to	TO	O	O
peanut-positive	JJ	B-cell_line	B-cell_line
glucocorticoid	NN	O	O
correlated	VBN	O	O
mantle	NN	B-cell_type	B-cell_type
zone	NN	I-cell_type	I-cell_type
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
with	IN	O	O
content	NN	O	O
histone	NN	B-protein	B-protein
acetyltransferases	NNS	I-protein	I-protein
in	IN	O	O
in	IN	O	O
nm23	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
normal	JJ	O	O
humans	NNS	O	O
peanut-negative	JJ	B-cell_line	B-cell_line
subset	VBN	I-cell_line	O
.	.	O	O
Dexamethasone	NN	O	O
follicular	JJ	B-cell_type	B-cell_type
center	NN	I-cell_type	I-cell_type
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
loading	VBG	O	O
tests	NNS	O	O
CBP	NNP	B-protein	B-protein
(	(	O	O
0.1	CD	O	O
thymidine	CD	B-DNA	B-DNA
kinase	NN	I-DNA	I-DNA
locus	NN	I-DNA	I-DNA
mg	NN	O	O
dexamethasone/kg	kg	O	O
peanut-positive	JJ	B-cell_line	B-cell_line
","		O	O
iv	NN	O	O
Monocytoid	NNP	B-cell_type	B-cell_type
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
)	)	O	O
were	VBD	O	O
p300	CD	B-protein	B-protein
performed	VBN	O	O
in	IN	O	O
tk	NN	B-DNA	B-DNA
allele	RB	I-DNA	O
18	CD	O	O
normal	JJ	O	O
human	JJ	B-cell_line	B-cell_line
B-lymphoblastoid	JJ	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
males	NNS	O	O
to	TO	O	O
plasma	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
evaluate	VB	O	O
the	DT	O	O
P/CAF	CAF	B-protein	O
individual	JJ	O	O
responsiveness	NN	O	O
promoter	NN	B-DNA	B-DNA
element	NN	I-DNA	I-DNA
to	TO	O	O
glucocorticoid	NN	O	O
IM-9	CD	B-cell_line	B-cell_line
.	.	O	O
There	EX	O	O
extrafollicular	JJ	B-cell_type	B-cell_type
large	JJ	I-cell_type	I-cell_type
transformed	VBN	I-cell_type	O
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
were	VBD	O	O
inter-individual	JJ	O	O
EKLF	IN	B-protein	B-protein
differences	NNS	O	O
in	IN	O	O
BCL-6	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
increase	NN	O	O
in	IN	O	O
human	JJ	B-cell_line	B-cell_line
T-cell	NNP	I-cell_line	I-cell_line
leukemic	JJ	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
count	NN	O	O
","		O	O
mantle	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
decrease	NN	O	O
in	IN	O	O
CBP	NNP	B-protein	B-protein
count	NN	O	O
","		O	O
Ig	NNP	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
and	CC	O	O
increase	NN	O	O
CEM-C7	CD	B-cell_line	B-cell_line
in	IN	O	O
plasma	NN	O	O
MCLs	NNS	B-cell_type	B-cell_type
free	JJ	O	O
fatty	JJ	O	O
p300	CD	B-protein	B-protein
acids	NNS	O	O
levels	NNS	O	O
Immunoglobulin	NNP	B-DNA	B-DNA
(	(	I-DNA	I-DNA
Ig	NNP	I-DNA	I-DNA
)	)	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
after	IN	O	O
dexamethasone	NN	O	O
glucocorticoid	NN	B-cell_line	B-cell_line
receptor-deficient	JJ	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
injection	NN	O	O
.	.	O	O
MCLs	NNS	B-cell_type	B-cell_type
In	IN	O	O
addition	NN	O	O
P/CAF	CAF	B-protein	O
","		O	O
there	RB	O	O
non-Ig	NN	B-DNA	B-DNA
promoters	NNS	I-DNA	I-DNA
was	VBD	O	O
a	DT	O	O
ICR-27	CD	B-cell_line	B-cell_line
significant	JJ	O	O
correlation	NN	O	O
nonmalignant	JJ	B-cell_type	B-cell_type
mantle	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
between	IN	O	O
the	DT	O	O
EKLF	IN	B-protein	B-protein
maximum	NN	O	O
increase	NN	O	O
c-MYC	NN	B-DNA	B-DNA
","		I-DNA	I-DNA
S14	CD	I-DNA	I-DNA
","		I-DNA	I-DNA
or	CC	I-DNA	O
alpha-fetoprotein	RB	I-DNA	O
(	(	I-DNA	I-DNA
AFP	NNP	I-DNA	I-DNA
)	)	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
in	IN	O	O
and	CC	O	O
human	JJ	B-cell_line	B-cell_line
malignant	JJ	I-cell_line	I-cell_line
thymus	NN	I-cell_line	I-cell_line
derived	VBN	I-cell_line	O
T	NNP	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
the	DT	O	O
maximum	NN	O	O
tumor	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
decrease	NN	O	O
in	IN	O	O
EKLF	IN	B-protein	B-protein
(	(	O	O
r	NN	O	O
Ig	NNP	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
=	SYM	O	O
0.7514	CD	O	O
MOLT	NNP	B-cell_line	B-cell_line
3	CD	I-cell_line	I-cell_line
","		O	O
p	NN	O	O
B-cell	NN	B-cell_type	B-cell_type
lineage	NN	I-cell_type	I-cell_type
less	JJR	O	O
than	IN	O	O
tissue-specific	JJ	B-protein	B-protein
transcription	NN	I-protein	I-protein
factor	NN	I-protein	I-protein
0.0003	CD	O	O
)	)	O	O
BCL6	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
.	.	O	O
Simultaneous	JJ	O	O
MOLT	NNP	B-cell_line	B-cell_line
3	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
measurements	NNS	O	O
of	IN	O	O
B-cell	NN	B-cell_type	B-cell_type
subsets	NNS	I-cell_type	I-cell_type
content	NN	O	O
by	IN	O	O
EKLF	IN	B-protein	B-protein
whole-cell	JJ	O	O
assay	NN	O	O
huMIP-1	NN	B-DNA	B-DNA
alpha	NN	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
revealed	VBD	O	O
that	IN	O	O
OKT8	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
content	NN	O	O
in	IN	O	O
large-cell	RB	B-cell_type	O
lymphomas	NNS	I-cell_type	I-cell_type
linearly	RB	O	O
correlated	VBN	O	O
herpes	NNS	B-protein	B-protein
simplex	JJ	I-protein	I-protein
virus	NN	I-protein	I-protein
type	NN	I-protein	I-protein
2	CD	I-protein	I-protein
tegument	NN	I-protein	I-protein
proteins	NNS	I-protein	I-protein
with	IN	O	O
that	IN	O	O
proto-oncogene	NN	B-DNA	B-DNA
in	IN	O	O
the	DT	O	O
Ia-restricted	JJ	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
hybridomas	NNS	I-cell_line	I-cell_line
corresponding	VBG	O	O
(	(	O	O
follicular	JJ	B-cell_type	B-cell_type
lymphomas	NNS	I-cell_type	I-cell_type
r	NN	O	O
=	SYM	O	O
tegument	NN	B-protein	B-protein
protein	NN	I-protein	I-protein
0.9482	CD	O	O
","		O	O
t	NN	B-DNA	B-DNA
(	(	I-DNA	I-DNA
14	CD	I-DNA	I-DNA
;	:	I-DNA	O
19	CD	I-DNA	I-DNA
)	)	I-DNA	I-DNA
p	NN	O	O
less	JJR	O	O
T	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
hybridomas	NNS	I-cell_line	I-cell_line
than	IN	O	O
0.0001	CD	O	O
channel	NN	B-cell_type	B-cell_type
catfish	NN	I-cell_type	I-cell_type
lymphoid	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
)	)	O	O
.	.	O	O
VP22	CD	B-protein	B-protein
There	EX	O	O
were	VBD	O	O
human	JJ	B-DNA	B-DNA
immunodeficiency	NN	I-DNA	I-DNA
virus-type	JJ	I-DNA	I-DNA
1	CD	I-DNA	I-DNA
(	(	I-DNA	I-DNA
HIV-1	CD	I-DNA	I-DNA
)	)	I-DNA	I-DNA
kappaB-TATA-luceriferase	NN	I-DNA	I-DNA
reporter	NN	I-DNA	I-DNA
plasmid	NN	I-DNA	I-DNA
also	RB	O	O
significant	JJ	O	O
Ia-bearing	JJ	B-cell_line	B-cell_line
stimulator	NN	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
correlations	NNS	O	O
between	IN	O	O
endotoxin-stimulated	JJ	B-cell_type	B-cell_type
human	JJ	I-cell_type	I-cell_type
blood	NN	I-cell_type	I-cell_type
monocytes	NNS	I-cell_type	I-cell_type
the	DT	O	O
maximum	NN	O	O
viral	JJ	B-protein	B-protein
dUTPase	NN	I-protein	I-protein
increase	NN	O	O
in	IN	O	O
kappaB-containing	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
and	CC	O	O
content	NN	O	O
T	NNP	B-cell_line	B-cell_line
hybridoma	NN	I-cell_line	I-cell_line
in	IN	O	O
(	(	O	O
human	JJ	B-cell_type	B-cell_type
monocyte	NN	I-cell_type	I-cell_type
r	NN	O	O
=	SYM	O	O
T-cell	NNP	B-protein	B-protein
antigens	NNS	I-protein	I-protein
0.7239	CD	O	O
","		O	O
kappaB	NN	B-DNA	B-DNA
enhancer	NN	I-DNA	I-DNA
p	NN	O	O
less	JJR	O	O
TA3	CD	B-cell_line	B-cell_line
stimulator	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
than	IN	O	O
0.0007	CD	O	O
monocytes	NNS	B-cell_type	B-cell_type
)	)	O	O
","		O	O
epitopes	NNS	B-protein	B-protein
and	CC	O	O
between	IN	O	O
c-myb	NN	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
the	DT	O	O
maximum	NN	O	O
TA3	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
decrease	NN	O	O
in	IN	O	O
monocytes	NNS	B-cell_type	B-cell_type
and	CC	O	O
content	NN	O	O
VP22	CD	B-protein	B-protein
in	IN	O	O
(	(	O	O
c-myb	NN	B-DNA	B-DNA
kappaB-TATA-luceriferase	NN	I-DNA	I-DNA
reporter	NN	I-DNA	I-DNA
plasmid	NN	I-DNA	I-DNA
r	NN	O	O
=	SYM	O	O
T	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
hybridomas	NNS	I-cell_line	I-cell_line
0.7703	CD	O	O
","		O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
p	NN	O	O
less	JJR	O	O
tegument	NN	B-protein	B-protein
protein	NN	I-protein	I-protein
than	IN	O	O
0.0002	CD	O	O
kappaB-containing	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
)	)	O	O
.	.	O	O
glucocorticoid-sensitive	JJ	B-cell_line	B-cell_line
and	CC	I-cell_line	O
#NAME?	# NAME	I-cell_line	O
variants	NNS	I-cell_line	I-cell_line
These	DT	O	O
results	NNS	O	O
bone	NN	B-cell_type	B-cell_type
marrow	VB	I-cell_type	O
mononuclear	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
suggest	JJS	O	O
that	IN	O	O
VP16	CD	B-protein	B-protein
individual	JJ	O	O
differences	NNS	O	O
c-myb	NN	B-DNA	B-DNA
are	VBP	O	O
preserved	VBN	O	O
human	JJ	B-cell_line	B-cell_line
leukemic	JJ	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
both	DT	O	O
in	IN	O	O
bone	NN	B-cell_type	B-cell_type
marrow	VB	I-cell_type	O
cells	NNS	I-cell_type	I-cell_type
glucocorticoid	NN	O	O
responsiveness	NN	O	O
tegument	NN	B-protein	B-protein
protein	NN	I-protein	I-protein
and	CC	O	O
in	IN	O	O
IL-2	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
content	NN	O	O
in	IN	O	O
CEM	NNP	B-cell_line	B-cell_line
C7	CD	I-cell_line	I-cell_line
in	IN	O	O
normal	JJ	O	O
Proliferated	VBN	B-cell_type	O
blastic	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
humans	NNS	O	O
.	.	O	O
VP22	CD	B-protein	B-protein
Estradiol	NNP	O	O
receptors	NNS	O	O
IL-2	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
in	IN	O	O
the	DT	O	O
glucocorticoid-sensitive	JJ	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
cytosol	NN	O	O
of	IN	O	O
human	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
in	IN	O	O
hepatitis	NN	O	O
herpes	NNS	B-protein	B-protein
simplex	JJ	I-protein	I-protein
tegument	NN	I-protein	I-protein
proteins	NNS	I-protein	I-protein
B	NNP	O	O
virus	NN	O	O
TR3/nur77	nur77	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
carriers	NNS	O	O
treated	VBN	O	O
glucocorticoid-sensitive	JJ	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
with	IN	O	O
.	.	O	O
human	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
in	IN	O	O
the	DT	O	O
Fibrinogen	NN	B-protein	B-protein
cytosol	NN	O	O
of	IN	O	O
NOR-1	CD	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
and	CC	O	O
the	DT	O	O
glucocorticoid-resistant	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
effects	NNS	O	O
of	IN	O	O
B	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
(	(	O	O
)	)	O	O
NF-kappa	NN	B-protein	B-protein
B	NNP	I-protein	I-protein
transcription	NN	I-protein	I-protein
factors	NNS	I-protein	I-protein
on	IN	O	O
were	VBD	O	O
luciferase	NN	B-DNA	B-DNA
reporter	NN	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
studied	VBN	O	O
in	IN	O	O
glucocorticoid-sensitive	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
asymptomatic	JJ	O	O
hepatitis	NN	O	O
B	NNP	B-cell_type	B-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
B	NNP	O	O
virus	NN	O	O
NF-kappa	NN	B-protein	B-protein
B	NNP	I-protein	I-protein
transcription	NN	I-protein	I-protein
factors	NNS	I-protein	I-protein
(	(	O	O
HBV	NNP	O	O
NGFI-B	NNP	B-DNA	B-DNA
(	(	I-DNA	I-DNA
rat	NN	I-DNA	I-DNA
homolog	NN	I-DNA	I-DNA
of	IN	I-DNA	O
TR3/Nur77	Nur77	I-DNA	I-DNA
)	)	I-DNA	I-DNA
response	NN	I-DNA	I-DNA
element	NN	I-DNA	I-DNA
)	)	O	O
carriers	NNS	O	O
C7	CD	B-cell_line	B-cell_line
","		O	O
patients	NNS	O	O
memory	NN	B-cell_type	B-cell_type
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
with	IN	O	O
chronic	NN	O	O
fibrinogen-binding	JJ	B-protein	B-protein
integrins	NNS	I-protein	I-protein
hepatitis	NN	O	O
B	NNP	O	O
NBRE	RB	B-DNA	B-DNA
and	CC	O	O
normal	JJ	O	O
leukemic	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
controls	NNS	O	O
.	.	O	O
B	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
The	DT	O	O
level	NN	O	O
CD11b/CD18	CD18	B-protein	B-protein
of	IN	O	O
in	IN	O	O
TR3/nur77	nur77	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
sequence	NN	I-DNA	I-DNA
the	DT	O	O
cytosol	NN	O	O
Human	NNP	B-cell_line	B-cell_line
lymphoid	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
of	IN	O	O
was	VBD	O	O
memory	NN	B-cell_type	B-cell_type
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
significantly	RB	O	O
lower	JJR	O	O
CD11c/CD18	CD18	B-protein	B-protein
in	IN	O	O
asymptomatic	JJ	O	O
NBRE	RB	B-DNA	B-DNA
HBV	NNP	O	O
carriers	NNS	O	O
lymphoblastoid	NN	B-cell_line	B-cell_line
","		I-cell_line	I-cell_line
leukaemia	NN	I-cell_line	I-cell_line
and	CC	I-cell_line	O
lymphoma	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
and	CC	O	O
patients	NNS	O	O
CD45RA+	CD	B-cell_type	B-cell_type
and	CC	I-cell_type	O
CD45RO+	CD	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
with	IN	O	O
chronic	NN	O	O
fibrinogen	NN	B-protein	B-protein
hepatitis	NN	O	O
B	NNP	O	O
heat	NN	B-DNA	B-DNA
shock	NN	I-DNA	I-DNA
promoter-reporter	NN	I-DNA	I-DNA
construct	VB	I-DNA	O
","		O	O
compared	VBN	O	O
human	JJ	B-cell_line	B-cell_line
lymphoid	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
to	TO	O	O
normal	JJ	O	O
CD45RA+	CD	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
controls	NNS	O	O
.	.	O	O
NF-kappa	NN	B-protein	B-protein
B	NNP	I-protein	I-protein
This	DT	O	O
low	JJ	O	O
proximal	NN	B-DNA	B-DNA
promoters	NNS	I-DNA	I-DNA
level	NN	O	O
of	IN	O	O
HLCL	NNP	B-cell_line	B-cell_line
cytosol	NN	O	O
in	IN	O	O
CD45RA+	CD	B-cell_type	B-cell_type
(	(	I-cell_type	I-cell_type
naive	NN	I-cell_type	I-cell_type
)	)	I-cell_type	I-cell_type
and	CC	I-cell_type	O
CD45RO+	CD	I-cell_type	I-cell_type
(	(	I-cell_type	I-cell_type
memory/effector	effector	I-cell_type	I-cell_type
)	)	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
patients	NNS	O	O
with	IN	O	O
fibrinogen	NN	B-protein	B-protein
chronic	NN	O	O
hepatitis	NN	O	O
distal	JJ	B-DNA	B-DNA
elements	NNS	I-DNA	I-DNA
B	NNP	O	O
was	VBD	O	O
lymphoblastoid	NN	B-cell_line	B-cell_line
increased	VBN	O	O
by	IN	O	O
CD45RA+	CD	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
the	DT	O	O
administration	NN	O	O
Fibrinogen	NN	B-protein	B-protein
of	IN	O	O
.	.	O	O
cytokine	NN	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
loci	NNS	I-DNA	I-DNA
In	IN	O	O
addition	NN	O	O
lymphoma	NN	B-cell_line	B-cell_line
","		O	O
when	WRB	O	O
CD45RO+	CD	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
from	IN	O	O
patients	NNS	O	O
AP-1	CD	B-protein	B-protein
with	IN	O	O
chronic	NN	O	O
cytokine	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
hepatitis	NN	O	O
B	NNP	O	O
leukaemia	NN	B-cell_line	B-cell_line
were	VBD	O	O
incubated	VBN	O	O
CD45RA+	CD	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
with	IN	O	O
in	IN	O	O
SP1	CD	B-protein	B-protein
vitro	NN	O	O
","		O	O
inflammation	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
the	DT	O	O
level	NN	O	O
leukaemia	NN	B-cell_line	B-cell_line
and	CC	I-cell_line	O
lymphoblastoid	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
of	IN	O	O
cytosol	NN	O	O
CD45RA+	CD	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
also	RB	O	O
increased	VBN	O	O
cAMP	NN	B-protein	B-protein
response	NN	I-protein	I-protein
element-binding	JJ	I-protein	I-protein
protein	NN	I-protein	I-protein
(	(	I-protein	I-protein
CREB	NN	I-protein	I-protein
)	)	I-protein	I-protein
factors	NNS	I-protein	I-protein
by	IN	O	O
increasing	VBG	O	O
DNA	NN	B-DNA	B-DNA
response	NN	I-DNA	I-DNA
elements	NNS	I-DNA	I-DNA
the	DT	O	O
concentration	NN	O	O
HLCL	NNP	B-cell_line	B-cell_line
of	IN	O	O
.	.	O	O
CD45RO+	CD	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
We	PRP	O	O
previously	RB	O	O
mAbs	NNS	B-protein	B-protein
reported	VBN	O	O
that	IN	O	O
BCL-6	CD	B-DNA	B-DNA
5	CD	I-DNA	I-DNA
'	''	I-DNA	I-DNA
noncoding	VBG	I-DNA	I-DNA
regions	NNS	I-DNA	I-DNA
the	DT	O	O
response	NN	O	O
hemopoietic	JJ	B-cell_line	B-cell_line
lineage	NN	I-cell_line	I-cell_line
of	IN	O	O
to	TO	O	O
CD45RA+	CD	B-cell_type	B-cell_type
and	CC	I-cell_type	O
CD45RO+	CD	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
estrogen	NN	O	O
is	VBZ	O	O
CD18	CD	B-protein	B-protein
impaired	VBN	O	O
in	IN	O	O
inflammatory	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
HBV	NNP	O	O
carriers	NNS	O	O
p65-expressing	JJ	B-cell_line	B-cell_line
Jurkat	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
","		O	O
and	CC	O	O
CD45RA+	CD	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
our	PRP$	O	O
present	VB	O	O
CD11b	CD	B-protein	B-protein
results	NNS	O	O
suggested	VBN	O	O
cytokine	NN	B-DNA	B-DNA
and	CC	I-DNA	O
chemokine	NN	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
that	IN	O	O
this	DT	O	O
B7-1-costimulated	JJ	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
may	MD	O	O
be	VB	O	O
CD45RA+	CD	B-cell_type	B-cell_type
and	CC	I-cell_type	O
CD45RO+	CD	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
due	JJ	O	O
to	TO	O	O
fibrinogen	NN	B-protein	B-protein
the	DT	O	O
low	JJ	O	O
cytokine	NN	B-DNA	B-DNA
and	CC	I-DNA	O
chemokine	NN	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
level	NN	O	O
of	IN	O	O
myeloid	NN	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
in	IN	O	O
the	DT	O	O
Lymphoma	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
cytosol	NN	O	O
of	IN	O	O
NF-kappa	NN	B-protein	B-protein
B	NNP	I-protein	I-protein
.	.	O	O
Association	NN	O	O
inflammatory	NN	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
of	IN	O	O
increased	VBN	O	O
promonocytic	JJ	B-cell_line	B-cell_line
U937	CD	I-cell_line	I-cell_line
(	(	I-cell_line	I-cell_line
U9-IIIB	NN	I-cell_line	I-cell_line
)	)	I-cell_line	I-cell_line
and	CC	I-cell_line	O
myeloblastic	NN	I-cell_line	I-cell_line
PLB-985	CD	I-cell_line	I-cell_line
(	(	I-cell_line	I-cell_line
PLB-IIIB	NN	I-cell_line	I-cell_line
)	)	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
lytic	JJ	O	O
effector	NN	O	O
monocytes	NNS	B-cell_type	B-cell_type
cell	NN	O	O
function	NN	O	O
fibrinogen	NN	B-protein	B-protein
with	IN	O	O
high	RB	O	O
bcl-6	CD	B-DNA	B-DNA
proto-oncogene	NN	I-DNA	I-DNA
levels	NNS	O	O
in	IN	O	O
parental	JJ	B-cell_line	B-cell_line
U937	CD	I-cell_line	I-cell_line
tumor-bearing	NN	O	O
patients	NNS	O	O
T-cells	NNS	B-cell_type	B-cell_type
with	IN	O	O
breast	NN	O	O
fibrinogen	NN	B-protein	B-protein
cancer	NN	O	O
.	.	O	O
bcl-6	CD	B-DNA	B-DNA
Tumor-bearing	JJ	O	O
patients	NNS	O	O
PLB-985	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
with	IN	O	O
breast	NN	O	O
transformed	VBN	B-cell_type	O
B-cells	NNS	I-cell_type	I-cell_type
cancer	NN	O	O
were	VBD	O	O
fibrinogen-derived	JJ	B-protein	B-protein
proteins	NNS	I-protein	I-protein
assayed	VBN	O	O
for	IN	O	O
bcl-6	CD	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
region	NN	I-DNA	I-DNA
their	PRP$	O	O
activity	NN	O	O
U937	CD	B-cell_line	B-cell_line
and	CC	I-cell_line	O
U9-IIIB	NN	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
and	CC	O	O
for	IN	O	O
monocytes	NNS	B-cell_type	B-cell_type
the	DT	O	O
function	NN	O	O
CD11b/CD18	CD18	B-protein	B-protein
of	IN	O	O
activated	VBN	O	O
bcl-6	CD	B-DNA	B-DNA
","		O	O
as	IN	O	O
U9-IIIB	NN	B-cell_line	B-cell_line
and	CC	I-cell_line	O
PLB-IIIB	NN	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
assessed	VBN	O	O
by	IN	O	O
B-cells	NNS	B-cell_type	B-cell_type
lectin-dependent	JJ	O	O
cellular	JJ	O	O
transcriptional	JJ	B-protein	B-protein
regulatory	JJ	I-protein	I-protein
factors	NNS	I-protein	I-protein
cytotoxicity	NN	O	O
(	(	O	O
mouse	NN	B-DNA	B-DNA
E2A	CD	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
LDCC	NNP	O	O
)	)	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
.	.	O	O
Tumor-bearing	JJ	O	O
T-cells	NNS	B-cell_type	B-cell_type
patients	NNS	O	O
with	IN	O	O
NF-kappa	NN	B-protein	B-protein
B	NNP	I-protein	I-protein
breast	NN	O	O
cancer	NN	O	O
human	JJ	B-DNA	B-DNA
HEB	NN	I-DNA	I-DNA
cDNA	NN	I-DNA	I-DNA
had	VBD	O	O
a	DT	O	O
U9-IIIB	NN	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
significant	JJ	O	O
increase	NN	O	O
proliferating	VBG	B-cell_type	B-cell_type
human	JJ	I-cell_type	I-cell_type
erythroid	NN	I-cell_type	I-cell_type
precursors	NNS	I-cell_type	I-cell_type
in	IN	O	O
activity	NN	O	O
hormone	NN	B-protein	B-protein
binding	VBG	I-protein	I-protein
domain	NN	I-protein	I-protein
and	CC	O	O
in	IN	O	O
mammalian	JJ	B-DNA	B-DNA
E2A	CD	I-DNA	I-DNA
","		I-DNA	I-DNA
HEB	NN	I-DNA	I-DNA
","		I-DNA	I-DNA
and	CC	I-DNA	O
E2-2	CD	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
LDCC	NNP	O	O
","		O	O
U9-IIIB	NN	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
as	IN	O	O
compared	VBN	O	O
early	RB	B-cell_type	O
burst-forming	VBG	I-cell_type	I-cell_type
unit-erythroid	JJ	I-cell_type	I-cell_type
(	(	I-cell_type	I-cell_type
BFU-E	NN	I-cell_type	I-cell_type
)	)	I-cell_type	I-cell_type
#NAME?	# NAME	I-cell_type	O
erythroid	NN	I-cell_type	I-cell_type
precursors	NNS	I-cell_type	I-cell_type
with	IN	O	O
healthy	JJ	O	O
functional	JJ	B-protein	B-protein
receptor	NN	I-protein	I-protein
proteins	NNS	I-protein	I-protein
control	NN	O	O
individuals	NNS	O	O
E2A	CD	B-DNA	B-DNA
.	.	O	O
Although	IN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
lymphocyte	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
the	DT	O	O
enhanced	VBN	O	O
hematopoietic	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
activity	NN	O	O
and	CC	O	O
wild	JJ	B-protein	B-protein
type	NN	I-protein	I-protein
ER	NNP	I-protein	I-protein
LDCC	NNP	O	O
were	VBD	O	O
HEB	NN	B-DNA	B-DNA
closely	RB	O	O
associated	VBN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T-cells	NNS	I-cell_line	I-cell_line
with	IN	O	O
high	RB	O	O
erythroid	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
levels	NNS	O	O
(	(	O	O
hormone	NN	B-protein	B-protein
binding	VBG	I-protein	I-protein
domain	NN	I-protein	I-protein
variants	NNS	I-protein	I-protein
greater	JJR	O	O
than	IN	O	O
E2-2	CD	B-DNA	B-DNA
31	CD	O	O
fmol/mg	mg	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
)	)	O	O
of	IN	O	O
granulocytic	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
(	(	O	O
)	)	O	O
Fas	NNS	B-protein	B-protein
ligand	NN	I-protein	I-protein
content	NN	O	O
in	IN	O	O
E2A	CD	B-DNA	B-DNA
the	DT	O	O
primary	NN	O	O
primary	NN	B-cell_line	B-cell_line
human	JJ	I-cell_line	I-cell_line
peripheral	JJ	I-cell_line	I-cell_line
blood	NN	I-cell_line	I-cell_line
mononuclear	JJ	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
tumor	NN	O	O
","		O	O
granulocytic	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
no	DT	O	O
other	JJ	O	O
NF-kappa	NN	B-protein	B-protein
B	NNP	I-protein	I-protein
clinical	JJ	O	O
or	CC	O	O
HEB	NN	B-DNA	B-DNA
histologic	NN	O	O
correlation	NN	O	O
lymphoma	NN	B-cell_line	B-cell_line
between	IN	O	O
the	DT	O	O
naive	NN	B-cell_type	B-cell_type
and	CC	I-cell_type	O
memory	NN	I-cell_type	I-cell_type
human	JJ	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
increase	NN	O	O
in	IN	O	O
AP-1	CD	B-protein	B-protein
either	DT	O	O
parameter	NN	O	O
E2-2	CD	B-DNA	B-DNA
of	IN	O	O
function	NN	O	O
EBV-associated	JJ	B-cell_line	B-cell_line
lymphomas	NNS	I-cell_line	I-cell_line
could	MD	O	O
be	VB	O	O
naive	NN	B-cell_type	B-cell_type
and	CC	I-cell_type	O
memory	NN	I-cell_type	I-cell_type
human	JJ	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
found	VBN	O	O
.	.	O	O
Fas	NNS	B-protein	B-protein
ligand	NN	I-protein	I-protein
Thus	RB	O	O
","		O	O
E2A	CD	B-DNA	B-DNA
levels	NNS	O	O
greater	JJR	O	O
B	NNP	B-cell_line	B-cell_line
lineage	NN	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
than	IN	O	O
31	CD	O	O
purified	VBN	B-cell_type	O
peripheral	JJ	I-cell_type	I-cell_type
blood	NN	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
fmol/mg	mg	O	O
might	MD	O	O
FasL	NNP	B-protein	B-protein
be	VB	O	O
associated	VBN	O	O
E12	CD	B-DNA	B-DNA
and	CC	I-DNA	O
E47	CD	I-DNA	I-DNA
exons	NNS	I-DNA	I-DNA
with	IN	O	O
increased	VBN	O	O
HS-72	CD	B-cell_line	B-cell_line
mouse	NN	I-cell_line	I-cell_line
hybridoma	NN	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
function	NN	O	O
in	IN	O	O
adherent	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
tumor-bearing	NN	O	O
patients	NNS	O	O
transcription	NN	B-protein	B-protein
factors	NNS	I-protein	I-protein
NF-kappa	NN	I-protein	I-protein
B	NNP	I-protein	I-protein
and	CC	I-protein	O
AP-1	CD	I-protein	I-protein
with	IN	O	O
breast	NN	O	O
E12	CD	B-DNA	B-DNA
and	CC	I-DNA	O
E47	CD	I-DNA	I-DNA
exons	NNS	I-DNA	I-DNA
cancer	NN	O	O
.	.	O	O
HS-72	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
Properties	NNS	O	O
of	IN	O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
human	JJ	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
(	(	I-cell_type	I-cell_type
PB-T	NN	I-cell_type	I-cell_type
)	)	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
in	IN	O	O
from	IN	O	O
FasL	NNP	B-protein	B-protein
patients	NNS	O	O
with	IN	O	O
human	JJ	B-DNA	B-DNA
HEB	NN	I-DNA	I-DNA
cDNA	NN	I-DNA	I-DNA
familial	JJ	O	O
cortisol	NN	O	O
HS-72	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
resistance	NN	O	O
.	.	O	O
CD28/CD3-costimulated	CD3-costimulated	B-cell_type	B-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
In	IN	O	O
a	DT	O	O
nondegradable	JJ	B-protein	B-protein
mutant	JJ	I-protein	I-protein
previous	JJ	O	O
report	NN	O	O
E2A	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
of	IN	O	O
two	CD	O	O
HS-72	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
patients	NNS	O	O
with	IN	O	O
CD4+	CD	B-cell_type	B-cell_type
familial	JJ	O	O
glucocorticoid	NN	O	O
I	PRP	B-protein	B-protein
kappa	NN	I-protein	I-protein
B	NNP	I-protein	I-protein
resistance	NN	O	O
due	JJ	O	O
HEB	NN	B-DNA	B-DNA
to	TO	O	O
reduced	VBN	O	O
MonoMac6	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
numbers	NNS	O	O
of	IN	O	O
CD4-	NN	B-cell_type	B-cell_type
(	(	O	O
)	)	O	O
FasL	NNP	B-protein	B-protein
","		O	O
we	PRP	O	O
endogenous	JJ	B-DNA	B-DNA
E2A	CD	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
have	VB	O	O
shown	VBN	O	O
MB-treated	JJ	B-cell_line	B-cell_line
THP-1	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
decreased	VBN	O	O
numbers	NNS	O	O
CD45RO+	CD	B-cell_type	B-cell_type
of	IN	O	O
in	IN	O	O
p65	CD	B-protein	B-protein
Rel	NNP	I-protein	I-protein
and	CC	O	O
but	CC	O	O
E2A	CD	B-DNA	B-DNA
normal	JJ	O	O
affinity	NN	O	O
monocytic	JJ	B-cell_line	B-cell_line
U937	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
of	IN	O	O
in	IN	O	O
CD45RO-	NN	B-cell_type	B-cell_type
both	DT	O	O
patients	NNS	O	O
Fos/Jun	Jun	B-protein	O
.	.	O	O
In	IN	O	O
E2A	CD	B-DNA	B-DNA
this	DT	O	O
study	NN	O	O
U937	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
","		O	O
from	IN	O	O
PB-T	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
these	DT	O	O
patients	NNS	O	O
NF-kappa	NN	B-protein	B-protein
B	NNP	I-protein	I-protein
","		O	O
one	CD	O	O
HEB	NN	B-DNA	B-DNA
patient	NN	O	O
's	POS	O	O
U937	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
son	NN	O	O
and	CC	O	O
CD45RO+	CD	B-cell_type	B-cell_type
and	CC	I-cell_type	O
CD4+	CD	I-cell_type	I-cell_type
subsets	NNS	I-cell_type	I-cell_type
daughter	NN	O	O
","		O	O
AP-1	CD	B-protein	B-protein
and	CC	O	O
normal	JJ	O	O
E12	CD	B-DNA	B-DNA
subjects	NNS	O	O
were	VBD	O	O
U937	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
transformed	VBN	O	O
with	IN	O	O
PB-T	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
Epstein-Barr	NN	O	O
virus	NN	O	O
FasL	NNP	B-protein	B-protein
.	.	O	O
Reduced	VBN	O	O
E47	CD	B-DNA	B-DNA
numbers	NNS	O	O
and	CC	O	O
cardial	JJ	B-cell_line	B-cell_line
or	CC	I-cell_line	O
eye	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lineages	NNS	I-cell_line	I-cell_line
normal	JJ	O	O
affinity	NN	O	O
human	JJ	B-cell_type	B-cell_type
T-lymphotropic	JJ	I-cell_type	I-cell_type
virus	NN	I-cell_type	I-cell_type
type	NN	I-cell_type	I-cell_type
1-infected	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
of	IN	O	O
were	VBD	O	O
granulocyte-colony-stimulating	VBG	B-protein	B-protein
factor	NN	I-protein	I-protein
found	VBN	O	O
in	IN	O	O
HEB	NN	B-DNA	B-DNA
the	DT	O	O
from	IN	O	O
MM	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
both	DT	O	O
patients	NNS	O	O
HTLV-1-infected	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
while	IN	O	O
the	DT	O	O
granulocyte-colony-stimulating	VBG	B-protein	B-protein
factor	NN	I-protein	I-protein
son	NN	O	O
and	CC	O	O
human	JJ	B-DNA	B-DNA
IL-2	CD	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
daughter	NN	O	O
had	VBD	O	O
melanoma	NN	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
normal	JJ	O	O
numbers	NNS	O	O
mammalian	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
and	CC	O	O
affinity	NN	O	O
G-CSF	NNP	B-protein	B-protein
of	IN	O	O
.	.	O	O
luciferase	NN	B-DNA	B-DNA
reporter	NN	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
constructs	NNS	I-DNA	I-DNA
The	DT	O	O
thermal	JJ	O	O
melanoma	NN	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
stability	NN	O	O
of	IN	O	O
body	NN	B-cell_type	B-cell_type
wall	NN	I-cell_type	I-cell_type
muscle	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
and	CC	O	O
thermal	JJ	O	O
G-CSF	NNP	B-protein	B-protein
activation	NN	O	O
of	IN	O	O
IL-2	CD	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
in	IN	O	O
both	DT	O	O
melanoma	NN	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
patients	NNS	O	O
were	VBD	O	O
T	NNP	B-cell_type	B-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
found	VBN	O	O
to	TO	O	O
multiple	JJ	B-protein	B-protein
signaling	VBG	I-protein	I-protein
proteins	NNS	I-protein	I-protein
be	VB	O	O
normal	JJ	O	O
IL-2	CD	B-DNA	B-DNA
promoter-enhancer	NN	I-DNA	I-DNA
region	NN	I-DNA	I-DNA
.	.	O	O
Although	IN	O	O
melanoma	NN	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
the	DT	O	O
percentages	NNS	O	O
macrophage	NN	B-cell_type	B-cell_type
infiltrate	NN	I-cell_type	I-cell_type
of	IN	O	O
nuclear	JJ	O	O
murine	NN	B-protein	B-protein
G-CSF	NNP	I-protein	I-protein
receptor	NN	I-protein	I-protein
bound	VBN	O	O
were	VBD	O	O
CD28	CD	B-DNA	B-DNA
response	NN	I-DNA	I-DNA
element	NN	I-DNA	I-DNA
similar	JJ	O	O
in	IN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
both	DT	O	O
patients	NNS	O	O
ovarian	JJ	B-cell_type	B-cell_type
cancer	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
and	CC	O	O
normal	JJ	O	O
oligomerizing	VBG	B-protein	B-protein
receptor	NN	I-protein	I-protein
chains	NNS	I-protein	I-protein
controls	NNS	O	O
","		O	O
DR3	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
the	DT	O	O
absolute	VB	O	O
Jurkat	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
amounts	NNS	O	O
of	IN	O	O
macrophages	NNS	B-cell_type	B-cell_type
nuclear	JJ	O	O
bound	VBN	O	O
PML/RAR	RAR	B-protein	O
alpha	NN	I-protein	I-protein
of	IN	O	O
the	DT	O	O
human	JJ	B-DNA	B-DNA
chromosome	NN	I-DNA	I-DNA
1p36	CD	I-DNA	I-DNA
patients	NNS	O	O
were	VBD	O	O
Jurkat	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
about	IN	O	O
one-half	NN	O	O
lamina	NN	B-cell_type	B-cell_type
propria	NN	I-cell_type	I-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
that	IN	O	O
of	IN	O	O
PML/RAR	RAR	B-protein	O
alpha	NN	I-protein	I-protein
normal	JJ	O	O
controls	NNS	O	O
human	JJ	B-DNA	B-DNA
DR3	CD	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
.	.	O	O
These	DT	O	O
lymphocytic	JJ	B-cell_line	B-cell_line
and	CC	I-cell_line	O
monocytic	JJ	I-cell_line	I-cell_line
lineages	NNS	I-cell_line	I-cell_line
abnormal	JJ	O	O
properties	NNS	O	O
lamina	NN	B-cell_type	B-cell_type
propria	NN	I-cell_type	I-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
of	IN	O	O
(	(	O	O
AML1/ETO	ETO	B-protein	B-protein
reduced	VBN	O	O
numbers	NNS	O	O
DR3	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
locus	NN	I-DNA	I-DNA
of	IN	O	O
)	)	O	O
CD4	CD	B-cell_line	B-cell_line
(	(	I-cell_line	I-cell_line
+	LS	I-cell_line	O
)	)	I-cell_line	I-cell_line
CD8	CD	I-cell_line	I-cell_line
(	(	I-cell_line	I-cell_line
+	LS	I-cell_line	O
)	)	I-cell_line	I-cell_line
thymocyte	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
were	VBD	O	O
preserved	VBN	O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
in	IN	O	O
the	DT	O	O
CD4	CD	B-protein	B-protein
from	IN	O	O
the	DT	O	O
human	JJ	B-DNA	B-DNA
chromosome	NN	I-DNA	I-DNA
band	NN	I-DNA	I-DNA
1p36.2-p36.3	CD	I-DNA	I-DNA
patients	NNS	O	O
.	.	O	O
CD4	CD	B-cell_line	B-cell_line
(	(	I-cell_line	I-cell_line
+	LS	I-cell_line	O
)	)	I-cell_line	I-cell_line
CD8	CD	I-cell_line	I-cell_line
(	(	I-cell_line	I-cell_line
+	LS	I-cell_line	O
)	)	I-cell_line	I-cell_line
thymocyte	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
Octamer	NNP	O	O
transcription	NN	O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
factors	NNS	O	O
1	CD	O	O
CD8	CD	B-protein	B-protein
and	CC	O	O
2	CD	O	O
DR3	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
each	DT	O	O
bind	NN	O	O
OX40-transfected	JJ	B-cell_line	B-cell_line
ACH-2	CD	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
","		I-cell_line	I-cell_line
ACH-2/OX40	OX40	I-cell_line	I-cell_line
to	TO	O	O
two	CD	O	O
PBMCs	NNS	B-cell_type	B-cell_type
different	JJ	O	O
in	IN	O	O
CD56	CD	B-protein	B-protein
the	DT	O	O
.	.	O	O
DR3	CD	B-DNA	B-DNA
and	CC	I-DNA	O
the	DT	I-DNA	O
DR3L	CD	I-DNA	I-DNA
sequences	NNS	I-DNA	I-DNA
contain	VB	O	O
two	CD	O	O
gp34-transfected	JJ	B-cell_line	B-cell_line
mouse	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
","		I-cell_line	I-cell_line
SV-T2/gp34	gp34	I-cell_line	I-cell_line
5	CD	O	O
'	''	O	O
monocytes	NNS	B-cell_type	B-cell_type
to	TO	O	O
the	DT	O	O
NF-kappaB	NNP	B-protein	B-protein
site	NN	O	O
of	IN	O	O
chromosome	NN	B-DNA	B-DNA
transcription	NN	O	O
initiation	NN	O	O
ACH-2/OX40	OX40	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
:	:	O	O
the	DT	O	O
PBMCs	NNS	B-cell_type	B-cell_type
octamer	NN	O	O
ATGCAAAT	NNP	O	O
CD4	CD	B-protein	B-protein
and	CC	O	O
the	DT	O	O
nuclear	JJ	B-DNA	B-DNA
chromatin	NN	I-DNA	I-DNA
heptamer	NN	O	O
CTCATGA	NNP	O	O
CXCR4-using	JJ	B-cell_line	B-cell_line
T-cell-line-tropic	JJ	I-cell_line	I-cell_line
.	.	O	O
Both	DT	O	O
germinal	JJ	B-cell_type	B-cell_type
center-related	JJ	I-cell_type	I-cell_type
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
of	IN	O	O
these	DT	O	O
protein	NN	B-protein	B-protein
tyrosine	NN	I-protein	I-protein
kinase	NN	I-protein	I-protein
(	(	I-protein	I-protein
s	NNS	I-protein	I-protein
)	)	I-protein	I-protein
elements	NNS	O	O
are	VBP	O	O
gene	NN	B-DNA	B-DNA
required	VBN	O	O
for	IN	O	O
MT-2	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
function	NN	O	O
.	.	O	O
GC	NNP	B-cell_type	B-cell_type
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
The	DT	O	O
present	VB	O	O
protein	NN	B-protein	B-protein
kinase	NN	I-protein	I-protein
A	DT	I-protein	I-protein
study	NN	O	O
demonstrates	NNS	O	O
pX	NN	B-DNA	B-DNA
region	NN	I-DNA	I-DNA
that	IN	O	O
both	DT	O	O
SV-T2/gp34	gp34	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
the	DT	O	O
(	(	O	O
mature	VB	B-cell_type	O
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
and	CC	O	O
","		O	O
protein	NN	B-protein	B-protein
kinase	NN	I-protein	I-protein
C	NNP	I-protein	I-protein
respectively	RB	O	O
)	)	O	O
IL-2	CD	B-DNA	B-DNA
receptor	NN	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
interact	VB	O	O
specifically	RB	O	O
THP-1	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
with	IN	O	O
each	DT	O	O
GC	NNP	B-cell_type	B-cell_type
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
of	IN	O	O
the	DT	O	O
transcription	NN	B-protein	B-protein
factor	NN	I-protein	I-protein
NF-kappaB	NNP	I-protein	I-protein
two	CD	O	O
","		O	O
chromatin	NN	B-DNA	B-DNA
forming	VBG	O	O
either	DT	O	O
Mo-7e	NN	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
.	.	O	O
This	DT	O	O
GC	NNP	B-cell_type	B-cell_type
B	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
was	VBD	O	O
surprising	JJ	O	O
endogenous	JJ	B-protein	B-protein
TNF-alpha	NN	I-protein	I-protein
","		O	O
since	IN	O	O
chromosomes	NNS	B-DNA	B-DNA
14	CD	I-DNA	I-DNA
and	CC	I-DNA	O
17	CD	I-DNA	I-DNA
the	DT	O	O
heptamer	NN	O	O
Mo-7e	NN	B-cell_line	B-cell_line
and	CC	I-cell_line	O
HEL	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
and	CC	O	O
octamer	NN	O	O
endothelial	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
sequence	NN	O	O
motifs	NNS	O	O
transcription	NN	B-protein	B-protein
factor	NN	I-protein	I-protein
bear	NN	O	O
no	DT	O	O
chromosome	NN	B-DNA	B-DNA
14	CD	I-DNA	I-DNA
obvious	JJ	O	O
similarity	NN	O	O
YT	PRP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
to	TO	O	O
each	DT	O	O
human	JJ	B-cell_type	B-cell_type
endothelial	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
other	JJ	O	O
.	.	O	O
activating	VBG	B-protein	B-protein
transcription	NN	I-protein	I-protein
factor	NN	I-protein	I-protein
Binding	VBG	O	O
of	IN	O	O
CD28RE	CD	B-DNA	B-DNA
either	DT	O	O
factor	NN	O	O
human	JJ	B-cell_line	B-cell_line
NK	NNP	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
to	TO	O	O
the	DT	O	O
ECV	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
occurred	VBN	O	O
independently	RB	O	O
cAMP	NN	B-protein	B-protein
response	NN	I-protein	I-protein
element	NN	I-protein	I-protein
binding	VBG	I-protein	I-protein
.	.	O	O
However	RB	O	O
IL-2	CD	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
","		O	O
interaction	NN	O	O
B	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lineage	NN	I-cell_line	I-cell_line
with	IN	O	O
the	DT	O	O
ECV	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
appeared	VBD	O	O
to	TO	O	O
ATF	IN	B-protein	B-protein
require	VB	O	O
the	DT	O	O
IL-2	CD	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
presence	NN	O	O
of	IN	O	O
T	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lineage	NN	I-cell_line	I-cell_line
an	DT	O	O
intact	JJ	O	O
PMA-activated	JJ	B-cell_type	B-cell_type
untreated	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
octamer	NN	O	O
motif	NN	O	O
CREB	NN	B-protein	B-protein
and	CC	O	O
occurred	VBN	O	O
IL-2	CD	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
with	IN	O	O
a	DT	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
spacing	VBG	O	O
of	IN	O	O
ECV	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
either	DT	O	O
between	IN	O	O
HMG	NNP	B-protein	B-protein
box	NN	I-protein	I-protein
containing	VBG	I-protein	I-protein
transcription	NN	I-protein	I-protein
factors	NNS	I-protein	I-protein
the	DT	O	O
two	CD	O	O
activation	NN	B-DNA	B-DNA
protein-1	NN	I-DNA	I-DNA
response	NN	I-DNA	I-DNA
element	NN	I-DNA	I-DNA
elements	NNS	O	O
","		O	O
CH12.LX.4933	CD	B-cell_line	B-cell_line
(	(	I-cell_line	I-cell_line
mu	NN	I-cell_line	I-cell_line
(	(	I-cell_line	I-cell_line
+	LS	I-cell_line	O
)	)	I-cell_line	I-cell_line
)	)	I-cell_line	I-cell_line
B	NNP	I-cell_line	I-cell_line
lymphoma	NN	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
suggesting	VBG	O	O
coordinate	VB	O	O
germinal	JJ	B-cell_type	B-cell_type
center	NN	I-cell_type	I-cell_type
(	(	I-cell_type	I-cell_type
GC	NNP	I-cell_type	I-cell_type
)	)	I-cell_type	I-cell_type
B	NNP	I-cell_type	I-cell_type
and	CC	I-cell_type	O
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
binding	VBG	O	O
resulting	VBG	O	O
HMG	NNP	B-protein	B-protein
box	NN	I-protein	I-protein
from	IN	O	O
protein-protein	NN	O	O
IL-2	CD	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
interactions	NNS	O	O
.	.	O	O
lymphoma	NN	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
The	DT	O	O
degeneracy	NN	O	O
immature	NN	B-cell_type	B-cell_type
thymic	JJ	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
in	IN	O	O
sequences	NNS	O	O
transcription	NN	B-protein	B-protein
factors	NNS	I-protein	I-protein
recognized	VBN	O	O
by	IN	O	O
nuclear	JJ	B-DNA	B-DNA
factor	NN	I-DNA	I-DNA
kappabeta	NNS	I-DNA	I-DNA
reporter	NN	I-DNA	I-DNA
construct	VB	I-DNA	O
the	DT	O	O
may	MD	O	O
human	JJ	B-cell_line	B-cell_line
T-cell	NNP	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
Kit	NNP	I-cell_line	I-cell_line
225	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
be	VB	O	O
important	JJ	O	O
splenic	JJ	B-cell_type	B-cell_type
T	NNP	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
in	IN	O	O
widening	VBG	O	O
HMG	NNP	B-protein	B-protein
box	NN	I-protein	I-protein
proteins	NNS	I-protein	I-protein
the	DT	O	O
range	NN	O	O
IL-2	CD	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
over	IN	O	O
which	WDT	O	O
resting	VBG	B-cell_line	B-cell_line
Kit	NNP	I-cell_line	I-cell_line
225	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
gene	NN	O	O
expression	NN	O	O
neutrophils	NNS	B-cell_type	B-cell_type
can	MD	O	O
be	VB	O	O
Sox-4	CD	B-protein	B-protein
modulated	VBN	O	O
and	CC	O	O
CD28	CD	B-DNA	B-DNA
response	NN	I-DNA	I-DNA
element	NN	I-DNA	I-DNA
(	(	I-DNA	I-DNA
CD28RE	CD	I-DNA	I-DNA
)	)	I-DNA	I-DNA
#NAME?	# NAME	I-DNA	O
reporters	NNS	I-DNA	I-DNA
in	IN	O	O
establishing	VBG	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
cell	NN	O	O
type	NN	O	O
splenic	JJ	B-cell_type	B-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
specificity	NN	O	O
.	.	O	O
TCF-1	CD	B-protein	B-protein
Identification	NN	O	O
of	IN	O	O
IL-2	CD	B-DNA	B-DNA
promoter-	NN	I-DNA	I-DNA
and	CC	I-DNA	O
CD28RE-driven	JJ	I-DNA	I-DNA
reporter	NN	I-DNA	I-DNA
constructs	NNS	I-DNA	I-DNA
a	DT	O	O
novel	NN	O	O
COS-7	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
(	(	O	O
)	)	O	O
T	NNP	B-cell_type	B-cell_type
and	CC	I-cell_type	O
B	NNP	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
by	IN	O	O
proteolytic	JJ	O	O
LEF-1	CD	B-protein	B-protein
clipping	VBG	O	O
bandshift	NN	O	O
CD28RE	CD	B-DNA	B-DNA
assay	NN	O	O
(	(	O	O
CD8+	CD	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
clones	NNS	I-cell_line	I-cell_line
PCBA	NN	O	O
)	)	O	O
immune	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
and	CC	I-cell_type	O
tissues	NNS	I-cell_type	I-cell_type
.	.	O	O
The	DT	O	O
TCF/LEF	LEF	B-protein	O
proteins	NNS	I-protein	I-protein
octamer	NN	O	O
sequence	NN	O	O
upstream	NN	B-DNA	B-DNA
nuclear	JJ	I-DNA	I-DNA
factor	NN	I-DNA	I-DNA
kappabeta-binding	JJ	I-DNA	I-DNA
site	NN	I-DNA	I-DNA
ATGCAAAT	NNP	O	O
is	VBZ	O	O
hematopoietic	JJ	B-cell_line	B-cell_line
stem	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
","		I-cell_line	I-cell_line
A-6	CD	I-cell_line	I-cell_line
found	VBN	O	O
in	IN	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
the	DT	O	O
promoters	NNS	O	O
TCF/LEF	LEF	B-protein	O
of	IN	O	O
and	CC	O	O
IL-2	CD	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
in	IN	O	O
the	DT	O	O
hematopoietic	JJ	B-cell_line	B-cell_line
stem	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
","		I-cell_line	I-cell_line
A-6	CD	I-cell_line	I-cell_line
and	CC	O	O
is	VBZ	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
a	DT	O	O
major	JJ	O	O
HMG	NNP	B-protein	B-protein
box	NN	I-protein	I-protein
proteins	NNS	I-protein	I-protein
determinant	NN	O	O
of	IN	O	O
CD28RE	CD	B-DNA	B-DNA
the	DT	O	O
cell	NN	O	O
A-6	CD	B-cell_line	B-cell_line
hematopoietic	JJ	I-cell_line	I-cell_line
stem	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
type	NN	O	O
specific	JJ	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
expression	NN	O	O
of	IN	O	O
C/EBP	EBP	B-protein	O
alpha	NN	I-protein	I-protein
and	CC	I-protein	O
#NAME?	# NAME	I-protein	O
in	IN	O	O
.	.	O	O
IL-2	CD	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
An	DT	O	O
apparent	JJ	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
paradox	NN	O	O
is	VBZ	O	O
monocytes	NNS	B-cell_type	B-cell_type
that	IN	O	O
the	DT	O	O
MRP14	CD	B-protein	B-protein
myeloid	NN	I-protein	I-protein
calcium	NN	I-protein	I-protein
binding	VBG	I-protein	I-protein
protein	NN	I-protein	I-protein
same	JJ	O	O
sequence	NN	O	O
CD28RE	CD	B-DNA	B-DNA
serves	NNS	O	O
as	IN	O	O
acute	NN	B-cell_line	B-cell_line
myeloid	NN	I-cell_line	I-cell_line
leukemias	NNS	I-cell_line	I-cell_line
an	DT	O	O
in	IN	O	O
B	NNP	B-cell_type	B-cell_type
lymphopoiesis	NN	I-cell_type	I-cell_type
a	DT	O	O
variety	NN	O	O
myeloid	NN	B-protein	B-protein
calcium	NN	I-protein	I-protein
binding	VBG	I-protein	I-protein
protein	NN	I-protein	I-protein
of	IN	O	O
such	JJ	O	O
IL-2	CD	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
as	IN	O	O
the	DT	O	O
M4Eo	CD	B-cell_line	B-cell_line
.	.	O	O
The	DT	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
differential	JJ	O	O
usage	NN	O	O
MRP14	CD	B-protein	B-protein
of	IN	O	O
this	DT	O	O
vav	NN	B-DNA	B-DNA
regulatory	JJ	O	O
sequence	NN	O	O
EBV-positive	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
motif	NN	O	O
is	VBZ	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
thought	VBN	O	O
to	TO	O	O
MRP14	CD	B-protein	B-protein
be	VB	O	O
mediated	VBN	O	O
vav	NN	B-DNA	B-DNA
by	IN	O	O
different	JJ	O	O
EBV-positive	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
species	NNS	O	O
of	IN	O	O
antigen-presenting	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
.	.	O	O
One	CD	O	O
nuclear	JJ	B-protein	B-protein
protein	NN	I-protein	I-protein
(	(	I-protein	I-protein
s	NNS	I-protein	I-protein
)	)	I-protein	I-protein
species	NNS	O	O
of	IN	O	O
vav	NN	B-DNA	B-DNA
100	CD	O	O
kd	NN	O	O
B95.8	CD	B-cell_line	B-cell_line
","		O	O
designated	VBN	O	O
APC	NNP	B-cell_type	B-cell_type
","		O	O
is	VBZ	O	O
C/EBP	EBP	B-protein	O
alpha	NN	I-protein	I-protein
present	VB	O	O
in	IN	O	O
NF-ATc1	CD	B-DNA	B-DNA
and	CC	I-DNA	O
egr-1	CD	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
all	DT	O	O
cell	NN	O	O
Raji	NNP	B-cell_line	B-cell_line
types	NNS	O	O
and	CC	O	O
co-stimulate	NN	B-cell_type	B-cell_type
human	JJ	I-cell_type	I-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
may	MD	O	O
exert	NN	O	O
nucleoprotein	NN	B-protein	B-protein
complex	NN	I-protein	I-protein
its	PRP$	O	O
activating	VBG	O	O
E-selectin	NNP	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
function	NN	O	O
only	RB	O	O
Jiyoye	NNP	B-cell_line	B-cell_line
when	WRB	O	O
it	PRP	O	O
CD4+	CD	B-cell_type	B-cell_type
T	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
can	MD	O	O
interact	VB	O	O
C/EBP	EBP	B-protein	O
beta	NNS	I-protein	I-protein
with	IN	O	O
additional	JJ	O	O
tetracycline-responsive	JJ	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
adjacent	JJ	O	O
.	.	O	O
cell	NN	B-cell_line	B-cell_line
lines	NNS	I-cell_line	I-cell_line
The	DT	O	O
of	IN	O	O
T	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
60	CD	O	O
kd	NN	O	O
nuclear	JJ	B-protein	B-protein
factor	NN	I-protein	I-protein
(	(	O	O
)	)	O	O
DNA	NN	B-DNA	B-DNA
termini	NNS	I-DNA	I-DNA
specifically	RB	O	O
stimulates	NNS	O	O
cell	NN	B-cell_line	B-cell_line
lines	NNS	I-cell_line	I-cell_line
which	WDT	O	O
consist	VBP	O	O
CD86+	CD	B-cell_type	B-cell_type
APC	NNP	I-cell_type	I-cell_type
essentially	RB	O	O
of	IN	O	O
anti-C/EBP	EBP	B-protein	B-protein
delta	NN	I-protein	I-protein
antibody	NN	I-protein	I-protein
a	DT	O	O
and	CC	O	O
DNA-ends	NNS	B-DNA	B-DNA
an	DT	O	O
upstream	NN	O	O
cell	NN	B-cell_line	B-cell_line
line	NN	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
of	IN	O	O
it	PRP	O	O
human	JJ	B-cell_type	B-cell_type
neuroblastoma	NN	I-cell_type	I-cell_type
.	.	O	O
Here	RB	O	O
C/EBP	EBP	B-protein	O
alpha	NN	I-protein	I-protein
and	CC	I-protein	O
#NAME?	# NAME	I-protein	O
we	PRP	O	O
present	VB	O	O
lineage-specific	JJ	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
evidence	NN	O	O
for	IN	O	O
lymphoid	NN	B-cell_line	B-cell_line
and	CC	I-cell_line	O
myeloid	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lineages	NNS	I-cell_line	I-cell_line
yet	RB	O	O
another	DT	O	O
thymocytes	NNS	B-cell_type	B-cell_type
of	IN	O	O
75	CD	O	O
C/EBP	EBP	B-protein	O
motif	NN	I-protein	I-protein
kd	NN	O	O
(	(	O	O
myeloid-specific	JJ	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
)	)	O	O
.	.	O	O
human	JJ	B-cell_line	B-cell_line
bronchial	JJ	I-cell_line	I-cell_line
epithelial	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
BEAS-2B	NN	I-cell_line	I-cell_line
From	IN	O	O
several	JJ	O	O
lymphocytes	NNS	B-cell_type	B-cell_type
findings	NNS	O	O
","		O	O
C/EBP	EBP	B-protein	O
alpha	NN	I-protein	I-protein
including	VBG	O	O
the	DT	O	O
proto-oncogene	NN	B-DNA	B-DNA
absence	NN	O	O
of	IN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
(	(	O	O
but	CC	O	O
mammalian	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
not	RB	O	O
)	)	O	O
C/EBP	EBP	B-protein	O
beta	NNS	I-protein	I-protein
from	IN	O	O
a	DT	O	O
pX	NN	B-DNA	B-DNA
open	JJ	I-DNA	I-DNA
reading	VBG	I-DNA	I-DNA
frame	NN	I-DNA	I-DNA
I	PRP	I-DNA	I-DNA
that	IN	O	O
can	MD	O	O
breast	NN	B-cell_line	B-cell_line
cancer	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
not	RB	O	O
respond	NN	O	O
normal	JJ	B-cell_type	B-cell_type
and	CC	I-cell_type	O
malignant	JJ	I-cell_type	I-cell_type
human	JJ	I-cell_type	I-cell_type
myeloid	NN	I-cell_type	I-cell_type
progenitors	NNS	I-cell_type	I-cell_type
to	TO	O	O
the	DT	O	O
C/EBP	EBP	B-protein	O
motif	NN	I-protein	I-protein
","		O	O
we	PRP	O	O
human	JJ	B-DNA	B-DNA
immunodeficiency	NN	I-DNA	I-DNA
virus	NN	I-DNA	I-DNA
type	NN	I-DNA	I-DNA
1-based	JJ	I-DNA	I-DNA
retroviral	NN	I-DNA	I-DNA
vector	NN	I-DNA	I-DNA
propose	VB	O	O
a	DT	O	O
murine	NN	B-cell_line	B-cell_line
fetal	NN	I-cell_line	I-cell_line
liver	RB	I-cell_line	O
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
AFT024	CD	I-cell_line	I-cell_line
role	NN	O	O
of	IN	O	O
CFU-GM	NNP	B-cell_type	B-cell_type
the	DT	O	O
in	IN	O	O
C/EBP	EBP	B-protein	O
motif	NN	I-protein	I-protein
the	DT	O	O
long	RB	O	O
local	JJ	B-DNA	B-DNA
DNA	NN	I-DNA	I-DNA
structure	NN	I-DNA	I-DNA
range	NN	O	O
activation	NN	O	O
HD-derived	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
by	IN	O	O
the	DT	O	O
normal	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
.	.	O	O
We	PRP	O	O
C/EBP	EBP	B-protein	O
motif	NN	I-protein	I-protein
have	VB	O	O
used	VBN	O	O
EBV-encoded	JJ	B-DNA	B-DNA
latent	RB	I-DNA	O
membrane	NN	I-DNA	I-DNA
protein	NN	I-DNA	I-DNA
1	CD	I-DNA	I-DNA
(	(	I-DNA	I-DNA
LMP1	CD	I-DNA	I-DNA
)	)	I-DNA	I-DNA
oncogene	RB	I-DNA	O
the	DT	O	O
proteolytic	JJ	O	O
human	JJ	B-cell_line	B-cell_line
mast	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
HMC-1	CD	I-cell_line	I-cell_line
clipping	VBG	O	O
bandshift	NN	O	O
normal	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
assay	NN	O	O
(	(	O	O
C/EBP	EBP	B-protein	O
beta	NNS	I-protein	I-protein
PCBA	NN	O	O
)	)	O	O
EBV	NN	B-DNA	B-DNA
latency	RB	I-DNA	O
genes	NNS	I-DNA	I-DNA
technique	NN	O	O
to	TO	O	O
HL-60	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
distinguish	VB	O	O
the	DT	O	O
Malignant	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
three	CD	O	O
different	JJ	O	O
C/EBP	EBP	B-protein	O
beta	NNS	I-protein	I-protein
forms	NNS	O	O
found	VBN	O	O
TNF-alpha	NN	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
in	IN	O	O
.	.	O	O
U-937	CD	B-cell_line	B-cell_line
This	DT	O	O
analysis	NN	O	O
granulocyte/macrophage	macrophage	B-cell_type	B-cell_type
progenitors	NNS	I-cell_type	I-cell_type
indicates	NNS	O	O
that	IN	O	O
CYP11A	CD	B-protein	B-protein
the	DT	O	O
75	CD	O	O
p21	CD	B-DNA	B-DNA
(	(	I-DNA	I-DNA
CIP1/WAF1	WAF1	I-DNA	I-DNA
)	)	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
kd-species	NNS	O	O
is	VBZ	O	O
KU812	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
closely	RB	O	O
related	VBN	O	O
CFU-GM	NNP	B-cell_type	B-cell_type
to	TO	O	O
the	DT	O	O
CYP17	CD	B-protein	B-protein
.	.	O	O
Inhibition	NN	O	O
p21	CD	B-DNA	B-DNA
(	(	I-DNA	I-DNA
CIP1/WAF1	WAF1	I-DNA	I-DNA
)	)	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
of	IN	O	O
#NAME?	# NAME	O	O
HMC-1	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
proliferation	NN	O	O
of	IN	O	O
malignant	JJ	B-cell_type	B-cell_type
progenitors	NNS	I-cell_type	I-cell_type
by	IN	O	O
glucocorticoids	NNS	O	O
HSD11L	CD	B-protein	B-protein
.	.	O	O
Possible	JJ	O	O
29-base	JJ	B-DNA	B-DNA
pair	NN	I-DNA	I-DNA
(	(	I-DNA	I-DNA
b	NN	I-DNA	I-DNA
)	)	I-DNA	I-DNA
region	NN	I-DNA	I-DNA
involvement	NN	O	O
of	IN	O	O
HL60	CD	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
an	DT	O	O
.	.	O	O
CML	NNP	B-cell_type	B-cell_type
progenitors	NNS	I-cell_type	I-cell_type
The	DT	O	O
ability	NN	O	O
11beta-hydroxysteroid	JJ	B-protein	B-protein
dehydrogenase	NN	I-protein	I-protein
I	PRP	I-protein	I-protein
of	IN	O	O
glucocorticoids	NNS	O	O
TATA	NNP	B-DNA	B-DNA
box	NN	I-DNA	I-DNA
to	TO	O	O
inhibit	NN	O	O
HL60	CD	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
(	(	O	O
)	)	O	O
CFU-GM	NNP	B-cell_type	B-cell_type
#NAME?	# NAME	O	O
proliferation	NN	O	O
HSD17B1	CD	B-protein	B-protein
in	IN	O	O
two	CD	O	O
29-b	CD	B-DNA	B-DNA
region	NN	I-DNA	I-DNA
has	VBZ	O	O
been	VBN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
studied	VBN	O	O
.	.	O	O
peripheral	JJ	B-cell_type	B-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
A	DT	O	O
complete	JJ	O	O
17beta-hydroxysteroid	JJ	B-protein	B-protein
dehydrogenase	NN	I-protein	I-protein
type	NN	I-protein	I-protein
I	PRP	I-protein	I-protein
inhibition	NN	O	O
of	IN	O	O
29-b	CD	B-DNA	B-DNA
region	NN	I-DNA	I-DNA
DNA	NN	O	O
synthesis	NN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
by	IN	O	O
dexamethasone	NN	O	O
leukemic	JJ	B-cell_type	B-cell_type
blasts	NNS	I-cell_type	I-cell_type
(	(	O	O
Dx	NNP	O	O
SRD5A1	CD	B-protein	B-protein
)	)	O	O
could	MD	O	O
PPAR-alpha/GAL4	GAL4	B-DNA	B-DNA
luciferase	NN	I-DNA	I-DNA
reporter	NN	I-DNA	I-DNA
be	VB	O	O
observed	VBN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
when	WRB	O	O
of	IN	O	O
leukemic	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
were	VBD	O	O
either	DT	O	O
5alpha-reductase	JJ	B-protein	B-protein
I	PRP	I-protein	I-protein
incubated	VBN	O	O
for	IN	O	O
PPAR-gamma/GAL4	GAL4	B-DNA	B-DNA
constructs	NNS	I-DNA	I-DNA
6	CD	O	O
h	NN	O	O
EBV-positive	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
with	IN	O	O
the	DT	O	O
leukemic	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
prior	RB	O	O
to	TO	O	O
CYP11B	NN	B-protein	B-protein
the	DT	O	O
addition	NN	O	O
PPAR	NN	B-DNA	B-DNA
response	NN	I-DNA	I-DNA
element	NN	I-DNA	I-DNA
luciferase	NN	I-DNA	I-DNA
reporter	NN	I-DNA	I-DNA
of	IN	O	O
or	CC	O	O
EBV-negative	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
treated	VBN	O	O
simultaneously	RB	O	O
human	JJ	B-cell_type	B-cell_type
chronic	NN	I-cell_type	I-cell_type
myeloid	NN	I-cell_type	I-cell_type
leukemia	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
with	IN	O	O
Dx	NNP	O	O
HSD3B1	CD	B-protein	B-protein
and	CC	O	O
a	DT	O	O
IL-12	CD	B-DNA	B-DNA
p40	CD	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
low	JJ	O	O
concentration	NN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
mutants	NNS	I-cell_line	I-cell_line
of	IN	O	O
.	.	O	O
intact	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
No	DT	O	O
significant	JJ	O	O
HSD3B2	CD	B-protein	B-protein
reduction	NN	O	O
in	IN	O	O
IL-12	CD	B-DNA	B-DNA
p40	CD	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
the	DT	O	O
number	NN	O	O
p56	CD	B-cell_line	B-cell_line
(	(	I-cell_line	I-cell_line
lck	NN	I-cell_line	I-cell_line
)	)	I-cell_line	I-cell_line
#NAME?	# NAME	I-cell_line	O
Jurkat	NNP	I-cell_line	I-cell_line
mutants	NNS	I-cell_line	I-cell_line
and	CC	O	O
affinity	NN	O	O
Exponentially	RB	B-cell_type	O
growing	VBG	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
of	IN	O	O
was	VBD	O	O
3beta-hydroxysteroid	JJ	B-protein	B-protein
dehydrogenase	NN	I-protein	I-protein
I	PRP	I-protein	I-protein
and	CC	I-protein	O
II	NNP	I-protein	I-protein
seen	VBN	O	O
after	IN	O	O
IL-12	CD	B-DNA	B-DNA
p40	CD	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
6	CD	O	O
h	NN	O	O
cancer	NN	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
incubation	NN	O	O
with	IN	O	O
lymphoid	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
Dx	NNP	O	O
.	.	O	O
CYP19	CD	B-protein	B-protein
The	DT	O	O
order	NN	O	O
IL-12	CD	B-DNA	B-DNA
p35	CD	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
of	IN	O	O
potency	NN	O	O
NB4	CD	B-cell_line	B-cell_line
","		I-cell_line	I-cell_line
a	DT	I-cell_line	O
human	JJ	I-cell_line	I-cell_line
promyelocytic	JJ	I-cell_line	I-cell_line
leukemia	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
observed	VBN	O	O
with	IN	O	O
human	JJ	B-cell_type	B-cell_type
leukemic	JJ	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
the	DT	O	O
different	JJ	O	O
HSD11K	CD	B-protein	B-protein
steroids	NNS	O	O
indicated	VBN	O	O
IFN-regulatory	JJ	B-DNA	B-DNA
factor-1	NN	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
that	IN	O	O
this	DT	O	O
NB4	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
inhibitory	NN	O	O
effect	NN	O	O
lymphoblasts	NNS	B-cell_type	B-cell_type
was	VBD	O	O
mediated	VBN	O	O
17-hydroxysteroid	JJ	B-protein	B-protein
dehydrogenase	NN	I-protein	I-protein
through	IN	O	O
binding	VBG	O	O
IL-12	CD	B-DNA	B-DNA
p40	CD	I-DNA	I-DNA
gene	NN	I-DNA	I-DNA
to	TO	O	O
a	DT	O	O
NB4	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
specific	JJ	O	O
.	.	O	O
normal	JJ	B-cell_type	B-cell_type
peripheral	JJ	I-cell_type	I-cell_type
blood	NN	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
The	DT	O	O
action	NN	O	O
5alpha-reductase	JJ	B-protein	B-protein
of	IN	O	O
these	DT	O	O
octamer	NN	B-DNA	B-DNA
site	NN	I-DNA	I-DNA
DNA	NN	I-DNA	I-DNA
possibly	RB	O	O
involves	NNS	O	O
NB4	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
the	DT	O	O
synthesis	NN	O	O
cell	NN	B-cell_type	B-cell_type
specimen	NNS	I-cell_type	I-cell_type
of	IN	O	O
an	DT	O	O
pterin	NN	B-protein	B-protein
carbinolamine	NN	I-protein	I-protein
dehydratase/dimerization	dimerization	I-protein	I-protein
cofactor	NN	I-protein	I-protein
(	(	O	O
s	NNS	O	O
Bcl-2	CD	B-DNA	B-DNA
transgene	NN	I-DNA	I-DNA
)	)	O	O
","		O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
since	IN	O	O
the	DT	O	O
ALL	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
presence	NN	O	O
of	IN	O	O
HNF1	CD	B-protein	B-protein
cycloheximide	NN	O	O
during	IN	O	O
tensin	NN	B-DNA	B-DNA
homologue	NN	I-DNA	I-DNA
the	DT	O	O
incubation	NN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
with	IN	O	O
Dx	NNP	O	O
human	JJ	B-cell_type	B-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
prevented	VBN	O	O
the	DT	O	O
Pterin	NNP	B-protein	B-protein
carbinolamine	NN	I-protein	I-protein
dehydratase/dimerization	dimerization	I-protein	I-protein
cofactor	NN	I-protein	I-protein
inhibition	NN	O	O
of	IN	O	O
chromosome	NN	B-DNA	B-DNA
10	CD	I-DNA	I-DNA
DNA	NN	O	O
synthesis	NN	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
.	.	O	O
Furthermore	RB	O	O
human	JJ	B-cell_type	B-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
","		O	O
supernatant	JJ	O	O
HNF1	CD	B-protein	B-protein
from	IN	O	O
Dx-treated	JJ	O	O
GC	NNP	B-DNA	B-DNA
box	NN	I-DNA	I-DNA
contained	VBN	O	O
a	DT	O	O
myeloid	NN	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
nondialyzable	JJ	O	O
factor	NN	O	O
human	JJ	B-cell_type	B-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
which	WDT	O	O
inhibited	VBN	O	O
PCD/DCoH	DCoH	B-protein	O
DNA	NN	O	O
synthesis	NN	O	O
minimal	NN	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
and	CC	O	O
cell	NN	O	O
human	JJ	B-cell_line	B-cell_line
and	CC	I-cell_line	O
murine	NN	I-cell_line	I-cell_line
B-cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
growth	NN	O	O
of	IN	O	O
lymphocyte	NN	B-cell_type	B-cell_type
induced	VBN	O	O
by	IN	O	O
pterin	NN	B-protein	B-protein
4alpha-carbinolamine	CD	I-protein	I-protein
dehydratase	NN	I-protein	I-protein
.	.	O	O
Blocking	VBG	O	O
consensus-binding	NN	B-DNA	B-DNA
sites	NNS	I-DNA	I-DNA
of	IN	O	O
synthesis	NN	O	O
ovalbumin	NN	B-cell_line	B-cell_line
expressing	VBG	I-cell_line	I-cell_line
tumour	PRP$	I-cell_line	O
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
and	CC	O	O
formation	NN	O	O
immunoglobulin	NN	B-cell_type	B-cell_type
secreting	VBG	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
have	VB	O	O
been	VBN	O	O
cofactor	NN	B-protein	B-protein
tetrahydrobiopterin	NN	I-protein	I-protein
proposed	VBN	O	O
as	IN	O	O
minimal	NN	B-DNA	B-DNA
promoters	NNS	I-DNA	I-DNA
one	CD	O	O
of	IN	O	O
E.G7-OVA	NN	B-cell_line	B-cell_line
the	DT	O	O
major	JJ	O	O
T	NNP	B-cell_type	B-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
mechanisms	NNS	O	O
of	IN	O	O
HNF1	CD	B-protein	B-protein
glucocorticoid-induced	VBN	O	O
immunosuppression	NN	O	O
galectins	NNS	B-DNA	B-DNA
-1	NNS	I-DNA	I-DNA
","		I-DNA	I-DNA
-2	NNS	I-DNA	I-DNA
","		I-DNA	I-DNA
and	CC	I-DNA	O
-3	NNS	I-DNA	I-DNA
.	.	O	O
Our	PRP$	O	O
murine	NN	B-cell_line	B-cell_line
myeloid	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
32D	CD	I-cell_line	I-cell_line
results	NNS	O	O
indicate	VB	O	O
lymphocyte	NN	B-cell_type	B-cell_type
that	IN	O	O
these	DT	O	O
HNF1	CD	B-protein	B-protein
may	MD	O	O
also	RB	O	O
GC	NNP	B-DNA	B-DNA
box	NN	I-DNA	I-DNA
affect	VB	O	O
proliferation	NN	O	O
32D	CD	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
by	IN	O	O
inhibiting	VBG	O	O
chronic	NN	B-cell_type	B-cell_type
lymphocytic	JJ	I-cell_type	I-cell_type
leukemia	NN	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
activity	NN	O	O
.	.	O	O
dual	JJ	B-protein	B-protein
functional	JJ	I-protein	I-protein
protein	NN	I-protein	I-protein
Identification	NN	O	O
and	CC	O	O
Oct	NNP	B-DNA	B-DNA
site	NN	I-DNA	I-DNA
purification	NN	O	O
of	IN	O	O
cultured	VBN	B-cell_line	O
human	JJ	I-cell_line	I-cell_line
mesangial	NN	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
a	DT	O	O
(	(	O	O
Human	NNP	B-cell_type	B-cell_type
chronic	NN	I-cell_type	I-cell_type
lymphocytic	JJ	I-cell_type	I-cell_type
leukemia	NN	I-cell_type	I-cell_type
(	(	I-cell_type	I-cell_type
CLL	NNP	I-cell_type	I-cell_type
)	)	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
)	)	O	O
that	IN	O	O
NF-Y	NNP	B-protein	B-protein
transcription	NN	I-protein	I-protein
factor	NN	I-protein	I-protein
complex	NN	I-protein	I-protein
activates	NNS	O	O
transcription	NN	O	O
GATA	NNP	B-DNA	B-DNA
and	CC	I-DNA	O
EoTF	NNP	I-DNA	I-DNA
sites	NNS	I-DNA	I-DNA
from	IN	O	O
a	DT	O	O
CHMC	NNP	B-cell_line	B-cell_line
in	IN	O	O
vitro	NN	O	O
prothymocytes	NNS	B-cell_type	B-cell_type
.	.	O	O
The	DT	O	O
transcription	NN	B-protein	B-protein
factor	NN	I-protein	I-protein
","		O	O
which	WDT	O	O
consensus	NN	B-DNA	B-DNA
GC	NNP	I-DNA	I-DNA
box	NN	I-DNA	I-DNA
is	VBZ	O	O
found	VBN	O	O
CHMC	NNP	B-cell_line	B-cell_line
only	RB	O	O
in	IN	O	O
immunoactivated	VBN	B-cell_type	O
T-lymphocytes	NNS	I-cell_type	I-cell_type
cells	NNS	O	O
that	IN	O	O
NF-Y	NNP	B-protein	B-protein
transcribe	NN	O	O
","		O	O
Oct	NNP	B-DNA	B-DNA
site	NN	I-DNA	I-DNA
has	VBZ	O	O
been	VBN	O	O
CHMC	NNP	B-cell_line	B-cell_line
purified	VBN	O	O
from	IN	O	O
peripheral	JJ	B-cell_type	B-cell_type
blood	NN	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
nuclear	JJ	O	O
extracts	NNS	O	O
heterotrimeric	JJ	B-protein	B-protein
NF-Y	NNP	I-protein	I-protein
complex	NN	I-protein	I-protein
of	IN	O	O
(	(	O	O
gal-1	NN	B-DNA	B-DNA
)	)	O	O
by	IN	O	O
FCS-stimulated	JJ	B-cell_line	B-cell_line
CHMC	NNP	I-cell_line	I-cell_line
sequence-specific	JJ	O	O
DNA	NN	O	O
thymocytes	NNS	B-cell_type	B-cell_type
affinity	NN	O	O
chromatography	NN	O	O
NF-Y	NNP	B-protein	B-protein
complex	NN	I-protein	I-protein
.	.	O	O
The	DT	O	O
GC	NNP	B-DNA	B-DNA
box	NN	I-DNA	I-DNA
purified	VBN	O	O
has	VBZ	O	O
CHMC	NNP	B-cell_line	B-cell_line
been	VBN	O	O
identified	VBN	O	O
CLL	NNP	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
as	IN	O	O
a	DT	O	O
anion	NN	B-protein	B-protein
exchangers	NNS	I-protein	I-protein
by	IN	O	O
UV-crosslinking	NN	O	O
consensus	NN	B-DNA	B-DNA
AML	NNP	I-DNA	I-DNA
site	NN	I-DNA	I-DNA
analysis	NN	O	O
.	.	O	O
DT40	CD	B-cell_line	B-cell_line
B	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
``	``	O	O
Footprint	NNP	O	O
dead	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
''	''	O	O
and	CC	O	O
trimeric	JJ	B-protein	B-protein
complex	NN	I-protein	I-protein
methylation-interference	NN	O	O
analyses	NNS	O	O
Inr	NNP	B-DNA	B-DNA
sequence	NN	I-DNA	I-DNA
have	VB	O	O
shown	VBN	O	O
Hodgkin	NNP	B-cell_line	B-cell_line
disease	NN	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
that	IN	O	O
purified	VBN	O	O
rat	NN	B-cell_type	B-cell_type
or	CC	I-cell_type	O
murine	NN	I-cell_type	I-cell_type
lymphocytes	NNS	I-cell_type	I-cell_type
has	VBZ	O	O
a	DT	O	O
NF-Y	NNP	B-protein	B-protein
binding	VBG	O	O
activity	NN	O	O
gal-10	NN	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
specific	JJ	O	O
for	IN	O	O
cutaneous	JJ	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lymphoma	NN	I-cell_line	I-cell_line
(	(	I-cell_line	I-cell_line
CTCL	NNP	I-cell_line	I-cell_line
)	)	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
the	DT	O	O
.	.	O	O
cells	NNS	B-cell_type	B-cell_type
The	DT	O	O
purified	VBN	O	O
NF-YA	NNP	B-protein	B-protein
factor	NN	O	O
activated	VBN	O	O
MHC	NNP	B-DNA	B-DNA
class	NN	I-DNA	I-DNA
II	NNP	I-DNA	I-DNA
genes	NNS	I-DNA	I-DNA
in	IN	O	O
vitro	NN	O	O
CTCL	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
HuT-78	CD	I-cell_line	I-cell_line
and	CC	I-cell_line	O
HH	NNP	I-cell_line	I-cell_line
transcription	NN	O	O
of	IN	O	O
mononuclear	JJ	B-cell_type	B-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
the	DT	O	O
by	IN	O	O
NF-YB	NNP	B-protein	B-protein
:	:	I-protein	O
C	NNP	I-protein	I-protein
binding	VBG	O	O
to	TO	O	O
class	NN	B-DNA	B-DNA
II	NNP	I-DNA	I-DNA
transactivator	NN	I-DNA	I-DNA
an	DT	O	O
binding	VBG	O	O
CTCL	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
in	IN	O	O
depression	NN	O	O
Percoll-separated	JJ	B-cell_type	B-cell_type
control	NN	I-cell_type	I-cell_type
monocytes	NNS	I-cell_type	I-cell_type
:	:	O	O
normal	JJ	O	O
subunit	NN	B-protein	B-protein
fractions	NNS	I-protein	I-protein
values	NNS	O	O
following	VBG	O	O
B	NNP	B-DNA	B-DNA
cell-specific	JJ	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
recovery	NN	O	O
.	.	O	O
CTCL	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
The	DT	O	O
number	NN	O	O
monocytes	NNS	B-cell_type	B-cell_type
of	IN	O	O
sites	NNS	O	O
MPC11	CD	B-protein	B-protein
plasma	NN	I-protein	I-protein
B-cell	NN	I-protein	I-protein
derived	VBN	I-protein	O
NF-Y	NNP	I-protein	I-protein
A	DT	I-protein	I-protein
:	:	I-protein	O
B	NNP	I-protein	I-protein
:	:	I-protein	O
C	NNP	I-protein	I-protein
complex	NN	I-protein	I-protein
in	IN	O	O
and	CC	O	O
HLA-DR	NNP	B-DNA	B-DNA
plasma	NN	O	O
cortisol	NN	O	O
CTCL	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
lines	NNS	I-cell_line	I-cell_line
concentrations	NNS	O	O
were	VBD	O	O
circulating	VBG	B-cell_type	B-cell_type
human	JJ	I-cell_type	I-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
measured	VBN	O	O
in	IN	O	O
NF-Y-associated	JJ	B-protein	B-protein
factors	NNS	I-protein	I-protein
20	CD	O	O
patients	NNS	O	O
HLA-DP	NNP	B-DNA	B-DNA
who	WP	O	O
had	VBD	O	O
human	JJ	B-cell_line	B-cell_line
Jurkat	NNP	I-cell_line	I-cell_line
T-cell	NNP	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
recovered	VBD	O	O
from	IN	O	O
mononuclear	JJ	B-cell_type	B-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
major	JJ	O	O
depressive	JJ	O	O
YAFs	NNS	B-protein	B-protein
disorder	NN	O	O
and	CC	O	O
HLA-DQ	NNP	B-DNA	B-DNA
20	CD	O	O
healthy	JJ	O	O
mouse	NN	B-cell_line	B-cell_line
T-cell	NNP	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
control	NN	O	O
subjects	NNS	O	O
circulating	VBG	B-cell_type	B-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
.	.	O	O
The	DT	O	O
NF-Y	NNP	B-protein	B-protein
number	NN	O	O
of	IN	O	O
HLA-D	NNP	B-DNA	B-DNA
isotypes	NNS	I-DNA	I-DNA
sites	NNS	O	O
in	IN	O	O
T-cell	NNP	B-cell_line	B-cell_line
line	NN	I-cell_line	I-cell_line
from	IN	O	O
the	DT	O	O
circulating	VBG	B-cell_type	B-cell_type
mononuclear	JJ	I-cell_type	I-cell_type
leukocytes	NNS	I-cell_type	I-cell_type
recovered	VBD	O	O
depressed	VBN	O	O
intact	JJ	B-protein	B-protein
trimeric	JJ	I-protein	I-protein
complex	NN	I-protein	I-protein
group	NN	O	O
was	VBD	O	O
HLA-D	NNP	B-DNA	B-DNA
genes	NNS	I-DNA	I-DNA
not	RB	O	O
significantly	RB	O	O
Jurkat	NNP	B-cell_line	B-cell_line
cells	NNS	I-cell_line	I-cell_line
different	JJ	O	O
from	IN	O	O
lymphoid	NN	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
that	IN	O	O
of	IN	O	O
native	NN	B-protein	B-protein
NF-YA	NNP	I-protein	I-protein
:	:	I-protein	O
B	NNP	I-protein	I-protein
:	:	I-protein	O
C	NNP	I-protein	I-protein
complex	NN	I-protein	I-protein
the	DT	O	O
control	NN	O	O
promoter	NN	B-DNA	B-DNA
III	NNP	I-DNA	I-DNA
group	NN	O	O
.	.	O	O
T-cell	NNP	B-cell_line	B-cell_line
line	NN	I-cell_line	I-cell_line
Although	IN	O	O
the	DT	O	O
macrophage	NN	B-cell_type	B-cell_type
mean	VB	O	O
plasma	NN	O	O
transcriptional	JJ	B-protein	B-protein
cofactor	NN	I-protein	I-protein
cortisol	NN	O	O
concentration	NN	O	O
CIITA	NNP	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
in	IN	O	O
recovered	VBD	O	O
monocytic	JJ	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
depressives	NNS	O	O
was	VBD	O	O
lymphoid	NN	B-cell_type	B-cell_type
tissue	NN	I-cell_type	I-cell_type
higher	JJR	O	O
than	IN	O	O
PC4	CD	B-protein	B-protein
in	IN	O	O
control	NN	O	O
CIITA	NNP	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
III	NNP	I-DNA	I-DNA
subjects	NNS	O	O
","		O	O
Mono	NNP	B-cell_line	B-cell_line
Mac	NNP	I-cell_line	I-cell_line
6	CD	I-cell_line	I-cell_line
monocytic/macrophage	macrophage	I-cell_line	I-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
the	DT	O	O
difference	NN	O	O
lymphocyte	NN	B-cell_type	B-cell_type
only	RB	O	O
just	RB	O	O
high	RB	B-protein	O
affinity	NN	I-protein	I-protein
NF-Y	NNP	I-protein	I-protein
reached	VBN	O	O
significance	NN	O	O
CIITA	NNP	B-DNA	B-DNA
.	.	O	O
This	DT	O	O
Mono	NNP	B-cell_line	B-cell_line
Mac	NNP	I-cell_line	I-cell_line
6	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
study	NN	O	O
shows	NNS	O	O
Lymphocytes	NNS	B-cell_type	B-cell_type
that	IN	O	O
the	DT	O	O
anion	NN	B-protein	B-protein
exchangers	NNS	I-protein	I-protein
reduction	NN	O	O
in	IN	O	O
promoter	NN	B-DNA	B-DNA
III	NNP	I-DNA	I-DNA
numbers	NNS	O	O
which	WDT	O	O
Mono	NNP	B-cell_line	B-cell_line
Mac	NNP	I-cell_line	I-cell_line
6	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
occurs	NNS	O	O
during	IN	O	O
T	NNP	B-cell_type	B-cell_type
helper	NN	I-cell_type	I-cell_type
cell	NN	I-cell_type	I-cell_type
acute	NN	O	O
depressive	JJ	O	O
NF-Y	NNP	B-protein	B-protein
illness	NN	O	O
does	VBZ	O	O
IL-2	CD	B-DNA	B-DNA
gene	NN	I-DNA	I-DNA
not	RB	O	O
persist	NN	O	O
Mono	NNP	B-cell_line	B-cell_line
Mac	NNP	I-cell_line	I-cell_line
6	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
on	IN	O	O
recovery	NN	O	O
Natural	NNP	B-cell_type	B-cell_type
Killer	NNP	I-cell_type	I-cell_type
cells	NNS	I-cell_type	I-cell_type
and	CC	O	O
is	VBZ	O	O
PC4	CD	B-protein	B-protein
","		O	O
therefore	RB	O	O
major	JJ	B-DNA	B-DNA
histocompatibility	NN	I-DNA	I-DNA
complex	NN	I-DNA	I-DNA
(	(	I-DNA	I-DNA
MHC	NNP	I-DNA	I-DNA
)	)	I-DNA	I-DNA
region	NN	I-DNA	I-DNA
","		O	O
state-dependent	JJ	O	O
Mono	NNP	B-cell_line	B-cell_line
Mac	NNP	I-cell_line	I-cell_line
6	CD	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
.	.	O	O
Identification	NN	O	O
lymphocyte	NN	B-cell_type	B-cell_type
and	CC	O	O
purification	NN	O	O
NF-Y	NNP	B-protein	B-protein
of	IN	O	O
a	DT	O	O
genome	NN	B-DNA	B-DNA
(	(	O	O
)	)	O	O
T	NNP	B-cell_line	B-cell_line
cell	NN	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
that	IN	O	O
activates	NNS	O	O
normal	JJ	B-cell_type	B-cell_type
and	CC	I-cell_type	O
leukaemic	JJ	I-cell_type	I-cell_type
peripheral	JJ	I-cell_type	I-cell_type
leucocytes	NNS	I-cell_type	I-cell_type
transcription	NN	O	O
of	IN	O	O
C-terminal	JJ	B-protein	B-protein
region	NN	I-protein	I-protein
an	DT	O	O
in	IN	O	O
MHC	NNP	B-DNA	B-DNA
genomic	JJ	I-DNA	I-DNA
region	NN	I-DNA	I-DNA
vitro	NN	O	O
.	.	O	O
T-cell	NNP	B-cell_line	B-cell_line
lines	NNS	I-cell_line	I-cell_line
The	DT	O	O
octamer	NN	O	O
leukaemic	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
sequence	NN	O	O
5'-ATGCAAAT	JJ	O	O
PC4	CD	B-protein	B-protein
","		O	O
in	IN	O	O
pericentromeric	JJ	B-DNA	B-DNA
heterochromatin	NN	I-DNA	I-DNA
either	DT	O	O
orientation	NN	O	O
SupT1	CD	B-cell_line	B-cell_line
T-cell	NNP	I-cell_line	I-cell_line
line	NN	I-cell_line	I-cell_line
","		O	O
serves	NNS	O	O
leukaemic	JJ	B-cell_type	B-cell_type
cells	NNS	I-cell_type	I-cell_type
as	IN	O	O
an	DT	O	O
subunit	NN	B-protein	B-protein
interaction	NN	I-protein	I-protein
subdomain	NN	I-protein	I-protein
in	IN	O	O
a	DT	O	O
lymphocyte-specific	JJ	B-DNA	B-DNA
TdT	NNP	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
variety	NN	O	O
of	IN	O	O
CD3/CD28-costimulated	CD28-costimulated	B-cell_line	B-cell_line
Jurkat	NNP	I-cell_line	I-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
and	CC	O	O
also	RB	O	O
NK	NNP	B-cell_type	B-cell_type
cell	NN	I-cell_type	I-cell_type
occurs	NNS	O	O
as	IN	O	O
highly	RB	B-protein	O
conserved	VBN	I-protein	O
DNA	NN	I-protein	I-protein
binding-subunit	NN	I-protein	I-protein
interaction	NN	I-protein	I-protein
domain	NN	I-protein	I-protein
a	DT	O	O
.	.	O	O
integrated	VBN	B-DNA	O
TdT	NNP	I-DNA	I-DNA
promoter	NN	I-DNA	I-DNA
It	PRP	O	O
is	VBZ	O	O
Jurkat	NNP	B-cell_line	B-cell_line
T	NNP	I-cell_line	I-cell_line
cells	NNS	I-cell_line	I-cell_line
of	IN	O	O
particular	JJ	O	O
lymphoid	NN	B-cell_type	B-cell_type
cell	NN	I-cell_type	I-cell_type
interest	NN	O	O
in	IN	O	O
DBD	NNP	B-protein	B-protein
since	IN	O	O
it	PRP	O	O
TdT	NNP	B-DNA	B-DNA
promoter	NN	I-DNA	I-DNA
is	VBZ	O	O
found	VBN	O	O
			O
